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ABSTRACT
Each year approximately 26,000 British women develop breast cancer and
16,000 die from their disease. Breast cancer is the most common cancer in
women in the United Kingdom. Previously, most studies have focused on
the needs of women following surgery for the treatment of primary breast
cancer. However, few systematic studies have monitored the needs of
women with metastatic disease. The median survival of women with
metastatic breast cancer is 19 months and therefore it would seem
appropriate to monitor the rehabilitation needs of these women.
This study examines the physical, psychological, and social rehabilitation
needs of a consecutive series of 80 patients following definitive diagnosis
of metastatic breast cancer. These patients were interviewed every eight
weeks at home on eight separate occasions and were asked to complete the
following standardised questionnaires: The Cancer Rehabilitation
Evaluation System (CARES); The Hospital Anxiety and Depression Scale
(HAD); and The Rotterdam Symptom Checklist (RSCL). In addition, the
researcher completed an interview schedule to detail demographic details,
current treatment, and which members of the medical team the patient
had seen in the previous month. The researcher also completed the
Edinburgh Rehabilitation Status Scale (ERSS) which gives a total score of
disability.
The results of the descriptive component demonstrated that patients had a
range of different rehabilitation needs throughout the course of their
illness as defined by the CARES and the ERSS. These needs do not change
throughout the course of the metastatic phase of the disease but detection
of these problems is extremely low and, as a result, referral to appropriate
services does not usually occur. Demographic factors such as age, marital
status, social class, and number and age of children were not found to be
associated with rehabilitation status. A significant problem in this group of
patients was found to be that of mood disturbance and a complex inter¬
relationship was found to exist between rehabilitation status, age, physical
symptomatology and mood using multiple stepwise regression analyses
and factor analysis.
In addition, a small pilot intervention study was carried out to evaluate a
method of detecting and referring patients with rehabilitation needs
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through the intervention of a "rehabilitation co-ordinator". Seventeen
consecutive patients were recruited to this pilot study and were
randomised to either the "intervention" (n-10) or "control" group (n=7).
Patients were interviewed on four occasions using the same standardised
questionnaires as those in the main descriptive study, and the results
demonstrated that there were no significant differences between the two
groups in terms of the following: rehabilitation status; mood; physical
symptomatology; and contact with multidisciplinary team members.
However, patients in the intervention group displayed high levels of
satisfaction with the rehabilitation co-ordinator service perceiving it as
having improved their quality of life.
The results of both studies are discussed in the context of previous
research and future research directions are examined. The role of the
"rehabilitation co-ordinator" in cancer care is discussed and
recommendations are made regarding further evaluation and
implementation of this concept.
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EPIDEMIOLOGYAND TREATMENT OF CANCER OF THE BREAST
Introduction
Breast cancer, like any disease, consists of various stages: diagnosis,
primary treatment, adjuvant treatment, recurrence and palliation. In
order to understand the rehabilitation needs of women with metastatic
breast cancer, it is necessary to understand the epidemiology and
treatment of cancer of the breast as patients may have previously had
many types of treatment which may have lasted many months. This
Chapter will therefore outline the epidemiology and treatment for cancer
of the breast.
DESCRIPTIVE EPIDEMIOLOGY
Breast cancer is the commonest malignant tumour affecting women in
the U.K., with approximately 26,000 women being diagnosed each year and
16,000 women dying from it [Cancer Research Campaign, 1991]. In the U.K.
it is estimated that 1 out of 12 women will develop breast cancer in her
lifetime [Cancer Research Campaign, 1991]. The median age of the patients
with breast cancer is 55 with about one third of all cases appearing before
50. Recently however there appears to be an increasing number of cases
among young women in their 20's and 30's [Khafif, 1986]. Breast cancer
accounts for 19 per cent of all new cases of female cancer, whereas breast
cancer in men is a rare cancer with approximately 175 cases and 90 deaths
occurring annually in the U.K. [Cancer Research Campaign, 1991].
World-wide, it was estimated by Parkin et al [1988] that in 1980 over half a
million women were first diagnosed as having breast cancer. The
implications of these facts are clear in that breast cancer poses an
important public health concern. Considerable world-wide attention has
been focused in attempting to discern trends in the epidemiology of breast
cancer. In a review of the literature regarding the descriptive
epidemiology of breast cancer Boyle [1988] writes:
"different populations throughout the world experience
different levels of breast cancer and these levels change with
1
time. Within countries, breast cancer rates vary among racial
groups, by socio-economic status, among religious groups
When migration takes place, groups of migrants tend to acquire
the breast cancer pattern of their new home For reasons such
as these, it is believed that environmental factors, rather than
genetic factors, are of paramount importance in the aetiology of
breast cancer: 'environment' being defined in its broadest sense
to include a wide range of factors such as dietary, social and
cultural practices."[Boyle, 1988, p 21]
ANALYTICAL EPIDEMIOLOGY
As a result of the structure and function of the human breast, it is evident
that there is a close link between ovarian function and production of
breast growth: at puberty ovarian secretion of oestrogen and progesterone
stimulates growth of the breast. This link has also led to the hypothesis
that there is a link between tumour growth in breast cancer and hormone
activity. Therefore many studies have focused on related factors e.g.
menarche, menopause, and childbirth where there is alteration of
hormonal balance. In addition, studies have been conducted monitoring
the effects of oral contraceptives and hormone therapy.
This section will accordingly be sub-divided to deal with each of the above,
(a) The relation of age at menarche and breast cancer.
The findings of studies monitoring the potential relationship between age
at menarche and incidence of breast cancer vary considerably. It has been
reported [Bucalossi and Veronesi, 1959; Henderson et al, 1974; Herity et al,
1975] that age at menarche was slightly younger in breast cancer patients
compared with a control group.
However this relationship has been shown not to be significant in other
studies. Interestingly all studies referred to above were retrospective
studies which could account for the apparently contradictory findings. In
more recent prospective studies [Tulinius et al, 1978] the findings
supported the relationship between early age at menarche and incidence
of breast cancer.
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(b) Age at first full-term pregnancy.
MacMahon et al [1970] supported the view that there is an inverse
relationship between parity and the risk of breast cancer. In addition, it
was shown that the age of first full term pregnancy relates to the risk of
breast cancer. The protective role of parity however is only apparent in
those women who give birth before the age of 32.
(c) Menopause.
It has clearly been demonstrated that a late age at menopause is associated
with increased incidence of breast cancer. The risk factor can be set out as
follows:
"risk of 1.00 in group with menopause 45-55 years
risk of 0.73 in group with menopause before 45 years
risk of 1.48 in group with menopause over 55 years."
[Trichopoulous et al 1972, p 609].
In addition artificial menopause as a result of oophrectomy reduces the
risk of breast cancer.
(d) Use of contraceptive pill.
Theoretically it would be possible that prolonged use of oestrogens and
progesterones may increase the risk of breast cancer. Many studies have
been conducted to see whether this is the case. However, to date, the
results of this research are inconclusive.
(e) Other factors related to breast cancer.
De Waard et al [1977] investigated the correlation between weight and the
risk of breast cancer. They found that there is a correlation between
increased risk of breast cancer with overweight people. However, it was
unclear from this and other studies whether this was due to body fat or
weight per se. Studies of rodents fed on a high fat diet has shown that they
have an increased risk of breast cancer. However this has not been
demonstrated conclusively with humans.
Family history of breast cancer is also relevant. Women with a female
relative who has had breast cancer have a risk two to three times that of
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the general population. Other studies have shown that the risk is greatest
for women with a first-degree relative with bilateral or premenopausal
breast cancer [Cady 1970; Anderson 1977].
Conclusion
The main factors related epidemiologically to breast cancer appear to relate
to menstrual and reproductive history. It has to be noted however that
these are factors related to breast cancer but the actual cause of breast
cancer, and hence prevention, is as yet unknown [Denton, 1989].
PATHOLOGICAL VARIETIES OF BREAST CANCER
The most commonly adopted histological classification of breast cancer is
that of the World Health Organisation [1981]. According to this, malignant
epithelial tumours are made up of three types: a/ non-invasive tumours;
b/ invasive tumours of several types; c/ Paget's disease of the nipple. The
majority of breast cancers are invasive ductal carcinomas followed by
invasive lobular carcinomas.
The significance of histopathological findings is emphasised by many
research studies. For example, Silverberg and Chitale [1973] suggested that
tumours with a large intraductal component have a better prognosis. A
retrospective study conducted by Rilke et al [1978] revealed that the vast
majority of cases of cancer of the breast (80 per cent) fall into the group
with the worst prognosis. For example the 30 year survival rate of patients
with invasive lobular and ductal carcinoma was reported to be 34 per cent
and 29 per cent respectively. However, the 30 year survival rate for
patients with the more rare papillary carcinoma was 65 per cent.
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PRE-OPERATIVE ASSESSMENT OF BREAST CANCER
Patients most commonly present with a lump in the breast [McKinna,
1983]. Traditionally patients with a breast lump either had a frozen section
of a sample obtained through open biopsy and mastectomy immediately
followed in the same operation if cancer was confirmed, or alternatively
patients underwent excisional biopsy followed several days later by
mastectomy if cancer was diagnosed. Nowadays, the more standard
preoperative procedure to confirm cancer is mammography, ultrasound
and fine needle aspiration cytology of the breast lump and, if there is
suspected node involvement, the node will be aspirated for cytological
investigation. Malberger et al [1981] demonstrated that this approach
greatly increases the accuracy of diagnosis.
In addition, patients are clinically staged following definitive diagnosis of
cancer of the breast. The system of staging which has been widely adopted
is the TNM (Tumour Node Metastases) staging system. This system was
developed over 35 years ago and the rules governing this system have
been clearly set out in a handbook published by the Union Internationale
Contre le Cancer [UICC, 1978]. This system of staging has replaced the
system formerly used which was the Manchester classification. Both of
these are detailed below:
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Fieure 1: Staging systems in breast cancer
Manchester staging system Description
Stage 1 Breast alone involved +/- overlying skin
Stage 2 Breast as for Stage 1 and axillary nodes
involved
Stage 3 Skin invaded, fixed or ulcerated, or
tumour fixed to underlying muscle or
pectoral fascia
Stage 4 Fixed axillary lymphadenopathy,
supraclavicular involvement and/or
distant metastases
TNM Staging Notation for Breast Cancer Description
T1 Tumour less than 2cm in diameter
T2 Tumour 2-5cm in diameter
T3 Tumour >5cm
T4 Tumour of any size with direct extension
to chest wall or skin
NO No palpable lymph node involvement
N1 Mobile ipsilateral nodes
N2 Fixed ipsilateral nodes
N3 Supraclavicular nodes or infraclavicular
nodes or oedema of the arm
MO No distant metastases
Ml Distant metastases
[Souhami and Tobias, 1986, p 229]
The characteristics of the primary tumour, the presence or absence of
axillary lymph node involvement, and the presence or absence of distant
metastases are detailed in these systems of staging. Patients therefore
undergo chest X-rays, a bone scan, a liver ultrasound and various blood
tests to ascertain the stage of the disease. These staging characteristics are
strongly correlated with survival. In addition the hormone receptor status
of the biopsy sample of breast and lymph gland tissue is established
because some breast cancer cells have receptors for oestrogen and other
hormones. The tumour is then classified as oestrogen receptor (ER)
positive or negative. Evidence suggests that tumours which are ER
positive are more likely to respond to hormone treatment, and those
which are ER negative rarely respond. Post menopausal women
commonly are ER positive (65 per cent) and only 30 per cent of pre
menopausal women have a positive ER status [Souhami et al 1986].
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SURGICAL MANAGEMENT OF PRIMARY BREAST CANCER
It is only within the last two decades that there is now some debate
surrounding the choice of operation in patients with early breast cancer.
Up until that time the approach to the management of breast cancer was
apparently straightforward: the standard approach involving a radical
mastectomy or in some instances an extended radical mastectomy. The
use of the Halstedian radical mastectomy was based on the hypothesis that
breast cancer can be divided into three distinct stages: (1) a local phase
where the tumour is completely confined to the breast; (2) a phase of
regional extension in which there is involvement of the draining lymph
nodes; (3) and finally a phase where the tumour is widely disseminated.
It seemed, according to this hypothesis, that patients in the first and
second "stage" could be cured by operation. The technique of such
operations was to remove the tumour and the breast tissue which would
be at risk of lymphatic infiltration and removal of the draining lymph
nodes.
However, the hypothesis behind such operative procedures has been
called into question. A new hypothesis suggested by Veronesi et al (1981)
proposes that breast cancer is often systemic even before an initial
diagnosis of breast cancer is made. The implication of such an hypothesis
would be that despite the extensive nature of such surgical techniques as
the Halstedian radical mastectomy they would fail ultimately to control
the disease as by that time the disease was already disseminated. The time
at which overt metastases appeared would be dependent upon the tumour
burden, growth rate and other biological factors.
The choice of surgical treatment for a resectable primary breast cancer
depends on several factors:
(1) the site, size and clinical features of the tumour;
(2) the clinical status of the axillary lymph nodes;
(3) the patient's age and general fitness; and when excisional biopsy has
been performed:
(4) the histological appearance of the sample;
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(5) the oestrogen receptor status and growth rate of the excisional
biopsy sample.
Radical Mastectomy
The classical operation of radical mastectomy was introduced by Halsted in
1894 and was based upon an anatomical approach. It was thought at this
time that lymphatic spread was of prime importance and the radical
mastectomy "ensured" local control by removing the breast and all the
primary lymphatic channels. Thus, in this procedure en bloc dissection of
the whole breast, with division of pectoralis major and minor muscles
and contents of the axilla is carried out. In order to achieve total clearance
a large incision is required and there remains a considerable loss of
contour.
The morbidity associated with radical mastectomy is high causing arm
swelling (lymphoedema), deformity (causing body image problems), and
wound healing problems.
Extended Radical Mastectomy
As a result of findings that other lymph nodes than axillary ones were
frequently involved with tumour it seemed to suggest that not even the
radical mastectomy was extensive enough. Hence an extended radical
mastectomy was introduced in 1949 where additional dissection of the
internal mammary nodes was carried out. However the results of a multi¬
centre prospective study where patients were randomised to undergo
either a radical or extended radical mastectomy failed to demonstrate
significant differences in terms of relapse free interval and overall
survival.
Modified Radical Mastectomy
This procedure which was chiefly ignored in the USA for 20 years has now
replaced the radical mastectomy as the standard operative procedure in
the USA. This procedure leaves the pectoralis major intact but removes
the breast, pectoralis minor and axillary contents.
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Total (simple) Mastectomy
McWhirter (1948) advocated a resection from the clavicle to the costal
margin and from the midline to the latissimus dorsi. The axillary nodes
are not removed in this procedure because McWhirter believed "when
the disease is confined to the breast: (1) dissection of the axilla is
unnecessary; (2) when the tumour has spread to the axillary nodes, radical
mastectomy frequently will fail because occult metastases may be present
in the supraclavicular nodes that are beyond the surgical dissection but
which can be eradicated by radiation therapy; (3) radical mastectomy alone
cannot influence the course of the disease in patients in whom metastases
to the internal mammary nodes might disseminate the disease; and (4)
oedema of the arm would not occur as frequently following the less
radical procedure" [Harris et al 1985, p 1137].
Hence McWhirter advocated total mastectomy combined with post
operative radiotherapy in the treatment of primary breast cancer.
Partial Mastectomy
Mastakallio [1954] advocated simple removal of the tumour and
administering post-operative radiotherapy in cases when there were no
palpable lymph nodes in the axilla and when the primary breast tumour
was no larger than a "hen's egg". This procedure of partial mastectomy is
also referred to as segmental mastectomy, local excision, lumpectomy or
tylectomy.
Wide local excision is a conservative surgical treatment of breast cancer
and involves local excision of the tumour achieving an excisional margin
of 1-2 cm. This procedure can also be accompanied by axillary node
clearance where the nodes have been clinically staged as having tumour
cells present.
In recent years the less radical operations have been widely adopted. Many
clinical research trials have been carried out to evaluate the various
techniques and compare the interval between initial diagnosis and
recurrence (disease-free interval) and survival. However, as a result of the
methodological shortcomings in the early studies many of the results
cannot be compared as often the studies were non-randomised and the
selection criteria were vague. However, a recent National Surgical
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Adjuvant Breast Project (NSABP) Study of 1665 patients followed up for
ten years showed that there is no evidence that a simple mastectomy is
less effective than a Halsted radical mastectomy [Fisher et al, 1977]. In
addition, a study by Veronesi et al [1981] carefully selected patients with
tumours staged as T1N0 and treated them with quadrantectomy and
irradiation. This and other similar studies strongly supported the
argument that segmental resection with irradiation is as effective as total
mastectomy and radical mastectomy.
The important conclusion to be drawn from these studies is that breast
cancer does not undergo a logical pattern of dissemination. Instead it
supports Veronesi's hypothesis that dissemination in the form of distant
micrometastases are present before initial surgery is carried out.
Reconstructive surgery after mastectomy
Nowadays, patients are encouraged to play an active role in the decision¬
making process regarding the treatment adopted. An important issue to
the woman is how she will look after surgery and to this end many
women are offered reconstructive surgery i.e. surgery to attempt to
reconstruct the breast to attain the "normal" contour of the breast. This
surgery may be carried out at the same time as mastectomy, or may be
carried out as a secondary procedure. Breast reconstruction may adopt
silicone implants which are embedded in a myocutaneous flap. This flap
is made up of skin, subcutaneous tissue and muscle and the flap is
transferred or "swung round" on a pedicle to cover the breast. The
myocutaneous flap most commonly used is that of latissimus dorsi. Some
women may be content to have only the contour of the breast achieved.
However in the event of some women wanting "complete" restoration of
the breast they may be offered nipple reconstruction. A recent advance in
breast reconstruction is the use of tissue expanders. During mastectomy an
expander is implanted under the skin on the chest wall. Over many weeks
following surgery a small volume of normal saline solution is injected
through a valve which fills the expander gradually. This procedure
depends on the elasticity of the skin and many patients find the tightness
of the skin caused by the tissue expander uncomfortable. A second
operation is required once symmetry with the other breast has been
achieved in order to remove the tissue expander and insert a silicone
implant. Many patients however decline reconstructive surgery and
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instead choose to use a prosthesis which is contained in the brassiere.
RADIOTHERAPY IN THE PRIMARY MANAGEMENT OF BREAST
CANCER
In 1927 the first patients were treated in Germany adopting tumour
excision followed by radium treatment. In 1939 Peters commenced a
research study to monitor the effectiveness of local excision and
radiotherapy. She matched each patient involved in the study with a
"control" patient who underwent radical mastectomy and included in the
matching was age, and size of primary tumour. In 1977 the results were
published [Peters, 1977] and there was not a statistically significant
difference between the two groups regarding survival and disease-free
interval.
A large randomised study by Veronesi [1981] gave more weight to this
approach. Patients in this study (n=701) had primary breast cancer where
the tumour measured less than 2cm and there were no palpable lymph
nodes. Similar to the findings of Peters study, no difference was found in
terms of local recurrence, overall survival or disease-free interval between
matched patients who had quadrantectomy and radiotherapy or radical
mastectomy.
Many studies have been conducted to monitor the effectiveness of
radiation therapy given as an adjuvant to primary surgery (simple
mastectomy to radical mastectomy). These have shown consistent results
over the last thirty years that irradiation reduces the risk of locoregional
relapse, but has no effect of distant disease free survival. Most importantly
there is no effect on overall survival. When radiotherapy is used in
conjunction with surgery it is not administered until the wound has
healed. The breast, the chest wall and regional lymph nodes are irradiated.
Commonly the dose given is between 40-50Gy given daily over five
weeks. Following this the patient may receive a "booster" dose to the
tumour site and this may be achieved by conventional methods or
through a radioactive implant. These implants consists of fine perspex
tubes which are inserted through the breast at the tumour site. The tubes
are then loaded with radioactive material, commonly irridium. The tubes




The use of chemotherapy has made a major impact on the survival of
patients with testicular cancer, leukaemia and lymphoma. However there
appears to be a degree of controversy regarding the value of adjuvant
chemotherapy in the treatment of breast cancer, particularly when there is
no evidence of active systemic disease [Keane et al, 1990]. The debate
concerns the issue of whether chemotherapy improves survival, or
whether it prolongs the remission free interval, or whether the
advantages are merely the result of ovarian oblation secondary to the use
of cytotoxic agents.
The National Surgical Adjuvant Breast Project (NSABP) carried out
research to monitor the effectiveness of a number of single agent and
combination chemotherapies. To date, 10,000 patients have been included
in this study. The most encouraging results in both disease free intervals
and decreased mortality appeared to be related to those women who were
premenopausal with positive nodes and were treated with adjuvant
melphalan or melphalan with 5 fluorouracil [Harris et al, 1985].
Bonnadonna compared adjuvant CMF (cyclophosphamide, methotrexate
and 5 fluorouracil) with a control group and showed improved survival
in the treated group, and this was most marked in premenopausal women
with more than three axillary nodes involved. Based on the Milan trial
the following conclusions have been argued [Bonnadonna et al, 1985]:
(1) Post menopausal women with Stage 2 breast cancer do not benefit
in terms of overall survival from adjuvant CMF.
(2) Premenopausal women with axillary node involvement benefited
in terms of relapse free survival from adjuvant CMF. The number
of nodes involved in these women was significant. In those
premenopausal women with one to three histologically positive
nodes the relapse free survival was 61 per cent compared with the
control 40 per cent and overall survival 68 per cent compared with
the control 51 per cent. For those patients with four to ten nodes
involved there was a significant improvement in disease free
survival, although this was not the case in overall survival.
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(b) Adjuvant endocrine therapy of breast cancer
Hormonal therapy used as a prophylactic measure in the adjuvant
treatment of primary breast cancer is not new. In 1889 Schinzinger first
proposed it and in 1905 De Courmelles proposed ovarian irradiation as an
alternative to surgical removal of the ovaries. The National Surgical
Adjuvant Breast Project Group [Fisher et al, 1968] commenced a trial of
surgical oophrectomy in 1961 with premenopausal women younger than
50 years. All patients underwent radical mastectomy and were randomised
to one of three post operative treatment groups: oophrectomy; thiotepa; or
a placebo. The results showed that there were no significant differences
between the treatment groups in terms of survival. Oophrectomy is
seldom carried out nowadays in patients with primary cancer of the breast.
This is due to the dubious effectiveness in terms of overall survival. In
addition, alternative endocrine treatments in the form of antioestrogens
have been found to be of use in patients with breast cancer.
(c) Adjuvant Tamoxifen
Despite the poor results yielded from such studies looking at
oophrectomy, many encouraging studies have been carried out looking at
Tamoxifen as adjuvant treatment. Tamoxifen, which is an antioestrogen,
appears to bind to the intracellular oestrogen receptors thereby rendering
the tumour cells less sensitive to the circulating oestrogen [Nicholson _et
al, 1977]. Controlled clinical trials of tamoxifen administered as adjuvant
therapy to women with early breast cancer have convincingly shown that
it prolongs the disease free interval and it reduces the rate of mortality in
the treatment group [Baum et al, 1985].
MANAGEMENT OF METASTATIC CANCER OF THE BREAST
The most common sites for metastatic spread from cancer of the breast are
bone, liver, lung, brain, and skin. It is doubtful whether any patients are
"cured" following diagnosis of metastatic breast cancer. However, it seems
probable that survival is prolonged by the administration of hormone
therapy, endocrine ablation or chemotherapy (or sometimes through a
combination of these). Even neurological symptoms caused by brain
metastases can be alleviated by the administration of radiotherapy. The
prognostic factors of primary advanced local disease were outlined by
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Rubens et al [1977]. He studied 184 women with unresectable Stage 3
cancer who were treated with radiotherapy. Survival was poor (median 25
months) and at five years only 13 per cent were alive. When surgery is a
possibility with Stage III patients five years survival is much improved
[Fracchia et al. 1980].
In metastatic breast disease the type of therapy is a major factor
influencing prognosis. However the most important prognostic factors in
metastatic breast disease are the disease-free interval and the site(s) of the
metastatic disease.
Patients with a very short disease-free interval (i.e. interval between
primary therapy and recurrence) have a very poor prognosis [Fracchia _et
al, 1967; Cutler et al, 1969]. In addition, the site of the metastatic disease
and also number of sites are critical as prognostic factors: "visceral"
patterns of metastatic disease herald a very poor prognosis (liver, lung,
brain, peritoneum and pleura). In addition, patients with multiple sites
have even worse prognosis.
In a study by Cutler et al [1975], the median survival for those with one
site of metastatic disease was 19 months. However, those with four or
more sites of metastases the median survival was six months. The sites of
involvement which carry the poorest prognosis are the liver and central
nervous system.
Oestrogen receptor status (ER) has been correlated with disease-free
interval and survival after primary surgery, tumour histology, tumour
cell kinetics and response to hormone therapy [Fisher et al, 1981]. An
important conclusion emerging from such studies is that tumours which
lack oestrogen receptors are kinetically more aggressive, and those patients
who are ER negative have shorter disease free intervals after surgery and
poorer survival than those patients who are ER positive. There also
appears to be a relationship between the oestrogen receptor status and the
site of recurrence: patients who are ER negative tend to have visceral
recurrences and those who are ER positive tend to have bony metastases.
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[Williams and Buchanan, 1987, pl48]
Medical management of local recurrence is dependent upon whether
there is systemic disease and what type of primary therapy has been given.
Those patients who have local recurrence with distant metastases and
those who have had surgery and irradiation as primary treatment are
generally treated with chemotherapy or hormonal therapy, or sometimes
a combination of both. Sometimes patients who had surgery followed by
radiotherapy may be suitable for further surgery or in the case of local
relapse have additional radiotherapy.
Hormonal Therapy in the Management of Metastatic Breast Cancer
Hormonal manipulation via endocrine therapy has become a standard
initial approach for patients with advanced disease. The hormone receptor
status of patients is crucial in these patients. Those who are oestrogen
receptor positive have the best response rate to hormonal therapy. Other
good indicators suggesting the patient will respond to hormone therapy
are a long tumour-free interval and that they responded previously to
endocrine therapy.
Nowadays ablative therapy is seldom used in advanced or metastatic
cancer because the range and effectiveness of drugs with hormone
blocking activity has increased in recent years. Tamoxifen, which is an
antioestrogen, appears to bind to the intracellular oestrogen receptors
thereby rendering the tumour cells less sensitive to the circulating
oestrogen [Nicholson et al, 1977], Tamoxifen is the treatment which is
commonly used with both pre and post menopausal women. The reason
for this preference is that it causes fewer troublesome side effects and not
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because it is more effective than other treatments.
Chemotherapy of metastatic breast cancer.
As with other therapies adopted as treatment for patients with metastatic
cancer of the breast, cytotoxic chemotherapy does not have a curative
effect. However nearly twice as many patients respond to chemotherapy as
to hormonal treatment. It has been found that combination chemotherapy
such as CMF (cyclophosphamide, methotrexate, and 5 fluorouracil) has a
better response rate than use of single agents [Rubens et al. 1992]. However
the response rates are similar if the single agent is given in higher and
more intensive doses. The optimal duration of chemotherapy is not
known. If there is obvious tumour response or the disease has remained
static after six weeks of chemotherapy, continuation of treatment is
advocated. The combination chemotherapies are most often used in the
U.K. Further research studies are being carried out as there is little
information on the effect of chemotherapy on long term survival. The
side-effects of chemotherapy for the control of metastatic breast cancer
include alopecia, nausea and vomiting, dry mouth, and sweating. Concern
is often expressed about the value of chemotherapy in palliating breast
cancer.
Radiotherapy in Metastatic Breast Cancer
Radiotherapy may be used to palliate the symptoms of metastatic breast
cancer. For example, patients with skeletal metastases can of ten have very
painful symptoms and this can be markedly relieved by administration of
a single dose of radiotherapy. In addition, radiotherapy reduces the risk of
pathological fractures where bony metastases are present. Radiotherapy
can alleviate the severe symptoms caused by collapse of vertebrae affected
by disease, and direct compression of nerves due to tumour growth (e.g.
tumours causing brachial plexus lesions). In all these examples cure is not
a possibility but palliation is the aim of treatment.
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CONCLUSION
This Chapter outlines the epidemiology and treatment of breast cancer. It
is clear from this discussion that the treatment of breast cancer adopts a
wide range of treatment options: surgery; radiotherapy; chemotherapy;
and hormonal therapy. As a direct consequence of this vast range of
treatment options, patients may face a wide range of side-effects from their
treatment which may cause a wide range of rehabilitation problems.
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Chapter Two
REHABILITATION IN CANCER CARE
Introduction
This Chapter outlines the generic definitions of rehabilitation and
disability and reviews the literature on rehabilitation in oncology, co¬
ordination of rehabilitation services and rehabilitation of patients with
breast cancer.
DEFINITION OF REHABILITATION
Rehabilitation has been defined as the "restoration of patients to their
fullest physical, mental and social capability" [Mair, 1972]. The dynamic
process of rehabilitation mirrors the view of the illness as a process which
consists of various stages: abilities and goals are continually changing as a
direct consequence of illness. A recent survey by Martin [1988] found that
one in eight of the population has a disability, therefore the need for
rehabilitation is great. Rehabilitation is most successful when it begins
early and is preceded by and coexists with effective preventative measures.
Prevention of unnecessary loss of function resulting from contractures,
pressure sores, nutritional deficits and other problems often shortens the
period of rehabilitation and maximises outcome.
Rehabilitation for the patient with cardiac disease, spinal injury, following
a stroke, or locomotor problems is recognised as essential, the ultimate
goal being the re-establishment of the patient as a functional individual in
his or her own environment. Rehabilitation, therefore, generally aims to
improve function when a disability has occurred due to illness or injury:
"disability" in the context of health experience being defined as any
restriction or lack of ability to perform an activity in the manner or within
the range considered normal for a human being [Wood, 1975], Although
the rehabilitation team is aware of the specific cause of the disease, their
emphasis is on the nature of the changes in function and requirements for
improving them rather than on the disease itself. Each individual with a
disability needs opportunities for improving and maintaining functional
ability, regardless of the cause of their disability.
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CANCER REHABILITATION
In recent years there has been increasing interest in rehabilitation of the
patient with cancer. There is a considerable amount of literature relating
to cancer rehabilitation, the overwhelming majority of which come from
the United States and have been published during the last fifteen years.
This literature falls roughly into two broad categories.
The first category consists of details of how and why rehabilitation of
patients with cancer should occur, and contains the majority of the
published papers. No data is included in these publications to give weight
to any proposed argument, and therefore these are based on arguments
from persuasion and rely on anecdotal "evidence" as opposed to recorded
data. Not surprisingly therefore, there are a number of questions and
doubts which come to mind when critically evaluating these discussions.
This category will be referred to as the "prescriptive category".
Only a minority of publications adopt a scientific method which has been
represented diagrammatically in a simplified form by Polgar and Thomas
[1991] (see Figure 3) and these form the second category: the "scientific
category".
Figure 3: The Scientific Method [Polgar and Thomas, 1991, p 11]
Observations Hypotheses Theories
PRESCRIPTIVE CATEGORY
Despite the fact that there is a considerable amount of literature subsumed
under this category, it lacks structure and a theoretical orientation. Many
authors have produced papers of a "philosophical" nature which describe
rehabilitation in cancer care or consist of observations derived from a
single case. The result of this approach is a body of papers containing
diverse beliefs and opinions that cover numerous disciplines and which
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necessarily lead to difficulties in making comparisons between them and
identifying a unified approach. However in order to evaluate these
contributions, they can be looked at according to: (a) method and
approaches to cancer rehabilitation; and (b) areas of interest/ concern in
cancer rehabilitation.
a) Method and approaches to rehabilitation of the cancer patient
Goal orientated approach
Dietz has written several papers spanning fifteen years in which he adopts
a goal orientated approach to rehabilitation of the patient with cancer.
Dietz refers to the notion of adaptation:
"Readaptation, defined as accommodation or adjustment to or
adjustment to personal needs for survival and maximum
function, is considered the synonym for rehabilitation.
Rehabilitation should be provided to enhance the quality of
survival, regardless of life expectancy. The objectives are
achievement of maximal physical, psychosocial, emotional, and,
when possible, vocational rehabilitation of patients and
development of training programs for medical and other
personnel involved in such rehabilitation." [Dietz, 1985, p 1501]
This approach to rehabilitation as adaptation avoids the popular
scepticism towards the application of the term "rehabilitation" to the area
of cancer. This appears to many as paradoxical because the traditional view
of cancer is one of despair and hopelessness with imminent death
whereas "rehabilitation" implies cure.
In addition, this view of rehabilitation of patients with cancer retains the
traditional or generic definition of the rehabilitation process which is
designed to maximise a patient's physical, mental, social and vocational
potential . Hence it would appear that there is a transfer of the traditional
model of rehabilitation to the area of oncology. However, despite the
widespread instigation of rehabilitation programmes to other medical
conditions a:
"deep seated fear of cancer has, for a long time, prevented
widespread public understanding of the potential for cure or
long- term survival and rehabilitation."[Dietz, 1980, p 145]
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Dietz adopts a goal orientated method of rehabilitation. These goals are
preventive (when the disability can be predicted), restorative ( when the
patient can be expected only to have minimal or residual handicap),
supportive ( if the patient will have to tolerate ongoing disease or
permanent disability), and palliative (if there is advanced disease and basic
disability cannot be corrected, but where training can aid performance)
[Dietz, 1974].
These goals, Dietz argues, must be "appropriate and obtainable toward
which treatment is directed" and " the goal for each patient is determined
by an aggregate of factors relevant to the individual" (age, type and stage of
neoplastic disease, other concomitant disease, inherent physical ability,
social background, basic education and job or work experience) [Dietz,
1985, pl502]. Dietz does give some practical guidelines to apply these
concepts by arguing that a rehabilitation programme for each cancer
patient should be implemented as soon as possible and not wait until
definitive treatment has been completed, by which time disability may not
be remediable.
Multidisciplinary Team
Dietz maintains that a multidisciplinary team approach to rehabilitation
of the patient with cancer is the best way to provide maximum help. The
members of the team include the patient's physician or surgeon, the
nurses, therapists and ancillary personnel.
Interestingly this list of members of the rehabilitation team does not
include the patient and his/her relatives. Kudsk and Hoffman [1987] argue
that the most important members of the team are the patient and his/her
family. They must be included and involved with all aspects of the
rehabilitation programme including identification of needs, goal setting
and determining the treatment and techniques. The inclusion of the
patients and his/her family in the rehabilitation team is very much in
keeping with the current view that only the patient can properly evaluate
his/her quality of life [Slevin, et al., 1988]. Dudas and Carlson [1988] make
the same point by making reference to the fact that the desirable aim in
rehabilitation of the patient with cancer is that there exist mutual
agreement within the multidisciplinary team which must include that
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patient and his/her family. This agreement concerns both long and short
term goals. In order to achieve the appropriateness of the goals:
" the involvement of the patient and family in the development
of these goals will enable them to verbalize the patterns of
activity that are most important for them to maintain or
restore Otherwise, time may be wasted teaching patients to
perform activities that are little significance to them." [Dudas
and Carlson, 1988 p 185]
Therefore it would seem an appropriate inclusion of the patient and
his/her relatives to the rehabilitation team. This, perhaps, would be one
way of achieving "appropriate" rehabilitation goals.
Habeck and colleagues [1984] on the basis of a review of the literature and a
single case study offer seven principles of cancer rehabilitation, which
embody some of the principles already mentioned.
"1. Comprehensive care is provided to address the needs of the
whole person - each person's life possesses a unique blend of
psychological, social, vocational, economic and physical factors.
2. A team approach is used to achieve co-ordinated
interdisciplinary care.
3. Goals for rehabilitation are derived from the effects of medical
problems in accordance with prognostic expectations.
4. Education is a major component of the rehabilitation process.
5. Intervention occurs as soon as the likelihood of disability is
anticipated.
6. The unit of care includes both the patient and the family.
7. Rehabilitation needs must be reassessed on a continuing basis
and met throughout all phases of care." [Habeck et al, 1984, pp
317-318]
These principles make common sense and Habeck's reference to a case
study makes the points more clear as to how these principles can be
transferred into practice.
One criticism which can be levelled at this type of approach however, is
that it lacks scientific evaluation. If these principles are to stand as the gold
standard for effecting comprehensive rehabilitation of patients with
cancer it must be tested against some other method. It is only through this
22
testing that rehabilitation in cancer care can avoid the anecdotal or
idiosyncratic tendencies which have plagued the development of the
paramedical "sciences".
b) Areas of interest/ concern in cancer rehabilitation
Barriers to cancer rehabilitation
Cancer is not just one disease; instead it is an "umbrella" term
manifesting itself in many varied ways depending on the nature of the
neoplasm and the specific site involved. As a result, both the cancer itself
and the particular therapy adopted can produce significant and diversified
long term and permanent functional restrictions and losses. This can be
the case even in instances of "cure" .
Rehabilitation of the patient with cancer can, however, attempt to redress
the balance, enabling the limitations imposed by the disease and/or
treatment to have a less debilitating effect on overall lifestyle. However,
application of rehabilitative principles is dependent on the attitudes of
both society and health care workers.
Many papers concerning rehabilitation in cancer care make reference to
the effect that the negative or fearful attitudes towards cancer has had on
the implementation of rehabilitation programs in this area [Dietz, 1980;
McAleer and Kluge, 1978; Dudas and Carlson 1988; Kurtzman et al!988l.
Dudas and Carlson [1988] refer to studies on nurses' attitudes towards
cancer patients to support her argument that the attitudes of health care
professionals have contributed to the barriers preventing the instigation
of comprehensive cancer rehabilitation programs. In particular, she
mentions the study by Groszek [1981] where he interviewed 32 randomly
selected registered nurses working on acute medical and surgical wards.
The findings of the study revealed that the nurses perceived cancer as a
terminal disease. In addition when the nurses were presented with
various scenarios of patient situations with either cancer or some other
chronic illness, the cancer patient was identified by the nurses as
terminally ill significantly more often than the patient with other chronic
diseases.
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Dudas also refers to the study by Solodky [1986] where 28 nurses working
on an oncology ward were interviewed. The nurses were asked their
perceptions of cancer patients' prognoses compared with patients with
coronary heart disease. The findings revealed that the nurses held a more
pessimistic view towards the prognosis of patients with cancer compared
with patients with coronary heart disease. Dudas points out, therefore,
that nurses "still express negative stereotypes and pessimism about
patients with cancer despite improved mortality statistics and
advancements in early detection and treatment" [Dudas and Carlson,
1988].
Watson [1986] argues that a rehabilitation philosophy provides a means of
fostering a positive attitude of nurses toward cancer. She writes that
attitudes are closely related to behaviour: a negative attitude manifests
itself typically in avoidance, dislike, discomfort etc. whereas positive
attitude is reflected in the desire to do the best for the object of the attitude,
and to help. Watson refers to the studies detecting nurses' negative
attitude toward caring for cancer patients. However, Watson argues that a
potential solution and a method of attaining a positive attitude is through
the adoption of a rehabilitation approach. The adoption of such an
approach, according to Watson, would provide the means by which the
nurses altered their perception of the patient with cancer: perceiving them
in a more positive light.
Adopting a rehabilitative approach allows the nurse to focus on the
disability encountered by the patient with cancer, instead of being
preoccupied with the "cancer". The rehabilitative role of the nurse
becomes one of reducing the degree to which the disability becomes a
permanent entity or interferes with everyday life, irrespective of how long
that life may be.
Other barriers to successful implementation to rehabilitation programs
which have been mentioned by authors appear to be a direct consequence
of the attitudes toward cancer. For example, Dietz [1978] points out that the
American Cancer Society estimated that 90 per cent of patients trying to
return to work face serious discrimination:
"
Basically, employers and fellow employees fear the cancer
patient, particularly if he has an obvious physical handicap, or
cosmetic deformity some employers fear increasing sickness
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and prolonged sick leave, higher costs for company health and
life insurance and other fringe benefits." [Dietz, 1978, p 27]
Such attitudes persist, despite current knowledge of potential for cure and
control of the disease. Dietz argues that it is the physician's responsibility
to take an active role in attempting to return his/her patient to work. This
can be done through educational programs to personnel directors, but also
through active participation in the legal and insurance agencies to attempt
to change out of date policies.
Allen and colleagues [Allen et al„ 1988] noted that despite over 5 million
persons being alive in the U.S. with a history of cancer (three million of
these considered cured), the state federal rehabilitation closures (case load)
for 1980 revealed that persons with cancer and coronary heart disease
constituted less than 3 per cent of all case closures.
These findings conform with the results of other research studies (Dietz
1981, Goldberg 1977, Goldberg et al. 1980] which suggest that:
"Many persons with life threatening disabilities are not
receiving the rehabilitation services for which they are eligible
under the 1973 Rehabilitation Act When considering the
financial loss to society as well as the loss of human potential the
cost is phenomenal." [Allen et al„ 1988, p 62]
Allen and his colleagues continue to elucidate the current barriers to
rehabilitation for individuals with life threatening disabilities. The
barriers which they examined were: (1) individual's physical condition; (2)
state federal agency policy; (3) employer attitudes; (4) the person's
psychosocial adjustment to the condition; (5) the competence and training
of the rehabilitation professional. According to Allen et al.. the person's
physical condition can be a potential barrier to successful rehabilitation:
"This barrier is deceptive because of the confusion between the
concept of diagnosis and that of physical condition. While
persons with the same diagnosed condition often share similar
symptomatology, it is a critical mistake to make broad
assumptions based exclusively on diagnosis." [Allen et al.. 1988,
pp 62-63]
The other barrier which Allen et al. refer to, which has not been covered
in this literature review, is the person's own psychosocial adjustment to
the disability. This is an important factor in the effective implementation
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of rehabilitation, and one which is rarely mentioned in the other articles
reviewed. The approach adopted by Allen et al. outlines the effect that
advancements in medical treatment have had in increasing functional life
expectancy. Allen et al. argued that an individual's psychosocial
adjustment to disability has a profound effect on the potential for
optimum rehabilitation and quality of life experienced by the individual:
"when adjustment is poor, rehabilitation is impeded, if not completely
thwarted" [Allen et al.. 1988, p 69].
Summary
Many authors have registered their concern for the need of
comprehensive rehabilitation programmes for patients with cancer. The
papers reviewed above concerning the method and approaches to
rehabilitation in cancer care do not rely on a 'scientific' method of
approach. Instead they rely upon arguments from persuasion, anecdotal
'evidence', or observations from a single case study. Despite intuitive
motivation behind these articles, problems arise in attempting to institute
the programmes and methods described because many interpretations can
be bestowed on the views expressed. As a result, authors need to be quite
strict and give specific details as to the method of how these principles are
to be transferred into practice.
However, the papers which surveyed the barriers to comprehensive
rehabilitation did use findings from other studies to support their
particular argument. Therefore, despite, not using data from the author's
own study, they made quite specific reference to 'scientific' studies on e.g.
nurses' perceptions of the prognosis of cancer patients etc. The argument
that there were potential barriers to rehabilitation seemed to be grounded
on 'fact' as opposed to personal opinion.
THE SCIENTIFIC CATEGORY
As mentioned above there are surprisingly few published papers which
adopt a scientific method of approach in rehabilitation . However one
such study which has been adopted as the paradigm example of
quantifying the need for rehabilitation in a population of cancer patients
and specifying the reasons for the lack of appropriate referral to an
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appropriate member of the rehabilitation team is the study by Lehmann
and his colleagues [Lehmann et al.. 1978].
This study is the main reference for the assessment of need for
rehabilitation services in a population of cancer patients. In addition
Lehmann et al. argued that a significant proportion of these patients with
functional limitations could be treated effectively once they were referred
to the appropriate therapist/ specialist.
Lehmann took a sample of 805 cancer patients and they were screened in
order to identify: (1) rehabilitation problems encountered in patients with
cancer at different sites; (2) the need for rehabilitation services; (3) gaps in
the delivery of rehabilitation care.
A major finding of this study, and regularly quoted in papers advocating
the necessity of rehabilitation in continuing cancer care, was that the main
barriers to optimal delivery of rehabilitation care were the lack of
identification of patients problems and/ or the lack of referral to available
services by physicians unfamiliar with the concepts of rehabilitation.
Despite the innovative ideas motivating this study, there are major
methodological shortcomings in both the design and analysis of
Lehmann's study. Lehmann's description of the methodology is unclear.
It would have been helpful, for example, if Lehmann had defined
"rehabilitation " and "rehabilitation problems". The assessment tools
which he adopted were unstandardised questionnaires therefore it is
unclear what was actually measured, and what the reliability and validity
of the tests/scales were. In addition, Lehmann omits to mention when
these assessments occurred because it would have been extremely helpful
for the reader to know if the patients were screened one month after
primary therapy or the stage of the cancer.
Harvey and colleagues [Harvey et al.. 1982] undertook a study to analyse
cancer rehabilitation programs implemented at various facilities
throughout the United States in order to identify key methods of
approach, team composition, program emphasis, evaluation procedures,
and program results. This was achieved by adopting a survey
questionnaire designed to gather information about method of
organisation, makeup of professional treatment teams, program
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emphasis, evaluation methods and results. Further details of these
questionnaires were not included.
These questionnaires were sent to 95 centres, and 54 completed
questionnaires were returned. However, 18 of these were disqualified
because the centre was undertaking a research project of its own or the
questionnaire was incorrectly completed. Therefore, data from 36
respondents were analysed.
The findings of this study appear to support the arguments discussed in
the earlier section described as the 'prescriptive studies': a
multidisciplinary team is implied by comprehensive rehabilitation of the
person with cancer; the team members include oncology/ rehabilitation
medicine specialist; social worker; psychologist; physical therapists;
oncology nurse; occupational therapist. In addition, the service was
delivered in goal/ problem orientated manner.
Contained in the scientific category are studies concerning vocational
rehabilitation. The long term vocational problems which face a cancer
patient can be profound. A person's sense of self-worth and identity are
often strongly associated with their work. Therefore when the ability to
work is affected due to a diagnosis of cancer the consequences are far more
widespread than simply financial.
Many papers concerning rehabilitation of the patient with cancer make
reference to the vocational rehabilitation problems encountered. These
papers [Mellette, 1985; Kutzman, et al., 1988] make reference to studies
concerned specifically with vocational problems encountered by patients
with cancer. Extensive investigations have been carried out by Feldman of
the Californian branch of the American Cancer Society. One study by
Feldman [1976] dealt mainly with the experiences of 92 white collar
workers with cancer of the breast, colo-rectal cancer and head and neck
cancer. These patients had been diagnosed in 1973 and were followed up
in the Cancer Surveillance Program of the University of Southern
California. Feldman found that patients frequently felt that they were
trapped in their job because they were afraid to change their job and
potential risk of losing medical insurance and sick leave entitlement. As a
result the cancer patient may be reluctant to seek promotion or a higher
paying job because of the possibility of employment discrimination, denial
of insurance coverage etc.
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Summary of literature on rehabilitation in cancer care
Cancer is a complex disease: it manifests itself in many forms dependent
on the particular site involved. In addition, there are many types of
treatment which, in themselves, can have dramatic side effects. Studies
suggest that the main barriers to optimal rehabilitation of the patient with
cancer are the lack of identification of patient problems and/ or the lack of
awareness of available rehabilitation services. In addition, the stigma of
cancer persists resulting in the lack of acknowledgement what
rehabilitation has to offer patients with cancer which can cause long-term
vocational and social problems.
The study of the impact of the disease on the patient's rehabilitation status
is compounded by many factors.'
(1) The type of cancer;
(2) The stage of the cancer;
(3) The treatment of the cancer.
Understanding of these three factors is crucial in the design of any study of
patients with cancer. Some of the methodological shortcomings inherent
in such studies of monitoring rehabilitation needs are:
1) Many studies "lump together" patients with cancer as a single group
[Lehman et al., 1978] As a result of treating cancer patients as a
homogeneous » group/ rnany factors such as site of the cancer, stage of the
cancer, treatment of the cancer are not examined and therefore findings
can be superficial or blurred.
The motivation behind a descriptive study of rehabilitation needs would
intuitively be to plan therapeutic intervention. If, however, such factors as
site of cancer, stage, and treatment are overlooked, little or inadequate
information would be provided in order to plan therapeutic intervention.
2) Many studies were conducted on the basis of a single interview with the
cancer patient [Ganz et al., 1987]. As a result, a single ' snap shot' view of
the rehabilitation problems encountered would have been generated.
However, on the basis of such a snap shot view one would not know the
29
duration of any rehabilitation problems- whether permanent or
transitory.
3) Many studies adopt unstandardised questionnaires, the psychometric
properties (validity and reliability) of which were not known.
Therefore the recommendations for methodological approach regarding
studies into rehabilitation needs of the patient with cancer would be:
1) disease specific
2) stage specific
3) need to identify cancer treatment adopted
4) need to adopt standardised questionnaires
5) need to repeat the interview at regular intervals.
CO-ORDINATION OF REHABILITATION SERVICES
It is clear that many areas of functioning are subsumed under the term
"rehabilitation": physical; psychological; sexual; vocational; and social. In
order to address these varied needs, rehabilitation is best addressed
through the combined efforts of the multidisciplinary team. However,
one clear finding of other studies in rehabilitation medicine is the
problem of co-ordination of rehabilitation services. McBride stated that:
"rehabilitation nurses have long been aware that to assist their
clients in maximizing their functional capabilities and
independence, coordination between health care providers and
community resources is essential" [McBride, 1992, p67].
In addition, in oncology, the problem of rehabilitation is complicated
further, as highlighted by Lehmann and his colleagues [1978] who found
that the main barriers to optimal delivery of rehabilitation care in cancer
care were the lack of identification of patients problems and / or the lack of
referral to available services by physicians unfamiliar with the concepts of
rehabilitation.
One possible way of resolving the problems of lack of co-ordination of
services, lack of identification of patient problems, and lack of referral to
available services has been to adopt a "case management approach" or
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"rehabilitation co-ordination". This approach has not been adopted
formally in the oncological setting, but over the last decade has been
adopted primarily in the area of mental health and more recently in
rehabilitation medicine. Case management has been defined by five major
functions: "assessment; planning; advocacy; linkage; and monitoring"
[Chamberlain and Rapp, 1991] and has been used to:
"coordinate services between organizations, within
multiinstitutional organizations, among networks of service
providers, and between professionals on interdisciplinary
teams" [Nettig et al, 1990, pl6].
The case manager has been seen to serve a dual purpose serving as both a
facilitator and a gate-keeper. The case manager fulfils a facilitatory role by
helping the client make informed-decisions about their care taking into
consideration identified needs, abilities and costs. The gate-keeper role of
the case manager ensures that the client is receiving the most appropriate,
timely, and cost-effective care available from both the perspective of the
client and the provider [McBride, 1992]. In addition, the central theme of
case management is co-ordination of service provision:
"the need for case management services is quite evident when it
is realised that an individual client may receive services from a
bewildering array of facilities and professionals" [McBride, 1992,
p69].
A recent study by Davey et al [1992] refers to a "rehabilitation co-ordinator
service". This term is perhaps more appropriate in rehabilitation
medicine because the meaning of the term is more apparent compared
with "case management". Few studies have been carried out, however, to
evaluate rehabilitation co-ordinator services.
Summary of rehabilitation co-ordinator services
Despite rehabilitation co-ordination not being formerly used in oncology,
the rationale for such a service to patients with cancer is clear: improving
detection of rehabilitation problems and referral to appropriate
rehabilitation professionals.
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REHABILITATION OF PATIENTS WITH BREAST CANCER
Introduction
In recent years there has been increasing interest in the psychosocial
sequelae of primary breast cancer and its treatment on women and the
literature in this area is vast (this is discussed separately in Chapter Three).
In stark contrast, however, few studies focus on the rehabilitation needs of
these women. Burdick [1975] argued that "no program concerned with the
management of the patient with breast cancer can today be considered
complete without including a program for effective rehabilitation". Most
authors agree that programs for the rehabilitation of the breast cancer
patient should include the physical, functional, vocational and
psychosocial needs [Burdick, 1975; Knobf 1985; Wingate et al., 1989].
Functional and Physical Rehabilitation Following Surgery in the
Treatment of Primary Breast Cancer
The objective of functional rehabilitation is to "restore normal function to
the homolateral hand, arm and shoulder" [Burdick, 1975]. This goal is
achieved by careful attention to detail during operation (direction of
incisions, wound drainage), immediate post-operative care (elevation of
the homolateral arm following mastectomy), post-operative exercises and
prevention and treatment of lymphoedema.
Post-operative exercises
Historically indications and timing for post-operative exercise and use of
the arm have been at the discretion of the surgeon [Knobf, 1985].
Surprisingly few studies have been carried out monitoring the optimum
timing of post-operative exercises.
A prospective investigation was undertaken by Wingate and colleagues
[1989] to monitor the progress of patients following a modified radical
mastectomy for treatment of breast cancer. The purpose of the study was to
demonstrate that post-operative physical therapy was beneficial to to post-
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mastectomy patients and that it was not associated with prolonged
hospital stay.
The methodology of this study was clearly described. Following biopsy
confirmation of breast cancer those patients who were scheduled to have
modified radical mastectomy were asked to participate in the study.
Following a thorough examination (goniometric measurements of
shoulder range of movement, circumferential measurement of the arm),
completion of the SCL-90-R [Derogatis 1976] patients were randomly
assigned to either: a/ group to receive post-operative physical therapy (n=
61); or b/ group to receive no post-operative physical therapy (n= 54). The
assessment was repeated five days post-operatively, and during the post-
discharge follow up. Details of the physical therapy treatment given post¬
operatively to the intervention group were included in the report.
Data were then compared by group using an independent t-test or Chi
square test where appropriate. Goniometric measurements revealed that
a five days post-operatively a significant difference was found between the
treated and untreated goups. Both groups lost range of movement post
operatively but the mean shoulder abduction and flexion for the treated
group was 129 degrees whereas the untreated group had only 102 degrees
shoulder abduction and 105 degrees shoulder flexion (p<0.001).
Post-discharge follow up goniometric measurements showed that both
groups had improved range of movement, but statistically significant
differences were found between the means for shoulder abduction and
flexion. On the functional items, the treated group showed significantly
better performance on five of the six items than the untreated group. The
authors concluded that early physiotherapeutic intervention made a
significant contribution to the patient's early resumption of pre-operative
functional activities [Wingate et al.. 1989].
A more recent paper by Ganz et al. [1987] overcomes many of the
methodological problems highlighted above. The authors of this study
recognised the importance of specifying the group of cancer patients to be
studied because previously most studies had been undertaken on a
heterogeneous population of cancer patients and the findings of such
studies were difficult to analyse. The aim of the study by Ganz et al. was to
provide comprehensive information about the rehabilitation problems of
breast cancer patients one month after primary therapy.
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The methodology of this study was clear and well documented. A group of
50 cancer patients who had undergone either a modified radical
mastectomy (n=31) or a segmental mastectomy (n=19) were interviewed
three to five weeks after primary therapy. The sample excluded those with
metastatic disease and those who were non-English speakers. The
procedure of the interview carried out with the patients was clear. The
battery of tests and questionnaires were standardised and the validity and
reliability of these had already been ascertained and documented in other
publications.
The results were indicated that constitutional and physical problems were
the most common problems identified in these newly diagnosed breast
cancer patients one month after surgery. These problems consisted of a
tight chest wall, difficulty in lifting objects, decreased upper limb mobility,
arm weakness, lymphoedema, arm numbness, fatigue, difficulty with
household chores, difficulty with physical activities. There was no
significant difference between the modified radical mastectomy group and
the segmental mastectomy group. Psychological problems formed the next
most important category of rehabilitation problems. These included worry
about recurrence, anxiety, depression, body image problems and sexual
problems related to perceived loss of attractiveness.
Lymphoedema
The incidence of lymphoedema in the arm following treatment for
primary breast cancer (surgery and / or radiotherapy) has been estimated
between 7 to 63 per cent [Britton et al., 1962; Farrow 1966]. However, the
incidence of lymphoedema has decreased with the advent of less radical
surgical interventions and more sophisticated radiotherapy techniques
[Adcock, 1990]. However, data on aetiology, aggravating factors, preventive
measures and management strategies remain pertinent for those patients
who have undergone axillary lymph node dissection. Lymphoedema
represents the most frequent long term side effects of surgery.
Prevention is the ultimate goal because once it manifests itself,
management of the acute problem is followed by prolonged measures to
prevent and control it. Most authors agree of the program for prevention:
avoiding trauma and infection, avoiding strenuous lifting, avoiding
injections and blood transfusions in the homolateral arm [Burdick, 1975;
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Knobf, 1985; Adcock, 1990]. However, there appears to be some debate
concerning the management of lymphoedema. The options include
intermittent compression therapy (Flowtron) [Gray, 1987], multi-layered
compression bandaging [Badger, 1987], manual lymph drainage [Badger
and Twycross, 1988], massage, or compression garments. To date, there is a
lack of randomised control studies to evaluate the relative efficacy of the
various treatment approaches.
Employment and Vocational Rehabilitation Following Diagnosis and
Treatment of Breast Cancer
Few studies have been carried out monitoring the vocational
rehabilitation needs encountered by women with breast cancer. Given the
recent trend for many patients with primary breast cancer to undergo
adjuvant chemotherapy and radiotherapy following surgery, patients
have to make regular outpatient visits to hospital for many months. It
would make sense, therefore, to postulate that patients could incur
problems with their employers. Those studies which have monitored the
vocational rehabilitation needs have used heterogeneous samples of
cancer patients. However, interesting information can be gained from
surveying the results obtained from such studies.
Mellette [1985] pointed out that Feldman's study [1978] of blue collar
workers revealed that 63 per cent of breast cancer patients were working
full-time, 23 per cent working part-time and 64 per cent were working for
their pre-cancer employer. In Mellette's own study 63 per cent of the breast
cancer patients were working outside the home. Concerning the amount
of time lost from work by breast cancer patients, Mellette said:
"of the 58 women reporting, six missed only 2 weeks or less, and
another nine missed three to four weeks. An absence from work
of 6 weeks was the most frequent, with 16 women reporting this
amount. Half of the fifty women missed from six to eight weeks,
and only eight women took off longer periods of time." [Mellete,
1985, p 366 ]
Mellette noted that Feldman's study of blue collar workers [1978] showed
that 59 of the breast cancer respondents had an initial absence from work
of nine weeks or more.
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Mellette's own study [1985] was a non-randomised survey of 100 women
attending a breast cancer workshop, and patients from her own oncology
practice. The results gave information concerning the employment
problems encountered as a result of receiving adjuvant therapy for
treatment of breast cancer. Thirty-eight women out of 98 women had had
adjuvant chemotherapy. Of these, 25 were working, but only nine had
been off work as a result of the chemotherapy. Six women had been off
work two weeks or less, one woman for four weeks, one woman for six
weeks, and one for less than a week. Five women out of the 98 had
received adjuvant radiotherapy, and of these three missed four weeks off
work and the remaining two women did not lose any time off work.
Mellette maintained that women with metastatic breast cancer are more
likely to be able to return to work than those patients with metastatic lung
disease. In her study, Mellette found that of the 38 patients who had
returned to work, 27 patients had active metastatic disease. This contrasted
with Mellette's patients with metastatic lung cancer of whom only 13 of 44
continued working full time.
Summary of literature monitoring rehabilitation needs of women with
breast cancer
Studies monitoring the rehabilitation needs of women with breast cancer
have focused almost exclusively on those women with primary breast
cancer. In addition, these studies have focused on the physical
rehabilitation needs. The results of these studies suggest that women have
a range of physical and psychological problems following surgery for
primary breast cancer. The following Chapter surveys the literature




PSYCHOSOCIAL ISSUES RELATED TO BREAST CANCER
Introduction
The monitoring of psychological response to the treatment for breast
cancer received scant attention before the 1950's. However, since the 1950's
there has been increasing interest in the psychological response to a
diagnosis and treatment for breast cancer following the publication of two
seminal papers by Bard and Sutherland [1955] and Renneker and Cutler
[1952] researching the psychological sequelae of mastectomy. The interest
in psychological response to mastectomy grew and was due partly to the
debate concerning whether patients should be told their diagnosis. To
date, the psychological impact of the diagnosis and treatment of breast
cancer is the most widely studied of any cancer. The reasons for this
interest are that breast cancer is the most common cancer in women; the
breast is intimately associated with sexuality, self esteem and femininity;
that the treatment of breast cancer adopts all three cancer treatment
modalities (surgery, radiotherapy, and chemotherapy). It could be argued
that there is considerable overlap between psychosocial issues and
rehabilitation needs. Hence, this Chapter will review the literature
relating to the psychosocial sequelae of a diagnosis and treatment for
breast cancer.
STUDIES MONITORING THE PSYCHOSOCIAL SEQUELAE OF BREAST
CANCER.
Meyerowitz [1980] in an excellent review of the literature relating to the
psychosocial sequelae of breast cancer and its treatment described three
categories of psychosocial impact: (1) psychological discomfort (anxiety,
depression, anger); (2) changes in life patterns (consequent to physical
discomfort, marital or sexual dysfunction); (3) fears and concerns
(mastectomy and death).
Many studies looking at the psychosocial sequelae of breast cancer and its
treatment attempt to measure these domains by the adoption of
standardised questionnaires/ measures where details on the reliability and
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validity have been established. Indeed, much is owed to the psychologists
working in this area for they are mainly responsible for the development
of the sophisticated and thorough "tools" of measurement. The
development of these measures has meant that studies can be compared
with one another and large multicentre clinical trials can be conducted
enabling the study of large numbers of patients.
In order to gain some insight into the psychosocial sequelae of breast
cancer it is perhaps best to adopt the "process" analogy and look at the
various stages of the illness process.
Screening
It has been argued that screening for breast cancer may have adverse
psychological effects on the basis that an invitation for screening may
make women aware for the first time of their possible susceptibility to
breast cancer. In addition, women who are recalled for investigation
following the discovery of an abnormality on screening may suffer distress
even if further investigations are negative.
Maguire [1982] argued that women who are symptom free and on
attendance for screening are diagnosed as having cancer could find it
especially difficult to adapt to their diagnosis.
A study by Ellman et al [1989] investigated immediate and persistent
psychiatric morbidity in those referred for further investigation because of
an abnormal screening result. These results were compared with women
attending for screening and with women who were being investigated for
breast cancer because of symptoms. The 28 item General Health
Questionnaire (GHQ) [Goldberg, 1978] was used to assess psychiatric
morbidity in 302 women attending for routing breast cancer screening, 300
women attending for further investigation of a positive screening result
and 150 women referred for investigation of breast symptoms. The GHQ-
28 was administered to women at clinic and three months later. The
results indicated that breast cancer screening does not necessarily lead to
any sustained increase in the prevalence of psychiatric morbidity in a
community.
This was a thorough research study with good design and method of a
sizeable sample adopting a standardised questionnaire whose
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psychometric properties were well established. The results supported
findings of a previous by Dean et al [1986] that attendance for screening
does not increase psychiatric morbidity. The three month follow up
interview demonstrated that there were no lasting increase in anxiety or
psychiatric morbidity. This result qualms one of the fears about the
screening programme that the anxiety it causes in women with false
positive results outweighs the benefit of prolongation of life for some
cancer patients [Wright, 1986].
Mastectomy
The literature concerning the psychosocial sequelae of mastectomy for the
treatment of breast cancer is vast. This is due in part to the fact that for
many years mastectomy was the standard operative procedure for breast
cancer. This literature focused mainly on the physical, social and
emotional consequences of the loss of one or both breasts.
Despite the varied approaches and designs adopted in these studies, the
findings were consistent about women's concerns following mastectomy:
(1) threat of fatal disease;
(2) impact of the loss of the breast on body image;
(3) diminished sense of femininity;
(4) decrease in sexual attractiveness;
(5) fears of recurrence.
Numerous studies [Morris and Royle, 1988; Worden and Weismann, 1977;
Maguire et al. 1978] concluded that between 18-25 per cent of women
develop an affective disorder within the first year following mastectomy.
Bloom et al [1987] conducted a large prospective study to compare
psychosocial functioning in four groups of women. The groups were:
(1) Women who had mastectomy for Stage I or II breast cancer (n=145);
(2) Women who had cholecystectomy (n=90);
(3) Women following breast biopsy for benign disease (n=87);
(4) Women who had had no operation in the previous year (n=90).
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These patients were healthy controls.
All the women in the study had no history of significant psychiatric or
other medical illness. The findings demonstrated that the women who
had mastectomy did not experience serious psychiatric sequelae although
they did show higher levels of psychological distress related to social and
interpersonal relationships. At one year patients with Stage I breast cancer
had a "quality of life" equivalent to the unaffected peers. However those
patients with Stage 2 disease who received adjuvant chemotherapy
experienced greater levels of distress for 12 months.
In this country, Maguire has contributed substantially to this body of
knowledge. More recently, Maguire has been concerned with studies
looking at how to improve detection of psychiatric problems in breast
cancer patients. In one such study [Maguire et al, 1980] a controlled trial
was conducted to determine whether counselling by a specialist nurse
prevented the psychiatric morbidity associated with mastectomy and
breast cancer. Patients were randomised to have either counselling by a
specialist nurse (n=75) or the normal care given by the surgical unit
(n=77). The findings were interesting in that counselling failed to prevent
the occurrence of psychiatric problems. However, the regular monitoring
by the specialist nurse enabled the recognition of psychiatric problems and
the appropriate referral to a psychiatrist. Consequently, 12 to 18 months
later in the "counselled" group levels of psychiatric morbidity were 12 per
cent compared with 39 per cent in the "control" group.
Studies comparing psychological sequelae following mastectomy with
breast conserving procedures.
As mentioned in an earlier chapter, studies by Veronesi [Veronesi et al,
1981] demonstrated no difference in terms of survival or disease free
interval between those patients receiving either mastectomy or wide local
excision and radiotherapy. As a direct consequence surgeons thought they
could offer less mutilating surgery without compromising survival or
disease free interval. In addition, it was commonly thought that because
the operation of wide local excision was less mutilating, consequentially
the psychological distress would be substantially less in those patients
having wide local excision in the treatment of early breast cancer.
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Hence, many studies (at least fifteen) have been conducted to compare the
psychological morbidity associated with mastectomy and wide local
excision for the treatment of early breast cancer.
Fallowfield et al [1986] assessed 101 women with early breast cancer who
were randomised to receive either mastectomy (n=53) or breast
conservation (n=48). Psychiatric morbidity, sexual functioning and social
adjustment were determined post-operatively. Patients were interviewed
at home and the battery of tests were a semistructured interview (which
was tape recorded), the Present State Examination, the Hospital Anxiety
and Depression Scale and the Rotterdam Symptom Checklist.
According to the data yielded on such examination 11 (21 per cent) of the
patients with mastectomy had depressive illness and 14 (26 per cent) were
anxious. Among the breast conservation group 13 (27 per cent) of the
patients had depressive illness and 15 (31 per cent) had an anxiety state.
These figures mean that overall an anxiety state or depressive illness or
both was evident in 17(33 per cent) of the patients with mastectomy and 18
(38 per cent) of those treated by lumpectomy.
These figures challenged the common held belief that the mutilating
surgery involved in mastectomy was mainly responsible for the
psychiatric morbidity found post-operatively. The authors conclude that
this "study suggests that the suppositions that: (a) all women with breast
cancer wish to retain their breast; and (b) that breast conservation prevents
psychiatric morbidity, may well be displaced." [Fallowfield et al, 1986,
pl334]. The authors go on to add that "counselling services should be
provided for all women treated for breast cancer not just those who
undergo mastectomy."
In a more recent study by Fallowfield et al [1990] the objectives were to
assess outside a clinical trial the psychological outcome of different
treatment policies in women with early breast cancer who had either
mastectomy or breast conservation treatment depending on either the
surgeon's opinion or the patient's choice. The second objective was to
determine the psychiatric morbidity in women undergoing breast
conservation was due in part to their participation in a randomised
clinical trial.
This was an extremely thorough research study with large sample size
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(n=269). Anxiety and depression were assessed using standardise d tools of
measurement and were administered at two weeks, three months and one
year post-operatively.
The incidence of anxiety and depression and sexual dysfunction were high
in all treatment groups. There were no significant differences in the
incidences of anxiety and depression between women who underwent
mastectomy or breast conservation. Interestingly, there was a significant
effect of surgeon type on the incidence of depression observed: patients
treated by surgeons who offered a choice showed less depression that those
treated by other surgeons.
The authors conclude that there
"is still no evidence that women with early breast cancer who
undergo breast conservation surgery have less psychiatric
morbidity after treatment that those who undergo
mastectomy"[Fallowfield et al, 1990, p 580].
Hall and Fallowfield [1989] in a thorough review of these studies looking
at psychological outcome found that when psychological morbidity was
thoroughly investigated in the two groups (mastectomy and breast
conservation) using standardised and validated measures in a sizeable
sample of women, there was no significant difference in the number of
women who were anxious and/or depressed in the two groups. The
conclusion of this review was that a significant minority of women with
early stage breast cancer (approximately 35 per cent) develop moderate to
severe anxiety and/ or depression following treatment irrespective of what
surgical treatment was adopted. Hall and Fallowfield found that in those
studies which included details on body image, patients who had breast
conservation had fewer problems related to body image.
One of the disadvantages of the wide local excision technique and
radiation is the demand in terms of time: many patients will have had the
operative procedure and then, once the scar has healed, have to attend the
radiotherapy department as an outpatient on a daily basis for four to five
weeks. In addition, some women may also have to return to hospital on
an in-patient basis in order to have an irridium implant inserted. This
technique has already been mentioned in a previous chapter. However, it
should be noted that the patient has to put up with the physical
discomfort of the implant, the psychological distress that that may cause
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and the further psychological distress caused by isolation because each
patient who has the implant can have only "limited access" because of the
risk of irradiation to medical staff and friends. In addition, the
reassurances of medical staff that these implants are given in order to
"clear up any remaining cancer cells" may not act as reassurance, but
instead fuel fears that the patient may have that the disease has not been
totally removed/ treated.
The picture of psychological distress may be further complicated when the
patient is pre-menopausal. There is a policy in some cancer centres to treat
pre-menopausal women with adjuvant chemotherapy following breast
conservation treatment and radiotherapy. Therefore these women face an
even greater treatment time because often these courses of chemotherapy
can take up to six months to complete .
These facts can perhaps demonstrate the demands in terms of
psychological coping in patients who have breast conservation treatment
in early breast cancer and therefore can attempt to explain their apparently
high levels of psychological morbidity.
Some researchers have maintained that the counterintuitive findings of
equal levels of morbidity in both the mastectomy patients and
conservation patients result from the fact that the data is contaminated by
patients not being randomised to either treatment: some patients had
chosen to have either a mastectomy or breast conservation. The
hypothesis underlying this challenge was that if women were allowed to
choose their operation they would not suffer psychological distress.
Choice of surgery: psychosocial sequelae
There has been considerable debate concerning the issue of choice of
surgical procedure and levels of anxiety and/or depression. The rationale
underlying this debate is that if women were allowed to play an active role
in the decision-making process concerning the operative procedure for
treatment for early breast cancer, they would demonstrate lower levels of
distress (anxiety and/or depression) post-operatively. Hence, many studies
have been conducted in order to determine the accuracy of this
assumption.
Morris and Royle [1988] studied prospectively 30 patients with early breast
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cancer to assess whether being offered a choice of surgery (simple
mastectomy or wide local excision and radiotherapy) influenced the levels
of anxiety and depression pre and post-operatively. The 30 patients were
split into two groups who were matched for stage of disease and age: those
offered a choice of surgery and those offered no choice. The latter group
arose from the fact that they had centrally located tumours and the policy
at the study hospital was at that time to perform mastectomy on such
patients.
The first group, where a choice was given consisted of 20 patients. Seven
patients chose mastectomy and 13 chose wide local excision and
radiotherapy. The second group consisted of ten patients who underwent
mastectomy. Two groups of patients acted as controls: 31 patients with
benign breast disease who did not have surgery; 20 patients who had
surgery for varicose veins or gall stones.
Levels of depression and anxiety were assessed using the Hospital Anxiety
and Depression Scale (HAD), self esteem was measured using the
Rosenberg Scale and symptoms were assessed using the Rotterdam
Symptom Checklist. A semi-structured interview was also carried out to
monitor the effect of breast cancer on social and work activities and
marital relationships.
However only data from the HAD was analysed in this study. Husbands
were also given the questionnaires to complete. Patients were seen one
day before surgery and thereafter at 2-3 month intervals for a total of 10-12
months. The results demonstrated that there was a marked difference in
psychological adjustment between those patients offered a choice of
surgery and those not given any choice. Those patients (and husbands)
offered a choice suffered less anxiety and depression than those not offered
a choice. The authors suggest that:
"offering a choice of surgery does not appear to be doing any
harm to patients and may in fact be reducing the levels of
anxiety and depression commonly observed in breast cancer
patients" [Morris and Royle, 1988, p 585].
The obvious criticism which can be levelled at this study is the size of the
sample (30 patients: 20 patients offered a choice and 10 patients offered no
choice). In addition the phrase "offering patients a choice of surgery "
requires considerable qualification: how exactly were patients offered a
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choice? How was this manoeuvre standardised in order to avoid bias etc.
Extreme care has to be used in such studies addressing the issues of
decision-making and autonomy. However it remains that this study lends
some weight to the argument that choice of surgery reduces levels of
anxiety and depression .
However, a study by Levy et al [1989] arrived at a completely different
conclusion: when patients were offered a choice, patients were
psychologically worse-off compared with patients not given a choice. All
women in the study had Stage I or Stage II breast cancer. Two groups of
patients were interviewed in this study: 93 patients who were randomised
to excisional biopsy (wide local excision) and radiotherapy or mastectomy;
98 patients, 70 per cent of whom elected to have breast conservation
therapy (wide local excision and radiotherapy). All patients were
interviewed three to five days post-operatively and 3 months later using a
well validated mood measure, the Profile of Mood State, Karnofsky
ratings were carried out by independent observers on all patients. The two
groups were identical at the three month follow-up interview using the
Karnofsky rating. However, those patients in the first group who were
randomised to treatment i.e. not given any choice, demonstrated
decreased levels of distress over time irrespective of treatment
(mastectomy or wide local excision and radiotherapy). The second group
where choice was offered and 70 per cent opted to have wide local excision
and radiotherapy demonstrated significantly higher levels of distress over
time and were generally more depressed.
The design of this study was well thought out with good sample size, all
patients had similar stage of breast cancer, the researchers adopted
standardised tools of measurement and interviewed the patients on two
occasions. The statistical analysis was sophisticated. The researchers
concluded that "the assumption that a woman is psychologically better off
opting for breast conservation may need to be re-examined" [Levy et al ,
1989].
An interesting development of this study would be to interview these
women over a five year interval to measure mood state. The findings
would be particularly interesting in those women whose breast cancer
recurred and test out the hypothesis that women who chose wide local
excision and radiation suffered higher levels of distress compared with
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women who had no choice regarding surgery.
Psychosocial sequelae related to chemotherapy
It is well known that chemotherapy can cause significant side effects. The
most common side effects are nausea and vomiting but also include
alopecia, fatigue, anorexia, peripheral neuropathies, diarrhoea and sexual
problems [Penman et al, 1984]. The side effects vary widely depending on
the type of chemotherapy (whether single agent or combination), the dose
given, the number of cycles of treatment and whether chemotherapy is
given in combination with radiotherapy.
Chemotherapy for breast cancer is usually given in combination form -
cyclophosphamide, methotrexate, and fluorouracil with or without
prednisone (CMF/P) or cyclophosphamide, doxorubicin with or without
fluorouracil (AC/CAF).
An early study by Maguire et al [1980] cast doubt on claims that "adjuvant
chemotherapy causes little toxicity and psychiatric morbidity in patients
with breast cancer." Comparisons were made to find out the psychiatric
morbidity in women having CMF (n=26), melphalan alone (n=15), and no
chemotherapy following mastectomy (n=18) using the Present State
Examination shortly after surgery and three months and 12 to 18 months
later. In addition, the interviewers used a four point scale to rate any
physical toxicity. Though the sample was small, the findings seemed to
confirm a high level of psychiatric morbidity in patients given CMF and
suggested that it w as linked to physical toxicity.
Meyerowitz and colleagues [1983] interviewed 35 women who had
received CMF chemotherapy after surgery for Stage II breast cancer 21
months after treatment. All patients had earlier completed a similar
interview when undergoing chemotherapy and the results could
therefore be compared. This comparison indicated significant
improvement in levels of psychosocial functioning in 4 or 5 "life areas"
(marital/family relationships, sexual relationships (behavioural ratings),
sexual relationships (emotional ratings), financial situation, general
activity level, work related activity level). However patients did report
continuing disruption in their level of general activity. 44 per cent of
patients reported long term disruption in at least one "life area" and 56 per
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cent described continuing physical problems related to chemotherapy.
Despite these problems, however, 89 per cent said they would recommend
a close friend that she hypothetically have the treatment if found to have
breast cancer.
Love et al [1989] monitored side effects of chemotherapy, patient distress
and patient-practitioner communication in 238 patients having
chemotherapy for breast cancer (n=167) or malignant lymphoma (n=71).
Patients were interviewed at five points during their first six cycles of
chemotherapy using semistructured interviews; a subscale of these
patients kept brief symptom diaries. 80 per cent of patients experienced
nausea, alopecia, and tiredness. By the sixth cycle, 46 per cent of patients
had thoughts of giving up chemotherapy. Ratings of objective difficulty
with treatment increased over time. This difficulty could be predicted by
the experience of side effects, type of chemotherapy. The number of side
effects was the best predictor of objective difficulty with treatment. In
contrast, emotional distress was less sensitive to the directly assessable
characteristics of treatment. Doctor-patient communication was found to
be in adequate in a number of respects.
The psychosocial sequelae of reconstruction
An increasing number of women will choose or are offered breast
reconstruction following mastectomy. However, it is estimated that in
percentage terms fewer than 10 per cent of women undergoing
mastectomy have reconstruction.
Schain et al [1984] argued that there are five main areas of psychosocial
issues in breast reconstruction: informational; economic; medical;
intrapsychic or self determined needs; and interpersonal or other-
determined needs.
Women's response to reconstruction following mastectomy was studied
at Memorial Sloan Kettering Hospital [Jacobs et al. 1983] in a collaborative
study by psychiatrists and plastic surgeons. 150 women seeking
reconstruction were assessed in terms of psychological state and surgical
opinion as to the suitability for reconstruction. 117 were offered
reconstruction and 83 women were assessed post-operatively. At pre¬
operative assessment the women were generally well informed and the
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reason most often cited for opting for reconstruction was "to feel whole
again" and to be rid of the prosthesis. Post-surgical interviews
demonstrated that 83 per cent of women were happy (or delighted) with
the result. The net effect of surgery was to increase both observed and
stated levels of psychological, social and sexual functioning. Indeed the
development of more successful and sophisticated implantation
techniques may play an important part in rehabilitation the patient
following mastectomy.
Dean et al [1983] compared patients who were randomised to have either
mastectomy and immediate reconstruction or mastectomy alone. Patients
were interviewed using the General Health Questionnaire (GHQ) three
months post-surgery and significantly fewer (7 per cent) of the breast
implant group had signs of psychiatric morbidity than those women
without an implant of whom 36 per cent were experiencing psychiatric
problems. However, sexual dysfunction was apparent in both groups.
The Psychosocial Sequleae of Recurrent and Metastatic Disease
It would seem likely that the psychological impact of diagnosis of
recurrent disease would be immense given the hopes and expectations
invested in the initial treatment. Many years may have elapsed since the
initial diagnosis and this may have enabled the women to become
hopeful that the disease had been cured and would not return.
Compared with the number of studies looking at the psychosocial
sequelae of a diagnosis and treatment of early breast cancer, there is
surprisingly little research monitoring the psychosocial sequelae of
recurrent or metastatic breast disease.
Despite, for example, some researchers stating that recurrence causes even
more emotional distress than initial diagnosis [Holland, 1977], there have
been few studies which systematically test this theory. Of the few studies
which have been undertaken on patients with advanced disease most
have been carried out with "mixed" cancer patients [Plumb and Holland,
1977; Plumb and Holland, 1981]. These studies demonstrated that 20-23 per
cent of patients with advanced cancer (at various sites) reported
depression. Hopwood [1984] studied the psychiatric morbidity in 26
patients with metastatic breast cancer. She interviewed patients before and
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2-3 months after chemotherapy. The results demonstrated that 35 per cent
of women were anxious or depressed. In addition the majority of these
women responded well to anxiolytic or antidepressant therapy.
Conclusion
It is clear from the previous discussions that the psychosocial
consequences of a diagnosis and treatment for breast cancer can be
profound. There has been considerable interest in this area over recent
years. However, most studies focus on the psychosocial sequelae of
primary breast cancer and its treatment paying scant attention to later
stages of the disease.
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Chapter Four
MEASURES OF REHABILITATION STATUS IN ONCOLOGY
Introduction
Measurement in rehabilitation is beset with difficulties. The definition of
rehabilitation as "the restoration of patients to their fullest physical,
psychological and social capability" [Mair, 1972] highlights that it is a
broadly based topic which spans the activities of many professionals and
the multiple needs of patients. Nichols [1979] has argued that
rehabilitation owes its scientific development to a number of arts and
sciences including sociology, psychology, vocational education and
medicine. Due to this diverse background it has been estimated [Bolton,
1985] that there are over 10,000 different tests available to the
rehabilitationist. Hence, selection of the most appropriate measurement
tool in rehabilitation can be a difficult task.
In addition, in the context of oncology there are important issues to
consider in relation to the selection of measurement tools. Fortunately, in
the last decade there has been increasing interest in the impact of cancer
and its treatment on the quality of life because the benefit of surgery,
radiotherapy and chemotherapy on quantity of life is sometimes
marginal. The lessons learnt from this area of research can be usefully
applied to the present study.
This Chapter is divided into three main sections: a brief review of the
required properties of measurement instruments; a discussion of
measurement of rehabilitation needs in cancer care; and finally a
discussion of the recommendations of the psychosocial oncologists who
have been attempting to measure quality of life. Particular measurement
tools will also be discussed in detail in the latter two sections.
THE SCIENCE OF MEASUREMENT
In the laboratory disciplines, the term "measurement" implies precision;
development of appropriate instrumentation helps this process of
measurement. In the natural sciences, subjective judgement plays a
minor role in the measurement process. In contrast, however,
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measurement in the social sciences seems to rely heavily on subjective
judgement. In order to place the therapeutic efforts of medical disciplines
such as physiotherapy, occupational therapy, oncology, rheumatology etc.
on a sound scientific basis, methods have been devised to measure the
more subjective states of human experience and achieve a level of
precision. Certain criteria are crucial in choosing a measurement
instrument in the form of a questionnaire or scale.
Sensitivity
In choosing a measurement tool it is important that it is able to
discriminate or detect all cases of the relevant variable. This is sensitivity
which is usually expressed as a percentage.
Validity
When selecting a measurement instrument such as a questionnaire or
scale it should possess face and content validity. Face validity is the
simplest form of validity in that the instrument appears to be assessing
the desired qualities. Content validity is closely related and it is the extent
to which the instrument adequately probes the various aspects of the area
it is supposed to measure. These two forms of validity consist of a
judgement by experts whether the measure appears appropriate for the
intended purpose. This type of validity has been called "validity by
assumption" [Guilford, 1956] and therefore face and content validity
should be regarded as a minimum prerequisite of a measure.
More robust types of validity which require more than simple "peer
judgement" can be subsumed under the heading "empirical validity" :
empirical evidence which demonstrates that the measure is actually
measuring what it is supposed to: concurrent and construct validity. This
empirical evidence can be obtained by comparing the results of the "new"
measure with an independent external criterion or "gold standard" and
the concurrent validity of the "new" measure is usually expressed in
terms of a correlation coefficient. When no "gold standard" exists with
which to compare the new measure, the construct validity of a measure
can be ascertained by assessing the extent to which a measure fits into
theoretical constructs which in turn link with other observable
measurements. A particular theory should state predictions about
relationships between constructs. If accumulated evidence about a test
supports the predicted direction of these relationships then the test is
shown to have construct validity.
Reliability
A measure which is valid may not necessarily yield consistent results.
Hence a measure must also yield reproducible results i.e. the measure
must also be reliable. Reliability is defined as the degree to which two
separate, independent measurements of the same thing agree with one
another and is usually expressed by a co-efficient of correlation
representing the relationship between the two sets of measurements. Like
validity, there are different forms of reliability testing. The different forms
can be subsumed under two main headings: stability; and internal
consistency.
There are a variety of ways of ascertaining the stability of a measure. For
example: inter-rater reliability is the extent to which administration of the
same test by two or more people yields the same results; intra-rater
reliability is the agreement between observations made by the same rater
on two different occasions; and test-retest reliability is the agreement of
observations on the patient on two occasions separated by some interval
of time.
Measures of internal consistency are based on a single administration of a
measure. For example, a particular questionnaire may contain several
items which address the same underlying dimension. It would be
reasonable to assume, therefore, that the responses to each item would be
correlated with the scores on all other items. There are a number of ways
in ascertaining internal consistency: split half consistency, odd-even
consistency. Internal consistency is infrequently tested compared with the
stability of the measure over time and between raters.
Summary
It is clear from the discussion above that whatever measures are adopted
in a scientific research study looking at the rehabilitation needs of patients
with metastatic breast cancer they should possess respectable levels of
sensitivity, validity and reliability. The following discussion looks at a
variety of measures which have been adopted in this area of research.
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REHABILITATION MEASURES OF OUTCOME IN ONCOLOGY
It has already been mentioned that measurement of rehabilitation
outcome is fraught with difficulties due to the broad definition of
rehabilitation. This difficulty is therefore also inherent in measuring
rehabilitation needs of patients with metastatic breast cancer. Perhaps this
is one reason why there have been so few systematic studies monitoring
the impact of cancer on rehabilitation status. Given the definition of
rehabilitation in oncology as "the dynamic process directed toward the
goal of enabling persons to function at their maximum level of their
disease or disability in terms of their physical, mental, emotional, social
and economic potential" [Dudas, 1984], it is clear that in the present study,
functioning in each of the above domains has to be measured.
To the author's knowledge, following a detailed search of the literature,
the only scale which specifically purports to measure the rehabilitation
status of patients with cancer is the Cancer Rehabilitation Evaluation
System (CARES) [Schag and Heinrich, 1988].
The Cancer Rehabilitation Evaluation System (CARES) was developed
from the Cancer Inventory of Problem Situations (CIPS). The CARES is a
self-admininstered questionnaire which assesses the everyday problems
and rehabilitation needs of patients with cancer.
The theoretical basis for the development of this questionnaire is a
competency based model of coping which was first described by Goldfried
and D'Zurilla [1969] and applied to first year college students. It was later
used as a model of coping with chronic illness [Turk, 1979; Turk et al,
1980]. According to this conceptual model, coping is seen in operational
terms: coping is defined as competent responses to problematic situations.
The model has three components: problem specification; response
enumeration; and response evaluation. The first component identifies
the range of problems which a patient has to cope with and provides a
normative database. The CARES attempts to provide a method of data
collection, thereby giving a comprehensive database of the problems with
which cancer patients must cope. Therefore the CARES is attempting to
address the first component of this theoretical model of coping: problem
specification. It was the authors' intent with this questionnaire to address
more specific components of behaviour affected by cancer and its
treatment and not to concentrate solely on the emotional distress.
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Patients are asked to rate each problem statement on a five point scale,
zero representing "not at all" (no problem) and four representing "very
much" (severe problem). The patient is given the written instructions:
"Below is a list of Problem Statements that describe situations
and experiences of individuals who have or have had cancer.
Read each statement and circle the number that best describes
HOW MUCH EACH STATEMENT APPLIES TO YOU during the
PAST MONTH, INCLUDING TODAY. Some sections will not
apply to you. Please skip these sections and proceed to the next
one as directed."
The CARES can be scored into a Global Score, and five summary subscales
(physical, medical interaction, psychosocial, sexual, and marital). The
Global Score takes into consideration the varying number of possible
problems for each patient. The five summary subscales summarise the
major areas of function and at a clinical level they provide a general
summary of a patient's status in a particular area.
Two major reliability studies of the CARES have been conducted [Schag et
al 1983, Schag et al 1988]. In the first study, 71 patients completed the first
version of the CARES twice at a one week interval. CARES was found to
have excellent test-retest reliability (mean for reliability coefficients, r=
+0.89). In the second study, using the revised version of the CARES, 120
patients completed the questionnaire and then ten days later. Once again
all correlations were strong and positive with all the Pearson product-
moment correlations being high (r=+0.82). The authors argue that the
"instrument appears to have a high degree of reliability and this reliability
is consistent across time, patients and other changes" [Schag et al, 1983].
Validity issues have been addressed with the CARES. Because the CARES
represents an instrument which is made up of a variety of constructs all of
which relate to the range of problems encountered by patients with cancer,
validation is a difficult process as there are few other instruments which
address such a range of problems (concurrent validity is assessed by
comparing the results of the measure with another measure which is seen
as the "gold standard" with good reliability and validity). In the first study
[Schag et al 1983] CARES (then referred to as the Cancer Inventory of
Problem Situations-CIPS) was compared with the SCL-90-R [Derogatis
1977] in order to establish concurrent validity. The SCL-90-R is a measure
of psychological distress and has been frequently used with cancer
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patients. The authors hypothesised that if the CARES assessed the impact
of cancer on daily life accurately, then the overall number of problems
would be positively correlated with the results of the SCL-90-R. A high
correlation was established by a Pearson product-moment correlation
(r=+0.69) which indicated that the relationship between the number of
problems endorsed by patients on the CARES and the results of the SCL-
90-R was positive and strong.
A second study [Schag and Heinrich, 1988] looking at the concurrent
validity of the CARES was carried out with 120 patients with cancer. This
was a much more sophisticated study as the CARES was compared with
the SCL-90 (to give information about the concurrent validity of the
psychological items in the CARES), the Dyadic Adjustment Scale (DAS-to
measure the concurrent validity of the items concerned with marital and
sexual functioning), the Karnofsky Performance Status Score (to measure
the concurrent validity of the physical functioning items in the CARES),
and a quality of life visual analogue scale (to measure the concurrent
validity of quality of life items in the CARES). The correlations for the
validity measures and the CARES' scales were in the appropriate
directions. The correlation between the CARES Global Score and the other
five summary subscales and the SCL-90 was positive and strong. The
Karnofsky Performance Status Score was negatively related to the CARES
which is what one would intuitively expect because as the severity of
problems increased on the CARES, the Karnofsky Performance Status
Score would decrease. Interestingly, the correlation between the DAS and
the CARES was not so strong, particularly the relationship between the
DAS and the Sexual subscale on the CARES. The authors argued that this
lack of strong correlation was due partly to the fact that the DAS has only
two questions which relate to sexuality, whereas the CARES sexual
subscale has eight questions addressing interest, sexual performance, and
sexual dysfunction.
The CARES is available in two forms - as a questionnaire consisting of 139
items; and as a short form (SF) consisting of 59 items. The CARES - SF was
primarily developed for use in research studies to assess problem areas
and rehabilitation needs. All items contained on the short form are
included in the original CARES. The items for inclusion in the short form
were selected using data which had been collected from the long form.
The CARES - SF rating system is the same as the original 139- item
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CARES. Scoring the CARES - SF is similar to the CARES: there is one
single score the Global CARES - SF, and there are five higher order factors
representing: physical (the physical changes and disruption of daily
activity caused by the disease or treatment); psychosocial (psychosocial
issues, communication and relationship problems); medical interaction
(problems interacting and communicating with members of the medical
team); marital (problems associated with a significant marital type
relationship); and sexual (problems related to interest and performance of
sexual activity).
The psychometric properties of the CARES - SF have been evaluated
[Schag et al. 1991]. The data from four samples of cancer patients
demonstrated that the CARES - SF is highly related to the CARES (r= 0.98),
had excellent test-re-test reliability (86 per cent agreement), concurrent
reliability with related measures and acceptable internal consistency of
summary scales (alpha= +0.85 to +0.61). In additional longitudinal
evaluation of a newly diagnosed sample of breast cancer patients (n=109)
who were interviewed at three points in time (one month, 7 months and
13 months after diagnosis) suggested that the CARES - SF is responsive to
change over time and is highly related to the Functional Living Index-
Cancer [ Schipper et al, 1984). Research of the CARES-SF have
demonstrated that it possesses the same high levels of validity and
reliability [Schag and Heinrich, 1988]. The CARES - SF has been found to
be highly acceptable to patients and takes about ten minutes to complete.
The CARES-SF was selected for use in this study because it was thought
that the longer version would take too long to complete especially since it
was to be used in conjunction with other measures. Possible respondent
fatigue in the selected patient group was a risk because all patients had
metastatic disease and the likelihood of patients having problems with
concentration and lethargy.
Another measure which is specifically designed to measure rehabilitation
status is the Edinburgh Rehabilitation Status Scale (ERSS)[Affleck et al,
1988]. Although this was not specifically designed for use with cancer
patients, it was thought to be appropriate for use in the present study.
The ERSS measures four dimensions in which changes may occur in the
course of a disabling illness. This scale therefore gives a profile of
measures in each domain but an overall score can also be given indicating
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the overall level of performance of individuals.
The ERSS subscales:
1. Dependence/ independence: The subscale describes the frequency of
the patients' acceptance of support and the extent to which he/ she
depends on others for self care, economic arrangements and
administration of any medicine or treatment.
2. Activity/ inactivity: This subscale measures the patient's ability to
perform the physical and intellectual processes involved in
occupations, home life and leisure. There is no emphasis on paid
employment.
3. Social integration/ isolation: This is a social behavioural subscale to
monitor the involvement with others. The extent and quality of
domestic or social participation is rated.
4. Effect of symptoms on lifestyle: This subscale grades the frequency
and severity of any symptoms/signs and the difficulties and distress
that arise.
This scale is completed by a researcher or clinician and the patient is rated
on each subscale from zero to seven: the higher numbers indicating
greater severity.
Studies of the ERSS have been carried out to determine its reliability and
validity. It was shown that the ERSS is sensitive to change over time and
that it can be used as a simple assessment on the effectiveness of a
rehabilitation programme.
Correlations of the ERSS total scores with the total scores Barthel Index
[Mahoney and Barthel, 1965] and PULSES [Gresham and Labi, 1984] have
also been carried out producing a high degree of correlation between all
three scales. More recently, a larger study was conducted [Mattison et al,
1991] in a total of 364 patients attending day centres for the physically
disabled. Scores were obtained for the ERSS and the Barthel Index, and in
100 patients additional scores were obtained on the PULSES profile.
Correlation of total scores for all three scales confirmed that all three
succeeded in measuring disability and all three were significantly related.
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QUALITY OF LIFE ISSUES IN CANCER CARE
The explosion of cancer therapy over the past fifty years has brought
intense hopes and expectations concerning a "cure for cancer". However,
despite many advances in various treatments of cancer, the goal of cure
has not been achieved. As a direct consequence of the difficulty in
achieving this goal, there has been increasing attention on quality of
outcome with the recognition that quality of life is an important issue in
cancer treatment research. The addition of quality of life endpoints to the
traditional endpoints of overall survival, disease-free survival and
tumour response theoretically enables medical researchers to make more
informed decisions about risk-benefit trade-offs in the treatment of
particular cancers.
However, with the need to collect data on both profiles of quantity and
quality of life in patients with cancer, several problems have been
encountered. Quantity of life i.e. duration of survival, is relatively easy to
measure. However measurement of quality of life is much more complex
and basic issues related to its definition have caused considerable debate.
Over the past decade, however, there have been increasing efforts to
define and conceptualise quality of life. In cancer care the
multidimensional approach is widely adopted and many scales have been
designed to measure quality of life. Researchers appear to include the
three dimensions of health outlined in the World Health Organisation's
definition of health "health is not only the absence of infirmity and
disease but also a state of physical, mental and social well-being" [1958].
Hence, these researchers include the physical condition of the patient, the
psychological well being and the performance of activities to be important
in the measurement in the quality of life. It could be argued that there is
an extremely broad overlap between research monitoring quality of life
and research monitoring rehabilitation status.
Aaronson et al [1991] stated that:
"there is now general agreement on two central points. First,
health-related quality of life is a multidimensional concept that
includes the broad areas of functional status, psychologic and
social well-being, health perceptions, and disease and treatment
related symptoms Second, it is the consensus...that quality of
life assessment is essentially subjective, with the target
individual being the primary source of information on the
quality of his or her life" [p 840].
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In terms of operationalising this pragmatic approach to quality of life
there have been many developments in the design and the
implementation of studies monitoring the quality of life of patients with
cancer. A number of self administered questionnaires have been
developed which ask patients to quantify their psychosocial health status
within a range of areas. These questionnaires share the following features:
(1) The majority have been developed specifically for patients with
cancer.
(2) The questionnaires have demonstrated adequate levels of face,
content, construct and concurrent validity, and test-re-test
reliability.
(3) The questionnaire is designed for repeated use in order that the
patient's score can be followed over a period of time to evaluate
trends both within patients and between groups.
(4) The questions designed are of general applicability, ease and
consistency of interpretation: "sufficiently brief and comprehensible
to be of practical use in clinical research settings."[Aaronson et al,
1991].
A development has been made by Slevin et al [1988] in an attempt to
measure the subjective nature of quality of life. In a study which he
conducted it was clear that doctors and health care professionals could not
adequately measure the patient's quality of life when compared with
patients' self report of quality of life. Therefore it was suggested by Slevin
that if measurement of a patient's quality of life is required, it should be
done by the patients themselves and not by the doctors or nurses. As a
direct result of this and similar research studies, most of the present
questionnaires which measure quality of life are in a self report version.
Following a review of the literature on the measurement of quality of life,
two further scales were selected for use in the present study as they were
thought highly relevant in a study monitoring rehabilitation needs of
patients with metastatic breast cancer: the Rotterdam Symptom Checklist
[de Haes et al, 1983]; and the Hospital Anxiety and Depression Scale
[Zigmond and Snaith, 1983].
The Rotterdam Symptom Checklist (RSCL)[de Haes et al. 1983] was
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developed as a tool to measure the symptoms reported by patients with
cancer taking part in clinical research. In a study by Trew and Maguire
[1982] the RSCL was used to monitor the levels of the patients' anxiety and
depression, reflecting the presence of psychological illness.
The RSCL evolved from analysis of the data from three studies using
different checklists. These were:
(1) The Hopkins Symptom Checklist which was administered to 352
psychiatric patients, 147 patients with rheumatoid arthritis and 308
"normal" controls [Luteijn et al, 1979].
(2) A symptom checklist used in a study of 150 patients with breast
cancer [Linssen et al. 1979].
(3) A Dutch version of the Symptom Distress Scale developed by
McCorkle and Young [1978] which was administered to 49
hospitalised patients with cancer.
As a result of factor loadings, items which were thought to be most
relevant according to a group of oncology specialists, and answer-
distributions the authors arrived at a selection of items suitable for
inclusion in the Rotterdam Symptom Checklist. This yielded a 34 item
checklist comprising psychological and physical symptoms.
Patients are asked to rate the level of their symptoms over the last week
on a four point rating scale (categories: not at all, a little, somewhat, very
much). Eight items were added to cover the patient's functional status.
Completion of the RSCL takes about eight minutes.
Details regarding the reliability and validity of the RSCL were originally
established by de Haes et al [1983]. It was reported in a paper [de Haes and
van Knippenberg, 1987] to have established that the RSCL displayed a
level of internal consistency of 0.89 and satisfactory levels of content,
concurrent and discriminant validity. A more recent study [de Haes et al,
1990] discusses the use of the RSCL to measure psychological and physical
distress experienced by cancer patients. Principal component analyses was
undertaken in order to establish the stability of the RSCL in three studies.
The results demonstrated that the psychological dimension proved to be
stable across different populations (in different cancer populations and
"control" groups of patients). The reliability of the psychological distress
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dimension of the RSCL was consistently high (Cronbach's alpha 0.88-0.94).
The physical dimension of the RSCL demonstrated high levels of
reliability (0.71-0.88).
The RSCL has been used in a number of studies monitoring the
psychosocial impact of cancer and "quality of life" of patients with cancer
[Hopwood, 1984; de Haes and Welvaart, 1985; Fallowfield et al, 1986;
Morris and Royle, 1988]. In a paper by Maguire and Selby [1989] the authors
conclude that "the current "best-bet" for tapping key dimensions of quality
of life is the Rotterdam Symptom Checklist".
The Hospital Anxiety and Depression Scale (HAD) [Zigmond and Snaith,
1983] is a brief self-report rating scale which consists of 14 items: seven
concerned with the detection of anxiety and seven concerned with the
detection of depression. This measure was designed primarily for use with
non-psychiatric medical out-patients to detect mood disorders. The items
on the anxiety subscale were chosen by Snaith [1982] from the anxiety
items in the Present State Examination [Wing, 1973] and from Snaith's
own research. Due to the fact that it was designed for patients with
physical disease (particularly the depression subscale) it has the advantage
that it omits somatic items like tiredness, insomnia, or loss of appetite
which could be both due to mood disturbance and physical illness. The
depression subscale emphasises anhedonia. Another important feature is
that the concepts of anxiety and depression are separated in this scale:
some scales summate the two concepts into a "global" score of anxiety and
depression e.g. the Hamilton Depression Rating Scale [Hamilton 1967]. In
addition, the HAD is extremely simple and quick to complete, taking only
five minutes and has been found to be acceptable to patients.
The HAD is extremely easy to score with each item being rated on a four
point scale (0-3) and the raw scores for each sub-scale are summed. In
order to determine the patient's "caseness" Zigmond and Snaith give
"cut-off" points for both anxiety and depression.
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HAD "cut-off" scores for anxiety and depression:
0-7 Non-case
8-10 "Borderline " case
11-21 "Case"
Should a score above 11 persist on either the anxiety or depression score
(i.e. "case" levels of anxiety or depression) for a period of one month or
longer, the patient should be considered for referral to a psychiatrist or
psychologist for treatment.
In a recent paper by Maguire and Selby [1989] which reviews methods
adopted in measuring quality of life, the HAD scale is recommended as a
useful, reliable and valid tool to measure levels of anxiety and depression
in patients with cancer.
Many studies have been conducted to determine the reliability and
validity of the HAD scale in a variety of health care settings. Zigmond and
Snaith [1983] established the concurrent validity for the sub-scales on the
HAD and the independent rating of a psychiatrist as +0.70 for depression
and +0.74 for anxiety (both highly statistically significant). The sensitivity
and specificity were tested to establish the rate of false positive and false
negative results. The number of false positives and false negatives for
depression were both 1 per cent, and the number of false positives and
false negatives for anxiety were 5 per cent and 1 per cent respectively.
Further evidence for the concurrent validity of the HAD has been
reported in psychiatric patients [Bramley et al. 1988]. In a heterogeneous
group of patients with physical illness Aylard and colleagues [1987]
substantiated that the two sub-scales of the HAD were measuring different
aspects of mood disorder as the correlation between the two was only
+0.04. Furthermore, there were significant correlations of the sub-scales
with those patients known to have definite mood disorder
(depression=0.77, anxiety = 0.67) [Aylard et al, 1987].
One hundred patients attending a genito-urinary clinic were assessed
using the HAD and completed a semi-structured interview, DSMIII. The
sensitivity and specificity was compared between the two measures using
the cut-off scores suggested by Zigmond and Snaith. The sensitivity and
specificity was optimum with the recommended cut-off points. The
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specificity was 94 per cent and 68 per cent for depressive disorders and
anxiety disorders respectively. The sensitivity was 82 per cent and 70 per
cent for depressive disorders and anxiety disorders respectively [Barczak,
1988].
Ibbotson et al [19891 investigated the validity of the HAD as a screening
instrument for the psychological distress of 514 patients with cancer. The
HAD was compared with two other self-rating questionnaires, the General
Health Questionnaire (GHQ) [Goldberg, 1978] and the Rotterdam
Symptom Checklist (RSCL) [de Haes et al. 1983]. The three scales were also
compared with the Psychiatric Assessment Schedule (PAS) [Maguire et al.
1978] which is a semi-structured interview and in this study was used as a
gold standard. Ibbotson concluded that the HAD performed best overall.
Maguire and Selby [1989] on behalf of the Medical Research Council's
Cancer Therapy Committee on Quality of Life argued that the HAD is a
"useful tool for measuring the psychological dimensions of quality of life
in cancer patients".
CONCLUSION
There are many issues to consider in relation to measurement of
rehabilitation status in cancer care. The importance of sensitive, valid and
reliable measures in this area is crucial. Despite there being few systematic
studies monitoring rehabilitation needs of patients with cancer, measures
which have been tried and tested in the area of psychosocial oncology and
quality of life, could be usefully employed in the present study. This
follows in the tradition of development of rehabilitation research
generally to learn from other specialties [Nichols, 1979]. The next Chapter




THE STUDY: AIMS AND METHODS
Introduction
It has already been highlighted that there are few studies which monitor
the psychosocial and rehabilitation needs of patients with metastatic breast
cancer. A prospective study measuring the rehabilitation needs of these
patients would contribute to this inadequate body of knowledge and, in
addition, give a broader rehabilitative perspective on the needs of patients
with metastatic breast cancer. The relatively new research interest in
rehabilitation of patients with breast cancer can adopt the tried and tested
methodology utilised in the studies of the psychosocial sequelae of a
diagnosis and treatment for breast cancer and recent quality of life studies:
to use standardised tools of measurement; and assessing patients on a
regular basis in a prospective study design.
This Chapter is sub-divided into two sections: Section A outlines the aims
and hypotheses tested in the main descriptive study and the pilot
intervention study; Section B separately outlines the methodology and
procedures of both studies.
SECTION A
THE AIMS AND HYPOTHESES OF THE TWO STUDIES
The purpose of this section is to state the aims of the present study and the
hypotheses to be tested. The study comprised two components: a
descriptive component where patients (n=80) were interviewed every
eight weeks at home following diagnosis of metastatic breast cancer; and a
pilot intervention component where patients (n=17) were randomised to
either an intervention group or the control group. In order to describe
the aims and hypotheses, the two components will be discussed separately.
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THE DESCRIPTIVE STUDY
This component formed the major part of the research study under
discussion.
The aims of the descriptive study
(1) To describe the rehabilitation status of a sample of patients with
metastatic breast cancer throughout the course of their disease.
(2) To quantify the rehabilitation needs of a sample of patients with
metastatic breast cancer at different stages of their disease.
(3) To identify contributory factors to rehabilitation needs in a sample
of patients with metastatic breast cancer.
(4) To assess change in rehabilitation needs in a sample of patients
from diagnosis of metastatic breast cancer during the following 16-
18 months.
(5) To identify predictive factors in the rehabilitation needs in sample
of patients with metastatic breast cancer.
The hypotheses tested in the descriptive study
(1) Patients have » rehabilitation needs throughout the course of
their metastatic disease.
(2) Rehabilitation needs are not detected in the majority of patients
with metastatic breast cancer.
(3) Demographic factors (such as age, marital status, social class) are
associated with rehabilitation needs
(4) There is . a correlation between physical symptomatology and
anxiety and depression in patients
(5) Rehabilitation needs ' change during the metastatic phase of
breast cancer.
(6) There are differences in rehabilitation needs of patients
receiving different treatments for their metastatic disease
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THE PILOT INTERVENTION STUDY
This component took the form of a small "pilot" intervention study:
patients were randomised to either (a) the intervention group where they
were assessed by a "rehabilitation co-ordinator" or (b) the control group.
The aims of the pilot intervention study
(1) To test out a method of aiding detection of the rehabilitation needs
using a rehabilitation co-ordinator.
(2) To test out a method of aiding referring the patient for intervention
strategies using a rehabilitation co-ordinator.
(3) To describe the rehabilitation needs of a small sample of patients
with metastatic breast cancer throughout the course of their disease
in both the intervention and control group.
(4) To compare the rehabilitation needs of patients in the control group
and patients in the intervention group.
(5) To assess change in rehabilitation needs throughout the course of
the patients' metastatic breast cancer in both the intervention group
and the control group.
The hypotheses tested in the pilot intervention study
(1) Patients have rehabilitation needs throughout the course of
their metastatic disease.
(2) A rehabilitation co-ordinator does * improve the detection of
rehabilitation needs.
(3) A rehabilitation co-ordinator does improve referral for
treatment of rehabilitation needs.
(4) Patients perceived the services of a rehabilitation co-ordinator to be





This section describes the methodology and procedures adopted in order
to pursue the general objective of describing the rehabilitation needs of
patients with metastatic breast cancer.
The study comprised two parts: a prospective descriptive study
monitoring the rehabilitation needs of patients with metastatic breast
cancer at pre- determined intervals (every eight weeks); and secondly, a
small experimental component to test out whether these needs could be
resolved thereby reducing the overall needs over time. The methodology
and procedures of the two components will be described separately in this
section.
THE PROSPECTIVE DESCRIPTIVE STUDY: THE METHOD
Subjects
Patients with metastatic breast cancer form two main groups: those who
have been treated formerly for primary breast cancer and later re-present
with metastatic disease; and those patients who newly present with
metastatic breast cancer. Both "types" of patients were recruited to this
study.
All subjects in this study had "staging confirmed" metastatic disease
according to the TNM method of staging breast cancer. According to this
classification Ml indicates the presence of distant metastases. In addition,
because patients are usually only "staged" when they first present at the
Longmore Hospital, patients who are subsequently clinically diagnosed
and are "re-staged" as having metastatic breast disease were included in
the study. Eighty-six patients were approached and, as six patients declined
to participate in the study, 80 patients recruited in the descriptive
component.
67
Formal agreement with and approval from the physicians working at the
Longmore Hospital with metastatic breast cancer patients was obtained
before the research plan was implemented.
Approval from the Ethics Committee was obtained before the research
plan was implemented.
Procedure
Patients who were suitable for inclusion in this study were identified by
the researcher by two methods:
(1) By reading the staging list produced by the Breast Clinic at
Longmore Hospital (each week a list of patients who had been
staged a few days previously according to the Tumour Node
Metastases (TNM) method of classification was available) and if the
patient had been found to have metastatic spread, they were
subsequently seen at the Combined Breast Clinic held at the
Longmore Hospital;
(2) In addition, the researcher read all the reports and medical notes on
patients attending the Combined Breast Clinic in order to ensure
that no patients had been omitted for possible inclusion in the
study.
When a suitable patient had been identified, the researcher introduced
herself to the patient at the Combined Breast Clinic and explained verbally
the research study and gave the patient the written information sheet to
read (see Appendix). At this juncture, the patient was given the
opportunity to decline from participation in the study. However, if the
patient showed a willingness to participate, the researcher asked the
patient to give their home telephone number. The researcher
subsequently telephoned the patient at home and asked them whether
they still wished to participate in the study. If the patient was willing, an
appointment was made for the researcher to visit the patient at home. On
the initial visit, the patient was asked to give written informed consent
(one copy of which was retained by the patient) after outlining:
(1) the aim of the study;
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(2) that they were free to withdraw from the study if they wished to do
so;
(3) how often they were required to be interviewed (every eight weeks);
(4) the location of the interviews (in the patient's own home or if the
patient had been admitted to hospital, the interview would occur at
the patient's bedside).
Only those patients who gave informed consent following a full
discussion with the researcher participated in the study.
Participation involved the patient completing a battery of questionnaires
and assessment scales every eight weeks following diagnosis of metastatic
disease. This assessment usually occurred in the patient's own home.
However, if the patient had been admitted to hospital for treatment, the
assessment was conducted at the patient's bedside.
The criteria for excluding people from the study were:
(1) Patients not wishing to take part;
(2) Patients who did not have an Edinburgh Postcode;
(3) Non-English speaking patients;
(4) Patients who in the opinion of the consultant responsible are too ill
or too distressed to take part (only four patients were excluded on
this ground);
(5) Patients who had any previous history of psychiatric illness (only
two patients were excluded on this ground);
(6) Patients who had another disabling illness such as rheumatoid
arthritis, heart disease etc. (only four patients were excluded on this
ground);
(7) Patients over 75 years of age.
A letter was sent to the patient's General Practitioner outlining the aim of
the study informing him/her of the patient's decision to participate.
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Measurements
In order to describe the rehabilitation needs of a sample population of
patients with metastatic breast cancer, it was essential to be able to identify
the problems in each of those domains using a particular measure/scale.
This is shown in Figure 4.
Figure 4: Rehabilitation Domains and Relevant Standardised
Questionnaire
Physical Psychological Social Sexual Vocational
CARES CARES CARES CARES CARES
RSCL RSCL RSCL RSCL
HAD
ERSS ERSS ERSS ERSS
INTERVIEW INTERVIEW INTERVIEW INTERVIEW
(CARES: Cancer Rehabilitation Evaluation System;
RSCL: Rotterdam Symptom Checklist;
HAD: Hospital Anxiety and Depression Scale;
ERSS: Edinburgh Rehabilitation Status Scale;
Interview: interview schedule)
Following the recommendations given by Aaronson [1991] regarding
methodological approach for studies monitoring quality of life that "it is
today almost universally accepted that the patient is the most appropriate
source of information on his or her quality of life", the majority of
measures adopted in the present study were in a self-report version (the
exceptions being the interview schedule and the Edinburgh Rehabilitation
Status Scale [Affleck et al, 1988]). The study was multimodal in that a
range of tools were utilised. These comprised:
(a) Interview schedule (researcher completed this)
This was compiled by the researcher to record information concerning
age, marital status, employment, time since initial diagnosis, which
members of the medical team the patient had seen in the previous
month, which problems the patient was experiencing, presence of
lymphoedema, whether the patient required any functional aid, which
Social Security Benefits the patient received (Mobility Allowance,
Attendance Allowance etc). A separate checklist completed by the
researcher collated additional information obtained from the patient's
medical notes relating to the previous and present medical management,
site/s of metastatic spread, the severity of the patient's illness.
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(b) The Cancer Rehabilitation Evaluation System - short form for research
(CARES) [Schag and Heinrich, 1988]
The Cancer Rehabilitation Evaluation System (CARES) was developed
from the Cancer Inventory of Problem Situations (CIPS). The CARES-
Short Form for Research is a self-admininstered questionnaire which
assesses the everyday problems and rehabilitation needs of patients with
cancer. Reliability and validity details have been discussed in the previous
chapter. This scale takes approximately ten minutes to complete.
(c)The Rotterdam Symptom Checklist (RSCL) [de Haes et al, 1986]
The Rotterdam Symptom Checklist (RSCL) was developed as a tool to
measure the symptoms reported by patients with cancer taking part in
clinical research. The 34 item checklist was used in the present study in
order to monitor psychological and physical symptoms in addition to
performance of daily activities. The RSCL takes approximately ten
minutes to complete.
(d) The Hospital Anxiety and Depression Scale (HAD) [Zigmond and
Snaith, 1983]
The Hospital Anxiety and Depression Scale (HAD) is a brief self-report
rating scale which consists of 14 items: seven concerned with the detection
of anxiety and seven concerned with the detection of depression. This
scale takes about five minutes to complete.
(e) The Edinburgh Rehabilitation Status Scale [Affleck et al, 1988]
The ERSS measures four dimensions in which changes may occur in the
course of a disabling illness: independence; activity; social integration; and
effects of illness on lifestyle. The ERSS therefore gives a profile of
measures in each domain but an overall score can also be given indicating
the overall level of performance of individuals. This measure was
completed by the researcher.
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PILOT INTERVENTION STUDY ADOPTING REHABILITATION CO¬
ORDINATOR
A separate pilot study was conducted after collection of the data of the
initial descriptive phase of this study. This pilot study took the form of an
intervention study whereby a small group of patients (17 patients) with
"staging confirmed" metastatic breast cancer were randomised to either (a)
intervention group (n=10) or (b) "control" group (n=7). The primary
objective of this component was to test out a method of resolving these
rehabilitation needs in a pilot intervention study adopting a rehabilitation
co-ordinator.
Figure 5: Illustration of randomisation of patients to each group
Patients with metastatic breast cancer
n = 1 7
Intervention Non-intervention
GrouP Group
(n = 10) (n = 7)
Subjects
All subjects (n=17) had staging-confirmed metastatic breast cancer
according to the TNM method of tumour classification. The criteria for
excluding people from the pilot intervention study were:
(1) Patients not wishing to take part;
(2) Patients who did not have an Edinburgh Postcode;
(3) Non-English speaking patients;
(4) Patients who in the opinion of the consultant responsible are too ill
or too distressed to take part (only one patient was excluded on this
ground);
(5) Patients who had any previous history of psychiatric illness (no
patients were excluded on this ground);
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(6) Patients who had another disabling illness such as rheumatoid
arthritis, heart disease etc. (no patients were excluded on this
ground);
(7) Patients over 75 years of age.
Process of Randomisation
Patients were randomised to either the intervention group or the
"control" group by the following method: because a maximum of two
patients each week were staged as having metastatic breast cancer, patients
were randomised as they presented by putting the names of patients on
separate pieces of paper in an opaque bag. An independent observer
pulled the names out of the bag and were assigned to either the
intervention group or the "control" group accordingly.
Measurements
The same measurement tools were used in the pilot intervention study as
in the main descriptive study. These were the CAncer Rehabilitation
Evaluation System (CARES), the Hospital Anxiety and Depression Scale
(HAD), the Rotterdam Symptom Checklist (RSCL), the Edinburgh
Rehabilitation Status Scale (ERSS), and a semistructured interview.
Patients in the Control Group
Patients in the "control" group were interviewed every eight weeks at
home using the following tools of measurement. The rehabilitation needs
were accordingly recorded in order to describe the rehabilitation needs
over time.
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Patients in the Intervention Group
Patients in the intervention group were interviewed every eight weeks at
home. In the intervention group the researcher acted as a "rehabilitation
co-ordinator". A rehabilitation co-ordinator acted as a "case manager" on
behalf of the patient and, on the basis of the findings from the assessment
tools, the rehabilitation co-ordinator could detect various rehabilitation
needs. If and when a problem/need was detected, the rehabilitation co¬
ordinator referred the patient for appropriate treatment/ intervention
(physiotherapist, occupational therapist, social worker, clinical
psychologist etc.) through his/her physician, with the patient's consent .
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Therefore as soon as a rehabilitation problem was perceived it was acted
on: the rehabilitation co-ordinator referred the patient to the appropriate
therapist/ specialist, through the patient's consultant. Whether
intervention by a rehabilitation co-ordinator improves rehabilitation
status of the patient with metastatic breast cancer was tested out against
the "control" group.
A comparison between the two groups using the measures outlined above
indicated whether the presence of a rehabilitation co-ordinator effects the
rehabilitation status of the intervention group over time.
External Validation
A research assistant interviewed the patients (n=17) on the fifth occasion
following recruitment to the study. The purpose of this was to have an
objective assessment of patient's rehabilitation needs using the same
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measurement tools described above. In addition, the research assistant
administered a further questionnaire to ask the patients in the
intervention group about their perception of the "rehabilitation co¬
ordinator service" (whether it was of any value to them, whether the
patients felt they had any suggestions if it was offered in the future to
other patients etc.) (see Appendix).
Data Handling
All the data from the two studies were entered into a statistical package
called Statview on the researcher's personal computer.
Statistical Advice
Advice was obtained from the Medical Statistics Unit, of the University of
Edinburgh before the two research studies commenced in order to check
the viability of the research method. Subsequent advice was sought by the
researcher throughout the course of the study to check data handling and
the suitability of various statistical methods/ tests.
Ethical Approval





The Main Descriptive Study
Introduction
A consecutive series of 86 patients were approached and, as six patients
declined to participate in the study, 80 patients were recruited from the
Breast Unit at Longmore Hospital, Edinburgh. These women had
metastatic breast cancer confirmed according to the Tumour Node
Metastases (TNM) method of staging. Interviews were conducted every
eight weeks and data were collected from eight interviews.
Death from disease and effect on sample size
The sample of patients reduced from 80 to 36 during the course of the
study. This was due to 44 patients dying from their disease in the 16-18
months following diagnosis of metastatic breast cancer. The tables
presented throughout this Chapter give the number of patients
completing each interview.
Structure of Chapter Six
This Chapter is sub-divided into four sections: Section A gives details of
three vignettes; Section B gives details of the results of the main
descriptive study; Section C gives details of the analysis of the data from
the patients who survived throughout (n=36) and those patients who died
during the course of the study (n=44); Section D gives details of the
contribution and association of variables to rehabilitation status of patients




Before embarking on the analysis of the descriptive component, vignettes
of three patients will be presented in order to give some background
details of how patient's presented, their treatment, their daily level of
function, their concerns and worries, and their scores at each interview.
The rationale for this is that it may be difficult to glean from the "raw"
scores a picture of patient's rehabilitation status, without prior
understanding of the standardised questionnaires.
(1) Mrs A. was a 32 year old lady, married with one small child (aged
three). Mrs A. did not work because she was looking after her son at home.
Before the birth of her son, she had worked as a nurse. Her husband
worked full-time as a social-worker. Mrs A. had been diagnosed as having
breast cancer three years previously and had surgery, chemotherapy and
radiotherapy. Subsequently she was diagnosed as having breast cancer in
the remaining breast and had surgery, chemotherapy and radiotherapy. At
a subsequent follow-up appointment enlarged supra-clavicular nodes
were found and she was admitted for re-staging investigations. She was
found to have pleural metastatic disease and was referred to the Combined
Breast Clinic and her treatment was planned. She commenced combined
chemotherapy: cyclophosphamide, methotrexate and 5-fluorouracil
(CMF).
At Interview 1, Mrs A. had not yet commenced chemotherapy and was
extremely agitated and distressed. Her mother had died when Mrs A. was a
child and she felt certain that she was going to die from her disease just
like her mother who had been in great pain and distress at the time of her
death. Mrs A. was fully mobile and functionally she was able to carry out
all the activities which she had done in the months before the diagnosis of
metastases. However, she could not get her mind off her cancer and was
not sleeping well, or eating well. Her small son was annoying her
intensely as he wanted to play with her and she would shout at him, but
then she would feel guilty about it afterwards. She was getting on well
with her husband but could not understand why he still loved her.
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At Interview 2, Mrs A. continued to be extremely distressed about her
disease. She was not coping well with treatment: it did not make her feel
sick but she hated the idea of going for chemotherapy and got very agitated
before the chemotherapy was administered. She was desperate to know
whether the chemotherapy was working and was going to attend a review
clinic in two weeks time. Functionally she was able to do all the
household chores etc. but continued to be fraught by her young son. She
was also having problems talking to her husband about the future.
By Interview 3, Mrs A. had, in the interim eight weeks, been re-admitted
to Longmore Hospital for re-staging investigations as she had been
complaining of headaches. Metastatic brain disease was diagnosed.
Chemotherapy had been stopped and Mrs A. had commenced
radiotherapy for the brain metastases. At Interview 3, Mrs A. continued to
be extremely anxious. She had lost all her hair and was distressed by this.
She could not believe that the disease had progressed so rapidly
irrespective of the chemotherapy. Mrs A. had also commenced steroids
and they were making her feel hungry all the time and she was concerned
about putting on weight. Functionally, Mrs A. was still able to carry out all
the household chores but was finding it difficult to communicate with
family and friends about the disease.
At Interview 4 there was marked deterioration in Mrs A's condition. She
had completed her radiotherapy treatment. Functionally she was able to
carry out only light household tasks, was unable to do the weekly
shopping, she easily became out of breath and had difficulty climbing
stairs. She continued to be very agitated and was extremely worried about
her breathing difficulties. At a recent clinic appointment there had been
the suggestion that she may re-commence chemotherapy and this worried
her greatly because "it did not do any good before, so why should it now".
At Interview 5, Mrs A. continued to be very agitated. Functionally there
was not a great deterioration since the previous interview. Mrs A.
appreciated that she would not live much longer but this obviously greatly
distressed her.
She was concerned how her husband would cope looking after their son
after her death. Mrs A. died four weeks after Interview 5 in hospital.
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The HAD, CARES global and ERSS scores are shown in Table 1 at each
interview.
Table 1








1 11 6 1.00 7
2 11 7 1.06 7
3 13 7 1.10 8
4 14 9 1.46 16
5 14 11 1.50 18
It is clear from Table 1 that the HAD anxiety scores were high at each
interview. Using the cut-off scores suggested by the authors [Zigmond and
Snaith, 1983] Mrs A. scored in the "case" range on anxiety at each
interview and in the "case" range on depression at Interview 5. There was
also a marked increase in the CARES global score and ERSS total score at
Interview 4. The authors of the ERSS [Affleck et al. 1988] suggest that total
scores can give an indication of level of functioning and also give a
percentage level of dysfunction. Using these, the ERSS total scores of Mrs
A can be interpreted to indicate that her level of functioning at Interviews
1-3 was high (25-29 per cent dysfunction). At Interviews 4 her level of
functioning was moderate but noticeable (57 per cent dysfunction) and at
Interview her level of functioning was low (64 per cent dysfunction).
(2) Mrs B. was a 45 year old lady, married with two sons, one of whom was
still living at home. Mrs B. worked part-time as a book-binder at the
University of Edinburgh. Her husband worked full-time as an engineer
with Lothian Regional Council. Mrs B. had found a breast lump on self-
examination and had visited her general practitioner, who subsequently
referred her to Longmore Hospital. Mrs B. was admitted for staging
80
investigations. She was staged as T4, Nl, Ml- and therefore had metastatic
disease at first presentation. She was referred to the Combined Breast
Clinic and the treatment was planned. She commenced combined
chemotherapy: cyclophosphamide, 5-fluorouracil and methotrexate
(CMF). The aim of treatment was to reduce the size of the breast tumour
and control the metastatic disease. Mrs B. was told that if the breast
tumour reduced in size, a course of radiotherapy would be given to the
breast lump.
At Interview 1, Mrs B. had just started chemotherapy and had not found
many problems coping with it and had not had any noticeable side effects.
She was continuing to work part-time and her employers were very
supportive and allowing her time off work for clinic appointments and
chemotherapy. Her family were very supportive and she was able to carry
out the same level of activities as before starting treatment. She said that
she was thinking about the cancer quite a lot but that it did not interfere
with her work, social life, or relationship with her husband, family and
friends.
At Interview 2, Mrs B. had lost all her hair and she appeared distressed
and agitated. This had not been noted by the staff at the Western General
Hospital, where she was receiving her chemotherapy. She said that she
was unable to sleep at night and was finding that she was feeling nauseous
as a result of the chemotherapy. She was continuing to work part-time but
felt extremely self-conscious about wearing the wig which she said was so
obvious. She said that she had lost interest in food and said that she was
increasingly irritated with her son. She was not going out with friends as
much as she used to but instead was inviting them round to her house for
a coffee in the evening. She was feeling quite tired most of the time and
this had an effect on her level of function e.g. she could not be bothered to
do the housework, but would do still do it because she did not want to
look at the layer of dust gathering everywhere.
At Interview 3 Mrs B. was slightly less anxious but had just been referred
to see a Clinical Psychologist at the Western General Hospital. She was still
being troubled by nausea and said that she got very nervous two days
before going to receive chemotherapy because she knew "what the next
few days held in store" for her. However, she was pleased that when she
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attended the Combined Breast Clinic, the Consultants had noted that her
breast tumour had shrunk considerably.
At Interview 4, there was a marked improvement in her mood. She said
that the Clinical Psychologist had given her relaxation tapes which she
listened to at home. He had also shown her breathing techniques to help
her relax. She said the main help had come by being able to talk to
someone on a regular basis about how she was feeling and what her
worries were. She said that she could not be this "open" with members of
the family or with friends. She was still continuing to work but was
feeling very tired in the evening, so she was not able to see friends as
much during the week but was managing to see them at the weekend. She
was due to attend the Combined Breast Clinic the following week and was
hoping that the chemotherapy would soon be stopped because the breast
tumour had shrunk enough and then start a course of radiotherapy.
At Interview 5 Mrs B. had stopped chemotherapy and was receiving
radiotherapy on a daily basis for a two week period. She said that she was
feeling much more in control and she and her husband were planning a
short holiday after finishing her course of radiotherapy. She had noticed
that her hair was beginning to grow back and this pleased her. She was still
using the relaxation tape on a regular basis but said that it had become a
habit rather than really needing it. She had been discharged from the
Clinical Psychologist but she could contact him if she found she were
becoming distressed again in the future. She found this reassuring to
know that he was there if she needed to speak to him. There were no
major problems at that time and she seemed content with life although
she continued to feel tired and the skin on her breast was tender and red
(it did not please her that she could not bathe during her two-week course
of radiotherapy).
This pattern of improvement continued over the next interview period.
However, at Interview 8 Mrs B. said that she had been having bad
headaches and she had been admitted for further investigations. Brain
metastases were detected on a scan and Mrs B. was to receive further
chemotherapy. This had not yet commenced at the eighth interview and
she was still able to work. She said that she was worried about the spread
of the disease but was more concerned about having further
chemotherapy.
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Table 2 outlines Mrs B's scores on the Hospital Anxiety and Depression
scale (HAD), the Cancer Rehabilitation Evaluation System (CARES) global
score and the Edinburgh rehabilitation status scale (ERSS) total score.
Table 2








1 3 4 0.31 1
2 14 12 1.21 10
3 11 6 0.86 9
4 5 2 0.67 9
5 5 2 0.67 9
6 6 2 0.40 8
7 5 2 0.67 8
8 6 2 0.86 9
It can be seen from Table 2 that there was a marked increase in the HAD
scores at Interviews 2 and 3, and using the cut-off scores suggested by the
authors [Zigmond and Snaith, 1983] scored in the "case" range on anxiety
at Interview 2 and 3 and in the "case" range on depression at Interview 2.
There was also a marked increase in the CARES global score and ERSS
total score at Interview 2. The authors of the ERSS [Affleck et al. 1988]
suggest that total scores can give an indication of level of functioning and
also give a percentage level of dysfunction. Using these, the ERSS total
scores of Mrs B can be interpreted to indicate that her level of functioning
at Interviews 1 was high (4 per cent dysfunction). However, at Interview 2
this increased to a "moderate" level of functioning (36 per cent
dysfunction). This reduced slightly at subsequent interviews but remained
within the range of "moderate" dysfunction.
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(3) Mrs C. was a 60 year old lady with a son and daughter no longer living
at home. She had recently retired as a legal secretary and was married (her
husband recently having had a stroke). She had been treated for primary
breast cancer six years previously and had undergone surgery and
radiotherapy. For the previous three months she had been having
increasing back pain. Her general practitioner referred her to Longmore
Hospital for re-staging of her breast cancer. Metastatic disease was
confirmed; bony metastatic deposits being found in the lumbar spine. She
was referred to the Combined Breast Clinic at Longmore Hospital and was
prescribed Tamoxifen.
At Interview 1, Mrs C reported that she was getting some pain, but that she
was still able to do all the things she was previously able to do. She had
slight difficulty bending down to pick items off the floor and also use the
vacuum cleaner as it was quite heavy. She was able to do all the shopping.
Her main problem concerned her relationship with her husband who had
serious speech difficulties due to his stroke and she found him rather
unsympathetic to her needs. She made a point each day to meet a different
friend for lunch or coffee in order to get her out of the house and have
some independence. Other problems related to her weight (she had put on
a lot of weight since the menopause), and constipation but she did not
think that they had bore any relation to her disease. She said that she
sometimes worried about the disease but she knew how to cope with her
worries.
The other seven interviews took on the same pattern as Mrs C's condition
did not change over the period of the study. This is reflected in Mrs C's
scores at each interview (Table 3) with only minor changes.
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Table 3








1 6 3 0.75 6
2 5 4 0.98 7
3 6 4 0.93 7
4 2 2 0.90 7
5 2 2 0.93 7
6 2 2 0.81 6
7 2 2 0.85 6
8 2 3 0.93 7
It can be seen from Table 3 that the scores on the HAD scores indicate low
levels of anxiety and depression at each interview. Similarly, the CARES
and ERSS scores at each interview indicate high levels of function. Using
the suggestions of the authors of the ERSS [Affleck et al. 1988] to indicate
percentage dysfunction, Mrs C's was, approximately, 25 per cent
throughout the course of the study.
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SECTION B
CHARACTERISTICS OF THE SAMPLE (DESCRIPTIVE DATA)
Sex
All 80 patients recruited to the study were female.
Age
The mean age of the eighty patients recruited to the main descriptive
study was 53.75 years, the standard deviation being 10.26, ranging from 31
years to 72 years.
Marital Status
The majority of patients were married, with only a small number being
separated or divorced, widowed or single (Table 4). In addition, few
patients (n=ll) were living on their own.
Table 4
Marital Status of Patients (n=80)
MARITAL STATUS Number %
Married 64 80.00






The social class of patients in the study was coded using the Office of
Population, Consenses and Surveys [1980] classification of occupations.
This divides social class into five subdivisions (1-5: 1 signifying
professional to 5 signifying unskilled). The majority of patients in the
descriptive study were in the skilled category ( Table 5).
Table 5
Distribution of patient's social class
Social Class Number %
1 Professional 6 7.50
2 Intermediate 20 25.00
3 Skilled 37 46.25
4 Semi-skilled 9 11.25
5 Unskilled 8 10.00
Total 80 100.00
Number and age of children of patients living at home
The interview schedule gathered information on the number of children
the patient had, the age of the youngest child, and the number of children
living at home with the patient (Tables 6-8).
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Table 6
The distribution of patient's number of children
Number of children Number %
no children 14 17.5
one child 10 12.50
two children 41 51.25
three children 12 15.00
four children 3 3.75
Total 80 100.00
Table 6 shows that the majority of patients had two children.
Table 7
The distribution of the age of patient's youngest child




less than 5 years 2 2.50
between 5-10 years 6 7.50
between 10-18 years 5 6.25
older than 18 years 53 66.25
Not applicable 14 17.50
Total 80 100.00
Table 7 shows that the majority of patients had children who were older
than 18 years of age.
88
Table 8





One child 14 17.50
Two children 6 7.50
Three children 2 2.50
Four children 1 1.25
Total 80 100.00
Table 8 shows that the majority of patients had no children living with
them at home.
Time since initial diagnosis of breast cancer
The time since initial diagnosis of breast cancer was categorised into one of
four categories: under three months; between three months and one year;
between one and five years; and over five years. Those patients who had
been diagnosed in the previous three months were those patients whose
first contact with the medical team regarding breast cancer were at the
outset staged as having metastatic breast cancer ( Table 9).
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Table 9




<3 months 19 23.75
3months -1 year 10 12.50
1 year - 5 years 33 41.25
>5 years 18 22.50
Total 80 100.00
Table 9 shows that the majority of patients had been diagnosed to have
primary breast cancer between one and five years before the diagnosis of
metastatic breast cancer.
Original treatment received by patients at initial diagnosis of breast cancer
The first line treatment that patients received at initial diagnosis was
categorised into surgery alone, surgery and adjuvant chemotherapy,
surgery and adjuvant radiotherapy, surgery and adjuvant chemotherapy
and radiotherapy, chemotherapy and radiotherapy, hormone therapy,
radiotherapy, chemotherapy and no treatment ( Table 10).
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Table 10
First Line Treatment at Diagnosis of Breast Cancer (n=80)
Initial Treatment Number %
Surgery alone 16 20.00
Surgery and chemotherapy 11 13.75




Chemotherapy and radiotherapy 2 2.50
Hormone therapy 1 1.25
Radiotherapy 1 1.25
No treatment 18 22.50
Total 80 100.00
Table 10 shows that the majority of patients received a combination of
surgery and radiotherapy as first line treatment of breast cancer.
Site of metastatic breast cancer
The site of metastatic breast cancer was categorised into one of five
categories: bone; liver; lung; bone and one vital organ (lung, brain, or




The distribution of the metastatic site




Bone and one vital organ 5 6.25
Two vital organs 4 5.00
Total 80 100.00
Table 11 shows that the majority of patients had bone metastases at
presentation of metastatic breast cancer (n=33).
Treatment following diagnosis of metastatic breast cancer
The medical treatment patients received following definitive diagnosis of
metastatic breast cancer was categorised into: hormone therapy,
chemotherapy, radiotherapy, surgery, and no treatment (as some patients
had not yet commenced treatment) ( Table 12).
Table 12
Medical Treatment at the First Interview Following Diagnosis of




Hormone Therapy 33 41.25
Chemotherapy 28 35.00
Radiotherapy 1 1.25
No Treatment 18 22.50
Total 80 100.00
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It can be seen from Table 12 that at the first interview, the majority of
patients received hormone therapy following diagnosis of metastatic
breast cancer and that 18 patients were receiving no treatment, the reason
for this being that the first interview had occurred prior to the
commencement of treatment. Therefore, in order to obtain a more
meaningful picture of the medical treatment patients were receiving,
Table 13 details the medical treatment patients were receiving at the
second interview.
Table 13
Medical Treatment at the Second Interview Following Diagnosis of








At the second interview, all patients were receiving treatment, the
majority of whom were receiving hormone therapy, with a signficant
number receiving chemotherapy.
Contact with medical staff
At each interview, patients were asked which members of the
multidisciplinary team they had seen in the previous month. Table 14
shows the percentage of patients who had seen particular members of the
medical team in the previous month.
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Table 14
Medical professional contact during the month before each interview
(percentages shown of those patients who had seen the relevant member
of the multidisciplinary team).
INTERVIEW 1ST 2ND 3RD 4TH 5TH 6TH 7TH 8TH
n=80 n=69 n=62 n=57 n=54 rt=48 n=41 n=36
% % % % % % % %
hospital doctor 100 78 60 56 54 56 54 52
general practitioner 89 85 82 82 81 81 80 78
psychologist/
psychiatrist
5 6 4 6 4 2 2 3
nurse counsellor 40 23 11 23 15 13 12 16
district nurse/ health
visitor
19 13 16 13 11 10 12 13
social worker 2.5 0 0 0 0 0 0 0
physiotherapist 14 0 6 0 2 2 2 3
occupational
therapist
6 3 6 3 4 4 5 5
Table 14 shows the small proportion of patients who had been seen by a
member of the multiprofessional team in the previous month and in
particular the contact with social workers, occupational therapists and
physiotherapists. For example, no patients between interviews 2 and 8 had
seen a social worker in the previous month, and on average only 5 per
cent of patients had seen an occupational therapist or a psychologist. The
importance of these findings will be understood more fully when the
results are presented from the standardised measures of mood (Hospital
Anxiety and Depression Scale), rehabilitation status (Cancer Rehabilitation
Evaluation System and Edinburgh Rehabilitation Status Scale) and
symptomatology (the Rotterdam Symptom Checklist).
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DATA FROM STANDARDISED ASSESSMENT TOOLS
The Hospital Anxiety and Depression Scale (HAD)
The mood state of patients was assessed using the Hospital Anxiety and
Depression Scale (HAD) [Zigmond and Snaith, 1983]. The HAD is designed
to discriminate between anxiety and depression and is made up of a 7-item
anxiety subscale and a 7-item depression subscale. Each item (for example,
"I can laugh and see the funny side of things") is rated on a four-point
scale e.g. as much as I always do (0); not quite so much (1); definitely not so
much (2); and not at all (3), giving subscale scores of 21 for depression and
anxiety. This scale assesses both anxiety and depression experienced during
the previous week. The mean anxiety and depression scores of patients at
interviews 1-8 are shown in Table 15 and 16 respectively.
Table 15
Patients' HAD (Anxiety) Scores at Interviews 1- 8: means and standard
deviations.




1 80 7.24 4.56
2 69 7.54 4.16
3 62 7.57 3.89
4 57 7.47 4.04
5 54 7.89 4.02
6 48 7.44 3.87
7 41 6.85 3.79
8 36 6.56 3.91
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Table 16
Patients' HAD (Depression) Scores at Interview 1-8: means and standard
deviation.




1 80 6.70 4.42
2 69 6.97 4.24
3 62 6.71 3.98
4 57 6.74 3.84
5 54 7.11 3.94
6 48 6.79 3.96
7 41 6.37 3.99
8 36 6.36 4.08
Table 17
Analysis of variance of HAD (anxiety and depression) scores for patients
between interviews 1-8: F ratio and p value.







The analysis of variance described in Table 17 comparing the mean anxiety
and depression levels for each interview demonstrates that there is no
statistically significant difference in mood across the eight interviews. This
is shown graphically in Figure 8.
96
FIGURE 8: MEAN HAD (ANXIETY AND DEPRESSION)
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The scores of the HAD can be used to indicate "caseness". The authors,
Zigmond and Snaith, have devised "cut-off" scores dividing the scale into
normal (0-7), borderline (8-10), and "case" level (11-21). Tables 18-25 below
show the scores of patients on the anxiety and depression subscales of the
HAD at interviews 1-8 using the cut-off scores recommended by the
authors [Zigmond and Snaith, 1983].
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Table 18
HAD (Anxiety and Depression) scores at Interview 1 using the cut-off





0-7 (normal) 46 (57.50) 45 (56.25)
8-10 (borderline) 3 (3.75) 10 (12.50)
11-21 ("case" level) 31 (38.75) 25 (31.25)
Table 19
HAD (Anxiety and Depression) scores at Interview 2 using the cut-off
scores recommended by the authors (n= 69).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 36 (51.25) 38 (55.03)
8-10 (borderline) 14 (20.18) 14 (20.27)
11-21 ("case" level) 19 (28.57) 17 (24.70)
Table 20
HAD (Anxiety and Depression) scores at Interview 3 using the cut-off





0-7 (normal) 30 (48.37) 38 (61.32)
8-10 (borderline) 12 (19.34) 12 (19.34)
11-21 ("case" level) 20 (32.29) 12 (19.34)
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Table 21
HAD (Anxiety and Depression) scores at Interview 4 using the cut-off
scores recommended by the authors (n= 57).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 26 (45.55) 32 (55.99)
8-10 (borderline) 14 (24.54) 17 (29.91)
11-21 ("case" level) 17 (29.91) 8 (14.10)
Table 22
HAD (Anxiety and Depression) scores at Interview 5 using the cut-off





0-7 (normal) 22 (40.70) 28 (51.81)
8-10 (borderline) 13 (24.05) 14 (25.91)
11-21 ("case" level) 19 (35.25) 12 (22.28)
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Table 23
HAD (Anxiety and Depression) scores at Interview 6 using the cut-off
scores recommended by the authors (n= 48).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 22 (45.81) 27 (56.23)
8-10 (borderline) 11 (22.91) 12 (24.98)
11-21 ("case" level) 15 (31.28) 9 (18.79)
Table 24
HAD (Anxiety and Depression) scores at Interview 7 using the cut-off
scores recommended by the authors (n= 41).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 22 (53.60) 26 (63.36)
8-10 (borderline) 11 (26.81) 9 (21.93)
11-21 ("case" level) 8 (19.59) 6 (14.71)
Table 25
HAD (Anxiety and Depression) scores at Interview 8 using the cut-off
scores recommended by the authors (n= 36).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 20 (55.55) 23 (63.89)
8-10 (borderline) 10 (27.78) 7 (19.44)
11-21 ("case" level) 6 (16.67) 6 (16.67)
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Figure 9, below, illustrates the number of patients who scored in the
normal range, borderline range and case range for anxiety on the HAD at
each interview. This shows clearly the relatively large proportion of
patients who fell into the borderline and case ranges using the cut off
scores recommended by the authors.
FIGURE 9: HAD ANXIETY SCORES AT EACH







Figure 10 below illustrates the distribution of the depression scores on the
HAD at each interview using the cut-off scores suggested by the authors.
FIGURE 10: HAD DEPRESSION SCORES AT EACH































The reason for the drop in numbers at each interview (e.g. 80 at interview
1 and 36 at interview 8) was due to patients dying. It could be argued that
the reason for lower mean anxiety and depression scores at Interview 8 is
due to these patients being the "survivors" and higher mean scores at
previous interviews is due to the intrusion of those patients who were
dying and their scores "contaminated" the data from the HAD. Further
analysis was conducted on the data from the "survivors" and those who
died during the course of the study. The results of this analysis is
presented in a Section C.
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The Rotterdam Symptom Checklist (RSCL)
In addition to completing the HAD, patients completed the Rotterdam
Symptom Checklist (RSCL) [de Haes and van Knippenberg, 1983] at each
interview. This scale monitors symptoms in various domains:
psychological e.g. depressed mood, irritable (ten items); gastro-intestinal
e.g. nausea, constipation (seven items); sensory e.g. pain, tingling hands
(two items); fatigue e.g. tiredness, lack of energy (three items); and
miscellaneous symptoms e.g. loss of hair, short of breath (eight items).
Scoring of the RSCL is problem orientated: patients are asked the degree to
which they have been bothered by the indicated symptoms during the past
week on a four point scale from "not at all" (scoring zero) to "very much"
(scoring three) therefore higher scores indicate greater levels of symptoms.
The psychological subscale score yields a maximum score of 30; gastro¬
intestinal 21; sensory 6; fatigue 9; and miscellaneous 24. The means and
standard deviations at each interview are detailed in Tables 26-30 by
domain.
Table 26
Patients RSCL (Psychological Symptoms) Scores at Interviews 1-8: means
and standard deviations.




1 80 7.64 6.03
2 69 8.73 5.84
3 62 7.86 4.63
4 57 8.54 5.27
5 54 8.91 5.17
6 48 8.50 4.80
7 41 7.78 4.81
8 36 7.67 5.04
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Table 27
Patients RSCL (Gastro-intestinal) Scores at Interviews 1-8: means and
standard deviations.




1 80 5.01 3.19
2 69 5.55 4.69
3 62 5.50 3.42
4 57 5.89 3.73
5 54 6.11 3.70
6 48 5.79 3.57
7 41 5.51 3.63
8 36 5.44 3.63
Table 28
Patients RSCL (Sensory) Scores at Interviews 1-8: means and standard
deviations.




1 80 0.61 0.72
2 69 0.73 1.06
3 62 0.81 1.11
4 57 1.40 2.19
5 54 1.44 2.26
6 48 1.17 1.83
7 41 1.07 1.78
8 36 0.97 1.73
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Table 29
Patients RSCL (Fatigue) Scores at Interviews 1-8: means and standard
deviations.




1 80 4.84 2.19
2 69 5.17 2.46
3 62 5.26 2.41
4 57 5.45 2.55
5 54 5.48 2.56
6 48 5.23 2.57
7 41 4.98 2.48
8 36 4.72 2.47
Table 30
Patients RSCL (Miscellaneous Symptom) Scores at Interviews 1-8: means
and standard deviations.





1 80 4.42 2.69
2 69 4.73 3.26
3 62 4.69 2.91
4 57 4.71 3.16
5 54 4.59 2.95
6 48 4.27 2.76
7 41 4.00 2.76
8 36 4.08 2.81
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Table 31
Analysis of variance of RSCL domain scores for patients between
interviews 1-8: F ratios and p values.
RSCL SUBSCALE F ratio Significance
Psychological 2.75 p= 0.009
Gastro-intestinal 4.15 p= 0.0002
Sensory 1.63 p=0.13 (N.S.)
Fatigue 1.67 p=0.12 (N.S.)
Miscellaneous 1.09 p= 0.38 (N.S.)
Table 31 describes the analysis of variance between RSCL domain scores
for patients between interviews 1 and 8 indicating that only two domains
demonstrate a statistically significant difference across interviews: that of
psychological and gastro-intestinal symptoms. The analysis of variance for
the gastro-intestinal domain of the RSCL shows this to be significant at p=
0.002 and the Scheffe multiple range test reveals the significant difference
to be between interview 1 and interview 5 (F= 2.10; df= 7; p= <0.05). The
analysis of variance for the psychological domain of the RSCL
demonstrated this to be significant at p= 0.009. However, the Scheffe
multiple range test did not reveal any significant level of difference
between the interviews suggesting that no one pair of interviews can
account for the statistically significant difference seen overall with the
analysis of variance.
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Figure 11, below, illustrates differences is symptomatology as measured in
the various subscales of the RSCL.
FIGURE 11: RSCL MEAN
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The Cancer Rehabilitation Evaluation System- Short Form (CARES)
The rehabilitation status of each patient was monitored at each interview
using the Cancer Rehabilitation Evaluation System- Short Form (CARES)
[Schag and Heinrich, 1988]. This scale gives a global CARES score as well as
giving a score for each individual subscale (physical, psychosocial, medical
interaction, sexual and marital). The global score and the five subscale
scores were calculated according to the authors' instructions in the CARES
Manual. The raw scores of the CARES are used in the present analysis
because the normative scores which were developed by the authors were
conducted on a relatively small number of patients (n=150) who had
primary breast cancer. In a recent paper published by the authors [Ganz et
al., 1992] they recognise the shortcomings of the normative scores for
patient groups and recommend use of the raw scores of the CARES. Since
the CARES is problem orientated, a lower raw score indicates fewer and/
or less severe problems.
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Table 32
Patients CARES Global Scores at Interviews 1-8: means and standard
deviations.




1 80 0.92 0.64
2 69 0.95 0.56
3 62 0.93 0.49
4 57 0.92 0.48
5 54 0.95 0.50
6 48 0.88 0.45
7 41 0.82 0.44
8 36 0.80 0.46
Table 33
Patients CARES (Physical) Scores at Interviews 1-8: means and standard
deviations.




1 80 1.16 0.69
2 69 1.29 0.85
3 62 1.36 0.77
4 57 1.28 0.68
5 54 1.28 0.68
6 48 1.23 0.68
7 41 1.15 0.66
8 36 1.15 0.68
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Table 34
Patients CARES (Psychosocial) Scores at Interviews 1-8: means and
standard deviations.




1 80 1.05 0.70
2 69 1.53 0.67
3 62 1.11 0.63
4 57 1.09 0.62
5 54 1.11 0.62
6 48 1.08 0.62
7 41 1.01 0.63
8 36 1.01 0.65
Table 35
Patients CARES (Medical Interaction) Scores at Interviews 1-8: means and
standard deviations.




1 80 0.47 0.56
2 69 0.43 0.58
3 62 0.26 0.36
4 57 0.34 0.73
5 54 0.32 0.74
6 48 0.22 0.37
7 41 0.19 0.33
8 36 0.19 0.34
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Table 36
Patients CARES (Sexual) Scores at Interviews 1-8: means and standard
deviations.




1 80 1.34 1.60
2 69 1.40 1.53
3 62 1.19 1.32
4 57 1.06 1.27
5 54 1.07 1.29
6 48 0.81 1.06
7 41 0.68 0.99
8 36 0.61 0.97
Table 37
Patients CARES (Marital) Scores at Interviews 1-8: means and standard
deviations.




1 80 0.32 0.59
2 69 0.38 0.53
3 62 0.31 0.47
4 57 0.41 0.59
5 54 0.42 0.61
6 48 0.40 0.63
7 41 0.30 0.49
8 36 0.25 0.37
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Table 38
Analysis of variance of CARES global and domain scores for patients
between interviews 1-8: F ratios and p values.
CARES F ratio Significance
Global Score 0.42 p— 0.89 (N.S.)
Physical Domain 2.16 p= 0.04
Psychosocial Domain 3.10 p= 0.004
Medical Interaction
Domain
1.09 p= 0.37 (N.S.)
Sexual Domain 2.21 p= 0.03
Marital Domain 0.77 p= 0.61 (N.S.)
Table 38, describing the analysis of variance between CARES domain
scores for patients between interviews 1 and 8, indicates that the only three
domains which demonstrate a statistically significant difference across
interviews are that of the physical, the psychosocial and sexual domains.
The analysis of variance for the physical domain shows this to be
significant at p= 0.04. The Scheffe multiple range test, however, did not
reveal any significant level of difference between the interviews,
suggesting that no one pair of interviews can account for the statistically
significant difference seen overall with the analysis of variance. The
analysis of variance for the psychosocial domain demonstrated this to be
significant at p= 0.004 and the Scheffe multiple range test reveals the
significant difference to be between interview 1 and interview 2 (F= 2.69;
df= 7; p= <0.05). The analysis of variance for the sexual domain
demonstrated this to be significant at p= 0.03. However, the Scheffe
multiple range test did not reveal any significant level of difference
between the interviews suggesting that no one pair of interviews can
account for the statistically significant difference seen overall with the












FIGURE 12: MEAN CARES GLOBAL
SCORES AT EACH INTERVIEW
MEAN CARES GLOBAL SCORE
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The Edinburgh Rehabilitation Status Scale (ERSS)
The researcher also completed the Edinburgh Rehabilitation Status Scale
(ERSS). This scale gives a total score and four subscale scores: support (the
frequency and extent to which the patient relies on others); inactivity (the
ability to initiate, sustain and effectively perform activities); isolation
(involvement in roles, and relationships); and effects of symptoms on
lifestyle (the extent to which the severity and constancy of symptoms and
impairments affect the individual's lifestyle). Scoring of the ERSS is
problem-orientated; each subscale has eight levels (0-7) with the higher
scores representing greater disablement. Each subscale is graded from zero
to seven; zero where there is no abnormality and seven when the degree
of disability is extreme in this dimension. The means and standard




Patients ERSS Total Scores at Interview 1-8: means and standard
deviations.




1 80 7.24 6.16
2 69 6.69 3.53
3 62 8.08 4.95
4 57 9.39 5.42
5 54 6.32 3.51
6 48 5.96 3.52
7 41 6.05 3.63
8 36 5.97 3.73
Table 40
Patients ERSS (Support Subscale) Scores at Interviews 1-8: means and
standard deviations.




1 80 2.06 1.59
2 69 1.94 1.08
3 62 2.23 1.48
4 57 2.51 1.62
5 54 1.67 1.17
6 48 1.52 1.13
7 41 1.44 1.03
8 36 1.47 1.08
113
Table 41
Patients ERSS (Inactivity Subscale) Scores at Interviews 1-8: means and
standard deviations.




1 80 1.73 1.57
2 69 1.65 1.03
3 62 2.21 1.37
4 57 2.74 1.55
5 54 2.00 1.08
6 48 1.94 1.08
7 41 2.05 1.18
8 36 1.92 1.16
Table 42
Patients ERSS (Isolation Subscale) Scores at Interviews 1-8: means and
standard deviations.




1 80 0.87 1.56
2 69 0.36 0.54
3 62 0.57 1.00
4 57 0.59 0.79
5 54 0.22 0.46
6 48 0.21 0.46
7 41 0.02 0.16
8 36 0.11 0.32
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Table 43
Patients ERSS (Effect of Symptoms Subscale) Scores at Interviews 1-8:
means and standard deviations.





1 80 2.65 1.89
2 69 2.69 1.45
3 62 3.08 1.61
4 57 3.58 1.88
5 54 2.48 1.31
6 48 2.31 1.26
7 41 2.56 1.58
8 36 2.47 1.46
Table 44
Analysis of variance of ERSS total and subscale scores for patients between
interviews 1-8: F ratios and p values.
ERSS F ratio Significance
Total score 6.96 p=0.0001
Support subscale 4.64 P=0.0001
Inactivity subscale 9.92 p=0.0001





Table 44, describing the analysis of variance between ERSS total scores for
patients between interviews 1 and 8, indicates a statistically significant
difference across interviews. The analysis of variance for the ERSS total
score shows this to be significant at p= 0.0001 and the Scheffe multiple
range test reveals the significant difference to be between interview 2 and
interview 4 (F= 5.08; df= 7; p= <0.05). In addition the analysis of variance
between the ERSS support subscale scores between interviews 1 and 8,
indicates a statistically significant difference across interviews. The
analysis of variance for the support subscale score of the ERSS shows this
to be significant at p= 0.0001 and the Scheffe multiple range test reveals the
signficant difference to be between interviews 1 and 4 (F= 2.05; df= 7; p=
<0.05). The analysis of variance between the ERSS inactivity subscale
scores between interviews 1 and 8 indicates a statistically significant
difference across interviews. The analysis of variance for the inactivity
subscale score of the ERSS shows this to be significant at p= 0.0001 and the
Scheffe multiple range test reveals the significant difference to be between
interviews 1 and 3 (F= 3.49; df= 7; p<0.05), 1 and 4 (F= 8.04; df= 7; p<0.05), 1
and 5 (F= 2.27; df= 7; p<0.05), 1 and 6 (F= 2.65; df= 7; p<0.05), 1 and 7 (F=
3.49; df= 7; p<0.05), and 1 and 8 (F= 2.85; df= 7; p<0.05). The analysis of
variance between the isolation subscale between interviews 1 and 8
indicates a statistically significant difference across interviews. The
analysis of variance for the isolation subscale score of the ERSS shows this
to be significant at p = 0.005. However, the Scheffe multiple range test did
not reveal any significant difference between the interviews suggesting
that no one pair of interviews can account for the statistically significant
difference seen overall with the analysis of variance. The analysis of
variance between the effect of symptoms on lifestyle subscale between
interviews 1 and 8 indicates a statistically significant difference across
interviews. The analysis of variance for the effect of symptoms on lifestyle
subscale score of the ERSS shows this to be significant at p = 0.0001 and the
Scheffe multiple range test revealed the significant difference to be
between interviews 1 and 3 (F=3.69; df=7; p<0.05) and 1 and 4 (F= 4.49; df=
7; 0 <0.05). Figure 13 illustrates the mean ERSS total scores at each
interview.
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The authors of the ERSS [Affleck et al. 1988] suggest that total scores can
give an indication of level of functioning and also give a percentage level
of dysfunction. Using these, the mean ERSS total scores can be interpreted
to indicate that the mean level of functioning at Interviews 1-3 was high
(25-29 per cent dysfunction). At Interviews 4 the mean level of functioning
was moderate but noticeable (32 per cent dysfunction) and at Interviews 5-
8 the mean level of functioning was high (21 per cent dysfunction).
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SECTION C
ANALYSIS OF THE DATA FROM THOSE PATIENTS WHO SURVIVED
THROUGHOUT THE COURSE OF THE DESCRIPTIVE STUDY
Further analysis was conducted on the data obtained from patients who
survived throughout the course of the descriptive study (n=36). It was
thought appropriate to analyse this data in an additional data set, in order
to examine, in more detail, the rehabilitation status of these patients and
determine levels of symptomatology, anxiety and depression. In addition,
information is given regarding their demographic details.
Age
The mean age of the "survivors" was 59.3 years, the standard deviation
being 7.39, ranging from 45 to 72 years.
Marital status and social class
The majority of patients were married (n=28) and belonged to social class 3
(skilled).
Number and age of children
The majority of patients had two children (n=17) and majority of patients
had children who were older than 18 years of age (n= 17).
Time since initial diagnosis of breast cancer and treatment
The majority of these "survivors" had been diagnosed between 1 and 5
years previously (n= 16). However, a significant number had been
diagnosed more than five years previously (n= 12).
The majority of "survivors" had received surgery and radiotherapy (n=14)
as treatment at original presentation.
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Site of metastasis and current medical treatment
The majority of the "survivors" had bone metastases (n= 22) and the
majority of patients were receiving hormone therapy (n= 25).
DATA FROM THE STANDARDISED QUESTIONNAIRES OF THE
SURVIVORS
The Hospital Anxiety and Depression Scale (HAD)
Table 45
"Survivors" HAD (Anxiety) Scores at Interviews 1- 8: means and standard
deviations.




1 36 5.97 4.35
2 36 6.58 4.37
3 36 6.53 4.04
4 36 6.25 3.89
5 36 6.50 3.88
6 36 6.58 3.87
7 36 6.50 3.87
8 36 6.56 3.91
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Table 46
"Survivors'" HAD (Depression) Scores at Interview 1-8: means and
standard deviation.




1 36 5.19 4.05
2 36 5.86 3.91
3 36 6.19 4.21
4 36 6.00 4.15
5 36 6.17 4.19
6 36 6.19 4.18
7 36 6.17 4.19
8 36 6.36 4.08
Table 47
Analysis of variance of HAD (anxiety and depression) scores for the
"survivors" between interviews 1-8: F ratio and p value.






p = 0.25 (N.S.)
The analysis of variance described in Table 47 comparing the mean
anxiety and depression levels for each interview of the "survivors"
demonstrates that there is no statistically significant difference in mood
across the eight interviews.
Using the cut-off scores suggested by the authors of the HAD [Zigmond
and Snaith, 1983], Table 45 below show the scores of the "survivors" on
the anxiety and depression subscales of the HAD at interviews 1-8.
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Table 48
HAD (Anxiety and Depression) scores of the "survivors" at Interview 1-8
using the cut-off scores recommended by the authors (n=36).
HAD Score Anxiety Depression
n (%) n (%)
HAD 1 0-7 (normal) 24 66.67 24 66.67
8-10 (borderline) 3 8.33 4 11.11
11-21 ("case" level) 9 25.00 8 22.22
HAD 2 0-7 (normal) 22 61.11 24 66.67
8-10 (borderline) 6 16.67 5 13.89
11-21 ("case" level) 8 22.22 7 19.44
HAD 3 0-7 (normal) 22 61.11 24 66.67
8-10 (borderline) 5 13.89 5 13.89
11-21 ("case" level) 9 25.00 7 19.44
HAD 4 0-7 (normal) 21 58.33 24 16.67
8-10 (borderline) 9 25.00 7 19.44
11-21 ("case" level) 6 16.67 5 13.89
HAD 5 0-7 (normal) 20 55.55 24 66.67
8-10 (borderline) 10 27.78 6 16.67
11-21 ("case" level) 6 16.67 6 16.67
HAD 6 0-7 (normal) 20 55.55 24 66.67
8-10 (borderline) 9 25.00 6 6.67
11-21 ("case" level) 7 19.44 6 6.67
HAD 7 0-7 (normal) 21 58.83 24 66.67
8-10 (borderline) 9 25.00 6 16.67
11-21 ("case" level) 6 16.67 6 16.67
HAD 8 0-7 (normal) 20 55.55 23 63.89
8-10 (borderline) 10 27.78 7 19.44
11-21 ("case" level) 6 16.67 6 16.67
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The Rotterdam Symptom Checklist (RSCL)
Table 49
"Survivors" RSCL (Psychological Symptoms) Scores at Interviews 1-8:
means and standard deviations.




1 36 5.69 5.10
2 36 7.33 5.78
3 36 7.17 4.86
4 36 7.44 5.15
5 36 7.67 5.04
6 36 7.72 5.00
7 36 7.67 5.04
8 36 7.67 5.04
Table 50
"Survivors" RSCL (Gastro-intestinal) Scores at Interviews 1-8: means and
standard deviations.




1 36 4.39 2.76
2 36 3.86 3.67
3 36 5.08 3.29
4 36 5.31 3.85
5 36 5.44 3.69
6 36 5.47 3.67
7 36 5.44 3.69
8 36 5.44 3.63
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Table 51
"Survivors" RSCL (Sensory) Scores at Interviews 1-8: means and standard
deviations.




1 36 0.64 0.72
2 36 0.53 0.85
3 36 0.69 0.98
4 36 0.94 1.71
5 36 0.97 1.73
6 36 0.97 1.73
7 36 0.97 1.73
8 36 0.97 1.73
Table 52
"Survivors" RSCL (Fatigue) Scores at Interviews 1-8: means and standard
deviations.




1 36 4.06 1.97
2 36 4.28 2.37
3 36 4.75 2.42
4 36 4.69 2.45
5 36 4.72 2.47
6 36 4.72 2.47
7 36 4.72 2.47
8 36 4.72 2.47
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Table 53
"Survivors" RSCL (Miscellaneous Symptom) Scores at Interviews 1-8:
means and standard deviations.





1 36 4.33 2.92
2 36 3.44 2.47
3 36 4.31 2.57
4 36 4.08 2.81
5 36 4.08 2.81
6 36 4.08 2.81
7 36 4.08 2.81
8 36 4.08 2.81
Table 54
Analysis of variance of RSCL domain scores for "survivors" between
interviews 1-8: F ratios and p values.
RSCL SUBSCALE F ratio Significance
Psychological 2.72 p = 0.01
Gastro-intestinal 4.07 p = 0.0007
Sensory 1.60 p = 0.14 (N.S.)
Fatigue 1.66 p = 0.13(N.S.)
Miscellaneous 1.15 p = 0.33 (N.S.)
Table 54 shows the analysis of variance for the RSCL domain scores from
interviews 1 to 8. The analysis of variance of the psychological domain of
the RSCL between interviews 1 and 8 shows this to be statistically
significant (p= 0.01). However the Scheffe multiple range test did not
reveal this to be significant, therefore no two pair of interviews can
account for this statistical significance. The analysis of variance of the
gastro-intestinal domain of the RSCL between interviews between
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intervies 1 and 8 this to be statistically significant (p= 0.0007). The Scheffe
multiple range test found this to be significant between interviews 2 and 6
(F= 2.10; df=7; p<0.05).
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The Cancer Rehabilitation Evaluation System - Short Form (CARES)
In order to simplify the results of the data from the "survivors", only the
CARES Global scores will only be presented in table-form.
Table 55
"Survivors" CARES Global Scores at Interviews 1-8: means and standard
deviations.




1 36 0.77 0.72
2 36 0.81 0.50
3 36 0.87 0.52
4 36 0.79 0.46
5 36 0.80 0.46
6 36 0.81 0.46
7 36 0.80 0.46
8 36 0.80 0.46
Table 56
Analysis of variance of CARES global and domain scores for patients
between interviews 1-8: F ratios and p values.
CARES F ratio Significance
Global Score 0.44 p =0.85 (N.S.)
Physical Domain 2.22 p = 0.04
Psychosocial Domain 3.18 p = 0.005
Medical Interaction
Domain
1.10 p =0.36 (N.S.)
Sexual Domain 2.11 p = 0.05
Marital Domain 0.80 p = 0.57 (N.S.)
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Table 56 shows the results of the analysis of variance for the CARES global
and subscales scores indicating two statistically significant differences
across interviews: the physical; the psychosocial; and the sexual domains.
The analysis of variance for the physical domain shows this to be
significant at p = 0.04. The Scheffe multiple range test, however, did not
reveal any signficant level of difference between the interviews,
suggesting that no one pair of interviews can account for the statistically
significant difference seen overall with the analysis of variance. The
analysis of variance for the psychosocial domain demonstrated this to be
signficant at p = 0.005 and the Scheffe multiple range test reveals the
signficant difference to be between interview 1 and interview 3 ( F= 2.69;
df=7; p<0.05). The analysis of variance for the sexual domain
demonstrated this to be significant at p = 0.05. However, the Scheffe
multiple range test did not reveal any significant level of difference
between the interviews suggesting that no one pair of interviews can
account for the statistically signficant difference seen overall with the
analysis of variance.
The Edinburgh Rehabilitation Status Scale (ERSS)
Only the ERSS total scores are presented below in Table 57 .
Table 57
"Survivors" ERSS Total Scores at Interview 1-8: means and standard
deviations.




1 36 4.86 4.87
2 36 5.97 3.73
3 36 7.50 5.14
4 36 8.19 5.58
5 36 5.97 3.73
6 36 5.97 3.73
7 36 5.97 3.73
8 36 5.97 3.73
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Table 58
Analysis of variance of ERSS scores for the "survivors' between
interviews 1 and 8: F ratio and p value.
ERSS F ratio Significance
Total score 7.07 p = 0.0001
Table 58 shows the analysis of variance between ERSS scores for patients
between interviews 1 and 8, which indicates a statistically signficant
difference across interviews. The analysis of variance for the ERSS shows
this to be signficant at p = 0.0001 and the Scheffe multiple range test
reveals the signficant difference to be between interview 1 and interview 4
(F= 5.23; df= 7; p<0.05).
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ANALYSIS OF THE DATA FROM PATIENTS WHO DIED DURING THE
COURSE OF THE STUDY
In the present study, the sample reduced from 80 patients to 36 during the
course of 16 months, due to patients dying from their disease. However,
further analysis can also be carried out on the data from those patients
who died during the course of the study. Using the data from the last
interview before death to act as a "single point", separate analysis was
conducted and details were obtained regarding their demography,
rehabilitation status and symptomatology of this "sub-sample".
Characteristics of the patients who died during the course of the study
Age
The mean age of the 44 patients who died during the course of the study
was 49.2 years, the standard deviation being 10.1, ranging from 31 to 69
years.
Marital status
The majority of patients were married (n=36), with only a small number
being separated or divorced, widowed or single.
Social Class
Using the same OPCS coding classification as in the main study, the social
class of patients who died during the course of the study was coded,
dividing social class into five subdivisions (1-5: 1 signifying professional to
5 signifying unskilled). The majority of patients in this analysis belonged
to social class 3 (skilled category) (n=20).
Time since initial diagnosis of breast cancer
The time since initial diagnosis of breast cancer was categorised for this
sub-group of patients into one of four categories: under six months;
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between six months and one year; between one and five years; and over
five years. The majority of patients had been diagnosed between one and
five years before the diagnosis of metastatic breast cancer (n= 21).
Site of metastastic spread
The majority of patients who died during the course of the study had lung
metastases (n=13). In addition a large proportion had liver metastases
(n=9).
Medical treatment before death
The medical treatment patients were receiving before death was
categorised into: hormone therapy, chemotherapy, radiotherapy, surgery,
and no treatment. The majority of patients were receiving chemotherapy
before they died (n=25).
Contact with medical staff
Patients were asked which members of the multidisciplinary team they
had seen in the previous month. Table 59 below shows the medical




Medical professional contact during the month before last interview
before death (percentages shown who had seen the relevant member of





















DATA FROM THE STANDARDISED QUESTIONNAIRES OF THOSE
WHO DIED DURING THE STUDY:
The Hospital Anxiety and Depression Scale (HAD)
Using the HAD, patient's levels of anxiety and depression were assessed
before death. The mean anxiety and depression scores of patients at their
last interview before death are shown below in Table 60.
Table 60
Patients' HAD (Anxiety and Depression) Scores at the Last Interview
before Death: means and standard deviation (n=44).
Mean Score Standard
Deviation
HAD (Anxiety) 10.50 3.50
HAD(Depression) 9.82 4.00
Using the cut-off scores recommended by the authors to indicate
"caseness" [Zigmond and Snaith, 1983], Table 61 below shows the scores of
patients on the anxiety and depression subscales of the HAD at the last
interview before death.
Table 61
HAD (Anxiety and Depression) scores at last interview before death using
the cut-off scores recommended by the authors (n= 44).
HAD Score Anxiety Depression
n (%) n (%)
0-7 (normal) 9 (20) 12 (27)
8-10 (borderline) 6 (14) 10 (23)
11-21 ("case" level) 29 (66) 22 (50)
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An interesting finding from Table 61 above is the relatively high number
of patients who scored in the "case" level range for anxiety and depression.
This is illustrated in Figure 14.
FIGURE 14: HAD ANXIETY AND DEPRESSION
SCORES AT THE LAST INTERVIEW BEFORE




























The Rotterdam Symptom Checklist
Using the data obtained from the RSCL, patient's levels of symptoms
(means and standard deviations) at the last interview before death are
shown below in Table 62.
Table 62
Patients RSCL (Psychological Symptoms) Scores at Interviews 1-8: means
and standard deviations.
RSCL DOMAIN Number Mean RSCL Score Standard
Deviation
psychological 44 11.70 5.95
gastro-intestinal 44 7.50 3.88
sensory 44 1.50 2.15





The Cancer Rehabilitation Evaluation System (CARES)
Table 63
Patients CARES Global and Domain Scores (means and standard
deviations) at the last interview before death.
Number Mean CARES Score Standard
Deviation
Global score 44 1.33 0.52
Physical score 44 1.77 0.74
Psychosocial score 44 1.42 0.58
Medical Interaction 44 0.74 0.85
Marital score 44 0.62 0.76
Sexual score 44 1.93 1.53
The Edinburgh Rehabilitation Status Scale (ERSS)
Table 64
Patients ERSS total and subscale scores (means and standard deviations) at
the last interview before death.
ERSS Number Mean ERSS Score Standard
Deviation
Total score 44 10.02 5.15
Support subscale 44 2.57 1.70
Inactivity subscale 44 2.59 1.58





Comparison of data from those patients who died during the course of the
study and the "survivors"
Comparisons of the data from the "survivors" with those patients who
died during the course of the study were carried out. The reason for the
comparisons were to find out whether there were any significant
differences between the two groups.
Age
Table 65
Comparison of ages of the survivors and those patients who died during
the course of the study: means and standard deviations
Group of patients Number Mean Age Standard
Deviation
Survivors 36 59.31 7.40
Patients who died 44 49.21 10.10
Using an unrelated t test on the data (t = 5.00; df=78) the results were
found to be significant (p <0.001). Further inspection of the results suggest
that the survivors were older than those patients who died during the
course of the study.
Social class and marital status
Using a chi square test, the social class and marital status of the two groups
were compared to test whether they differed signficantly. The results were
found not to be significant.
Site of metastatic breast cancer
The data concerning the site of metastatic breast cancer in the survivors
and the patients who died was subjected to a chi square test. These results
did not reach statistical significance (X2= 11.46; df = 6; p = 0.10 N.S.).
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Medical treatment for the metastatic disease
The data concerning the medical treatment for the metastatic disease of
the survivors and those patients who died was subjected to a chi square
test. The results did achieve statistical significance (X2 = 15.92; df = 3; p
<0.01). On closer examination of the results, it would suggest that
significantly more patients who survived were receiving hormone
therapy compared to those patients who died.
Comparisons of the data from standardised questionnaires
Due to the bulk of data gathered on patients, it was necessary to select
items from the "survivors" and those patients who died for comparison.
To this end, comparisons will be described from the HAD scale, the
CARES global score and the ERSS total score. The point used for
comparison for the patients who died was the last interview before death,
and the point used for patients who survived was the eighth interview.
The Hospital Anxiety and Depression Scale
Table 66
Comparison of HAD anxiety scores of the survivors and those patients
who died during the course of the study: means and standard deviations
Group of patients Number Mean HAD anxiety Standard
score Deviation
Survivors 36 5.97 4.35
Patients who died 44 10.45 3.51
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Table 67
Comparison of HAD depression scores of the survivors and those patients
who died during the course of the study: means and standard deviations




Survivors 36 5.19 4.05
Patients who died 44 9.82 3.99
Using an unrelated t test on the anxiety subscale data from the HAD (t =
-5.11; df=78), the results were found to be significant at p <0.001 for a two-
tailed hypothesis. This means that the anxiety levels, as measured by the
HAD, differed significantly in the two groups. Further inspection of the
results suggest that those patients who died during the course of the study
had higher levels of anxiety than those patients who survived throughout
the course of the study.
The same test was used to analyse the depression subscale of the HAD (f=
-5.12; df=78), the results were found to be significant at p <0.001 for a two-
tailed hypothesis. This means that the depression levels, as measured by
the HAD, differed significantly in the two groups. Similar to the findings
of the analysis of the anxiety subscale, further inspection of the results
suggest that the depression levels of those patients who died during the
course of the study had higher levels of depression than those patients
who survived throughout the course of the study.
Table 67a
Comparison of HAD anxiety and depression scores of the survivors (n = 36) and those patients who
died after Interview 2 (n = 33) during the course of the study at Interview 1, 2 and the last interview























p = 0.08 (M.S.)
Interview 1


















Patients who died 10.39 3.03 9.33 3.73
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The Cancer Rehabilitation Evaluation System
Table 68
Comparison of CARES global scores of the survivors and those patients
who died during the course of the study: means and standard deviations
Group of patients Number Mean CARES global Standard
score Deviation
Survivors 36 0.77 0.72
Patients who died 44 1.33 0.52
Comparisons were made between the global scores of the CARES of the
two groups using an unrelated t test. The results (t= -4.04; df =78)) were
found to be significant at p <0.001 for a two-tailed hypothesis. This means
that the CARES global scores differed significantly in the two groups.
Further inspection of the results suggest that the patients who died during
the course of the study had significantly higher CARES global scores than
those patients who survived.
The Edinburgh Rehabilitation Status Score
Table 69
Comparison of ERSS total scores of the survivors and those patients who
died during the course of the study: means and standard deviations
Group of patients Number Mean ERSS total score Standard
Deviation
Survivors 36 2.94 1.04
Patients who died 44 10.02 5.15
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Comparisons were made between the total scores of the ERSS of the two
groups using an unrelated t test. The results (t = -8.10; df= 78) were found
to be significant at p <0.001 for a two-tailed hypothesis. Further inspection
of the results suggest that the patients who died during the course of the
study had significantly higher ERSS total scores at the last interview before
death than those patients who survived at outset.
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SECTION D
FACTORS WHICH CONTRIBUTE TO REHABILITATION STATUS
In order to identify contributory factors to the rehabilitation status in the
total sample of patients with metastatic breast cancer, correlations were
ascertained with the CARES global scores and the ERSS total scores.
The contribution of demographic variables to rehabilitation status
A range of demographic details were collected on patients and their
relationship to rehabilitation status was examined. No significant
associations were found between rehabilitation status as measured by the
CARES global score and the ERSS total score, and the following
demographic details: age, marital status, social class, number of children,
the age of their children and the number of children staying at home.
The contribution of illness and treatment variables to rehabilitation status
A range of variables were collected concerning medical treatment and
diagnosis and their relationship to rehabilitation status was examined. No
significant associations were found between rehabilitation status as
measured by the CARES global score and the ERSS total score and the
following variables: time since original diagnosis; original treatment at
presentation of primary breast cancer; patient's medical treatment; and
patient's site of metastatic spread.
The contribution of mood to rehabilitation status
The relationship between rehabilitation status and mood state was
examined. The correlations between HAD anxiety and depression scores
and the CARES global scores and the ERSS total scores achieved statistical
significance. The correlations are shown below (Table 70) for interview
variables at the first, fourth, and eighth interview, as it was necessary to
impose a structure on the data due to the bulk of data gathered.
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Table 70
Correlations and levels of statistical significance between the CARES
global score and ERSS total score, and HAD (anxiety and depression) score
at interviews 1, 4 and 8.
SCALE HAD SUBSCALE r p VALUE
ERSS 1 HAD (ANXIETY) 1 0.45 PcO.Ol
ERSS 1 HAD (DEIRESSICN)1 0.67 PcO.001
CARES GLOBAL 1 HAD (ANXIETY) 1 0.52 P<0.001
CARES GLOBAL1 HAD (DEPRESSION) 1 0.50 PcO.Ol
ERSS 4 HAD (ANXIETY) 4 0.65 P<0.001
ERSS 4 HAD (DEFKESSICN) 4 0.70 P<0.0001
CARES GLOBAL 4 HAD (ANXIETY) 4 0.76 P<0.0001
CARES GLOBAL4 HAD (DEPRESSION) 4 0.82 P<0.0001
ERSS 8 HAD (ANXIETY) 8 0.61 P<0.001
ERSS 8 HAD (DEPRESSION) 8 0.55 P<0.001
CARES GLOBAL 8 HAD (ANXIETY) 8 0.77 P<0.0001
CARES GLOBAL 8 HAD (DEPRESSION) 8 0.83 PcO.0001
Using Pearson product moment correlations, the results shown in Table
70 would appear to indicate that the total scores of the ERSS and the global
CARES scores correlate positively with anxiety and depression as
measured by the HAD, indicating that patients with higher levels of
anxiety and depression have higher ERSS total scores and higher CARES
global scores.
The contribution of symptomatology to rehabilitation status.
The relationship between rehabilitation status (as measured by the CARES
global score and the ERSS total score) and symptomatology (as measured
by the RSCL) was examined. The correlations between some subscales on
the RSCL scores and the CARES global scores and the ERSS total scores
achieved statistical significance. For ease of presentation, the correlations
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Symptoms correlated significantly with rehabilitation status at interviews
1,4 and 8.




CARES 1 RSCL (FATIGUE
SUBSCALE) 1
0.49 P<0.01
CARES 1 RSCL (SYMPTOM
SUBSCALE) 1
0.47 P<0.01
ERSS 4 RSCL (PSYCHOLOGIC
SUBSCALE) 4
LL 0.76 p<0.0001
ERSS 4 RSCL (FATIGUE
SUBSCALE) 4
0.62 p<0.001
CARES GLOBAL 4 RSCL (FATIGUE
SUBSCALE) 4
0.67 P<0.001




CARES GLOBAL 4 RSCL (SYMPTOM
SUBSCALE) 4
0.78 P<0.0001














CARES 8 RSCL (FATIGUE
SUBSCALE) 8
0.69 P<0.001








Using Pearson product moment correlation test, the results are shown in
Table 71 indicating that the ERSS total and CARES global scores correlate
significantly with symptomatology measured by the RSCL.
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Stepwise Multiple Regression Analysis
The variables contributing to rehabilitation status measured in patients by
the ERSS total score and CARES global score were examined in more
detail in order to determine the interrelationships between variables. This
was achieved by an automated stepwise multiple regression analysis with
alpha to enter at 0.05 level of significance and alpha to remove of 0.1
[Dillon and Goldstein, 1984]. It was necessary to impose a structure on the
data from this study and, due to the large quantity of data gathered, be
selective in the choice of variables to be examined. To this end, data from
interviews 1, 4 and 8 were selected and, in order to satisfy the aims of the
study, focus on the contribution and relationship of variables to the
CARES global score and ERSS total score. All the variables assessed by the
standardised measures at Interviews 1, 4, and 8 were entered, as well as
certain demographic details (age, and social class).
Automated stepwise regression analysis was utilised to examine the
contribution of variables to the ERSS total score at Interview 1 and the
CARES global score at Interview 1. Using the CARES global score at
Interview 1 as the dependent variable three variables were identified as
contributing significantly ( Table 72).
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Table 72
Stepwise multiple regression analysis with CARES global score at
Interview 1 as the dependent variable
Step Variable entered r Contribution to
R2
Cumulative R2
1 HAD(depression) 1 0.61 0.37 0.37
2 RSCL (fatigue) 1 0.71 0.14 0.51
3 RSCL (sensory) 1 0.74 0.03 0.54
The variables identified as contributing significantly to the variance of the
CARES global score at Interview 1, accounting for 54 per cent of the
variance, were the HAD depression score, the RSCL fatigue and sensory
subscales at Interview 1 (F=45.15; df=l, 79; p<0.001).
Using the ERSS total score as the dependent variable, three variables were
identified as contributing significantly to it (Table 73 ).
Table 73
Stepwise multiple regression analysis with ERSS total score at Interview 1
as the dependent variable.
Step Variable entered r Contribution to
R2
Cumulative R2
1 CARES (physical) 1 0.83 0.69 0.69
2 CARES (marital) 1 0.17 0.03 0.72
3 RSCL (sensory) 1 0.16 0.03 0.75
The three variables which were significantly associated with the ERSS
total score at Interview 1, and accounted for 75 per cent of the variance,
were the CARES physical and marital domain scores at Interview 1 and
the sensory subscale of the RSCL at Interview 1 (F= 177.44; df=l, 79;
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p<0.001). This would suggest that patients with a higher physical and
marital domain score and a high score on the sensory subscale of the RSCL
had a higher ERSS score at Interview 1.
The stepwise analysis of the CARES global score at Interview 4 as the
dependent variable produced four variables which significantly
contributed to it ( Table 74).
Table 74
Stepwise multiple regression analysis using patients' CARES global score
at Interview 4 as the dependent variable.
Step Variable entered r Contribution to
R2
Cumulative R2
1 Age -0.51 0.25 0.25
2 CARES (physical) 1 0.37 0.14 0.39
3 HAD (anxiety) 1 0.67 0.06 0.45
4 RSCL (psychological) 1 0.70 0.04 0.49
The four variables which significantly contributed to the CARES global
score at Interview 4 were the patient's age, the patient's CARES physical
domain score, HAD anxiety score and the RSCL psychological subscale
score at Interview 1. These four variables accounted for 49 per cent of the
variance of the dependent variable (F= 17.44; df= 1, 52; p<0.001). This data
would suggest therefore that younger patients with higher CARES
physical domain scores, higher HAD anxiety scores and higher RSCL
psychological subscale scores at Interview 1 had higher CARES global
scores at Interview 4.
The stepwise analysis of the ERSS total score at Interview 4 as the
dependent variable produced two variables which significantly
contributed to it ( Table 75 ).
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Table 75
Stepwise multiple regression analysis with ERSS total score at Interview 4
as the dependent variable
Step Variable entered r Contribution to
R2
Cumulative R2
1 Age -0.52 0.27 0.27
2 CARES (physical) 1 0.63 0.13 0.40
The variables which contributed significantly to the ERSS total score at
Interview 4 were the patient's age and the CARES physical domain score
at Interview 1 (F=19.20; df=l, 52; p<0.001) and these variables accounted for
40 per cent of the variance of the dependent variable.
The dependent variables were patients CARES and ERSS global and total
scores respectively at Interview 8. Two variables emerged from this
analysis as contributing to patients' CARES global scores at Interview 8
(Table 76).
Table 76
Stepwise multiple regression analysis using patients' CARES global score
at Interview 8 as the dependent variable.
Step Variable entered i Contribution to
R2
Cumulative R2
1 HAD(depression) 1 0.58 0.34 0.34
2 Age -0.67 0.11 0.45
The two variables significantly associated with the CARES global score at
Interview 8 were the HAD depression score at interview 1 and the
patient's age. These two variables accounted for 45 per cent of the variance
of the dependent variable and in combination produced a significant
association (F= 17.53; df=l, 35; p <0.001). This data would suggest that
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younger patients with the higher depression scores at Interview 1 have the
highest CARES global scores at Interview 8.
An automated stepwise procedure using the same levels of inclusion and
exclusion were performed using the ERSS total scores at Interview 8 as the
dependent variable (Table 77 ).
Table 77
Stepwise multiple regression analysis using patients' ERSS total score at
Interview 8 as the dependent variable.











In the latter analysis, the patient's HAD depression score at Interview 1
and the patient's CARES score in the sexual domain at Interview 1
emerged as contributing significantly to the patient's ERSS total score at
Interview 8 (F=24.05; df=l, 35; p<0.001), accounting for 49 per cent of the
variance of the dependent variable. This data would suggest, therefore,
that patients with higher HAD depression scores and higher CARES
sexual domain scores at Interview 1 would have higher ERSS total scores
at Interview 8 i.e the presence of depression at diagnosis of metastatic
breast cancer predicts poor rehabilitation status outcome.
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Reduction of the data: factor analysis
The main descriptive study examined a large number of variables in
patients with metastatic breast cancer. One method of reducing these data
sets and exploring further the possible underlying structure and
interrelationships between variables was to embark on a factor analysis
[Child, 1990]. The variables measured from Interviews 1,4 and 8 were
subjected to a factor analysis and the optimum explanation of the variance
obtained (only the standardised questionnaire data were entered into the
factor analysis and demographic data (age, and social class).
Using StatView [1988], the method of factor extraction was a principal
component analysis which performs a simple eigenvalue-eigenvector
analysis of the correlation matrix in its original form. The number of
factors was restricted to those factors having an eigenvalue of one or
greater than one. The data are shown as an unrotated factor matrix (Table
78) and then the data are subjected to an orthogonal, varimax rotation
thus producing factors which are independent of each other (Table 79).
Table 80 is included to demonstrate more clearly the nine factors, their




Unrotated factor matrix of variables associated with data from main
descriptive study.
VARIABLE Factorl Factor2 Factor3 Factor 4 Factors Factor6 Factor7 Factor 8 Factor9
AGE -0.28 -0.45 0.09 -0.01 -0.51 0.39 -0.16 -0.14 0.03
NUMBER OF
CHILDREN
-0.15 0.21 -0.06 -0.04 0.65 0.05 -0.25 0.04 -0.24
SOCIAL
CLASS
0.18 0.25 0.07 0.22 0.19 -0.31 0.74 -0.19 0.08
HAD(ANX) 1 0.71 -0.39 -0.01 0.14 -0.04 -0.46 -0.13 -0.11 -0.07
HAD(DEP)1 0.73 -0.49 0.19 0.07 -0.11 -0.10 -0.18 0.15 0.01
CARES
(PHYS)l
0.71 -0.33 0.37 -0.28 -0.19 0.15 0.08 0.04 0.11
CARE
(PSYCHO) 1
0.59 -0.37 0.26 -0.35 0.19 -0.04 0.31 -0.03 -0.22
CARES
(MED.INT.)1
0.44 -0.16 0.44 -0.29 0.15 0.45 0.19 0.14 -0.20
CARES
(SEXUAL) 1
0.15 0.54 0.53 -0.12 0.34 -0.31 -0.04 0.06 0.11
CARES
GLOBAL 1
0.41 -0.17 0.54 -0.17 0.23 -0.37 -0.16 0.01 -0.28
RSCL
(PSYCH) 1
0.55 -0.51 0.31 -0.04 -0.21 -0.22 -0.02 -0.12 0.31
RSCL(GI) 1 0.52 -0.01 0.33 0.44 0.09 0.19 -0.33 -0.18 0.29
RSCL
(SENSORY)l
-0.14 0.28 0.31 0.51 0.18 -0.26 -0.27 -0.23 -0.01
RSCL
(FATIGUE)l
0.40 -0.07 0.56 0.01 0.44 0.06 -0.02 0.25 0.31
RSCL
(MISCELL) 1
0.26 -0.17 0.74 0.21 0.24 0.01 0.03 -0.25 0.09
ERSS 1 0.58 -0.47 0.41 -0.36 -0.01 0.22 0.09 -0.04 -0.12
HAD(ANX) 4 0.87 -0.23 -0.16 0.19 -0.13 -0.25 -0.03 0.06 -0.06
HAD(DEP)4 0.88 -0.09 -0.18 -0.05 -0.02 0.05 -0.10 0.13 0.13
CARES
(PHYS)4
0.85 0.30 -0.26 -0.02 -0.01 0.11 0.07 -0.19 -0.09
CARES
(PSYCHO) 4





0.94 -0.03 -0.13 -0.09 -0.01 0.03 -0.08 0.03 -0.07
CARES
(MED.INT.)4
0.43 -0.35 -0.40 0.22 0.49 0.38 -0.05 -0.13 0.09
CARES
(SEXUAL) 4
0.53 0.62 0.06 -0.39 -0.05 0.14 -0.11 0.03 0.24
CARES
GLOBAL 4
0.93 0.19 -0.14 -0.11 -0.03 0.04 -0.09 -0.12 -0.09
RSCL
(PSYCH) 4
0.88 0.02 -0.21 0.11 -0.10 -0.27 -0.03 0.11 -0.13
RSCL(GI) 4 0.83 -0.05 -0.19 0.16 0.19 0.06 0.09 -0.22 -0.10
RSCL
(SENSORY)4
0.27 0.26 0.40 0.60 -0.26 0.32 0.07 0.28 -0.23
RSCL
(FATIGUE)4
0.80 0.03 -0.11 0.19 -0.08 -0.04 0.30 0.29 0.22
RSCL
(MISCELL) 4
0.78 0.37 0.21 0.01 -0.12 0.11 0.08 -0.22 -0.07
ERSS4 0.83 0.45 0.01 -0.01 -0.19 -0.01 -0.17 -0.01 -0.04
HAD(ANX) 8 0.86 -0.26 -0.18 0.13 -0.1 -0.19 -0.07 0.12 0.05
HAD(DEP)8 0.86 -0.10 -0.19 -0.08 0.02 -0.02 -0.06 0.19 0.13
CARES
(PHYS)8
0.86 0.29 -0.28 -0.03 0.02 0.13 0.06 -0.15 -0.05
CARES
(PSYCHO) 8
0.94 -0.03 -0.13 -0.10 0.02 0.02 -0.06 0.05 -0.08
CARES
(MED.INT.)8
0.43 -0.35 -0.40 0.22 0.49 0.38 -0.05 -0.13 0.09
CARES
(SEXUAL) 8
0.53 0.61 0.06 -0.39 -0.05 0.14 -0.11 0.03 0.24
CARES
GLOBAL 8
0.94 0.17 -0.16 -0.12 0.01 0.03 -0.09 -0.06 -0.05
RSCL
(PSYCH) 8
0.89 -0.01 -0.22 0.08 -0.06 -0.24 -0.06 0.17 -0.06
RSCL (GI) 8 0.84 -0.06 -0.22 0.13 0.25 0.06 0.09 -0.14 -0.08
RSCL
(SENSORY)8
0.29 0.21 0.41 0.64 -0.26 0.31 0.07 0.22 -0.18
RSCL
(FATIGUE) 8
0.81 0.02 -0.09 0.19 -0.09 -0.04 0.30 0.27 0.23
RSCL
(MISCELL) 8
0.78 0.37 0.21 0.01 -0.12 0.11 0.08 -0.21 -0.07
ERSS 8 0.78 0.13 0.26 -0.10 -0.12 -0.07 -0.22 -0.16 -0.14
VARIABLE Factorl Factor2 Factor3 Factor 4 Factor5 Factor6 Factor7 Factor 8 Factor9
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Table 79
Varimax rotated factor matrix of variables associated with data from main
descriptive study.
VARIABLE Factor 1 Factor2 Factor3 Factor 4 Factors Factor6 Factor7 Factor 8 Factor9
AGE -0.27 -0.23 0.13 0.13 0.57 0.02 -0.49 -0.15 -0.05
NUMBER OF
CHILDREN
-0.05 -0.14 -0.03 -0.01 -0.86 0.14 -0.12 0.02 0.04
SOCIAL
CLASS
0.06 0.06 0.01 0.07 0.05 -0.01 0.92 0.09 0.01
HAD(ANX) 1 -0.04 0.86 0.19 -0.11 0.13 0.05 0.04 0.3 -0.13
HAD(DEP)1 -0.03 0.76 0.44 0.11 0.14 0.08 -0.21 0.18 0.12
CARES
(PHYS)l
0.28 0.44 0.71 0.07 0.30 0.01 -0.09 0.01 0.22
CARE
(PSYCHO) 1
0.09 0.38 0.79 -0.13 -0.02 0.08 0.22 -0.3 -0.08
CARES
(MED.INT.)1
0.24 0.02 0.82 0.24 -0.09 0.15 -0.03 -0.09 0.06
CARES
(SEXUAL) 1
0.34 -0.09 0.13 -0.03 -0.41 -0.35 0.27 0.50 0.20
CARES
GLOBAL 1
0.03 0.35 0.57 -0.08 -0.25 -0.25 -0.01 0.46 -0.14
RSCL
(PSYCH) 1
-0.04 0.55 0.43 -0.11 0.47 -0.05 -0.04 0.29 0.25
RSCL (GI) 1 0.26 0.29 0.07 0.34 0.17 0.34 -0.15 0.61 0.23
RSCL
(SENSORY)l
-0.06 -0.11 -0.31 0.19 -0.12 -0.07 0.08 0.69 -0.12
RSCL
(FATIGUE)l
0.11 0.13 0.50 0.11 -0.26 0.11 0.07 0.42 0.54
RSCL
(MISCELL) 1
-0.02 -0.02 0.51 0.21 0.12 0.08 0.16 0.68 0.10
ERSS 1 0.13 0.29 0.88 -0.01 0.19 0.11 -0.11 0.01 0.01
HAD(ANX) 4 0.15 0.93 0.13 0.09 0.11 0.14 0.07 0.05 -0.04
HAD(DEP)4 0.41 0.74 0.19 0.03 0.02 0.27 -0.08 -0.06 0.18
CARES
(PHYS)4
0.67 0.53 0.05 0.09 0.03 0.30 0.19 -0.08 -0.17
CARES
(PSYCHO) 4





-0.01 -0.29 0.08 -0.05 -0.08 0.91 -0.03 -0.01 -0.05
CARES
(SEXUAL) 4
0.91 0.10 0.06 -0.04 -0.01 -0.10 -0.01 -0.02 0.24
CARES
GLOBAL 4
0.68 0.65 0.17 0.04 0.01 0.21 0.02 0.02 -0.12
RSCL
(PSYCH) 4
0.33 0.89 0.05 0.09 -0.05 0.05 0.11 -0.01 -0.08
RSCL (GI) 4 0.36 0.61 0.18 0.07 0.03 0.49 0.23 0.09 -0.16
RSCL
(SENSORY)4
0.12 0.11 0.05 0.95 -0.01 -0.05 0.02 0.13 0.02
RSCL
(FATIGUE)4
0.29 0.69 0.11 0.26 0.04 0.13 0.31 -0.15 0.35
RSCL
(MISCELL) 4
0.74 0.35 0.24 0.27 0.12 0.05 0.19 0.17 -0.11
ERSS4 0.77 0.54 0.02 0.23 -0.02 -0.04 -0.01 0.11 -0.04
HAD(ANX) 8 0.15 0.92 0.14 0.05 0.09 0.17 -0.01 0.02 0.09
HAD(DEP)8 0.36 0.76 0.19 -0.01 -0.04 0.23 -0.03 -0.09 0.21
CARES
(PHYS)8
0.69 0.54 0.05 0.08 0.01 0.33 0.18 -0.09 -0.11
CARES
(PSYCHO) 8
0.48 0.74 0.29 0.04 -0.05 0.23 -0.01 -0.04 -0.01
CARES
(MED.INT.)8
-0.01 0.29 0.08 -0.05 -0.07 0.91 -0.03 -0.01 0.05
CARES
(SEXUAL) 8
0.91 0.10 0.06 -0.04 -0.01 -0.10 -0.01 -0.2 0.24
CARES
GLOBAL 8
0.66 0.66 0.17 0.02 -0.04 0.23 0.03 -0.01 -0.06
RSCL
(PSYCH) 8
0.33 0.90 0.06 0.07 -0.08 0.09 0.07 -0.02 0.01
RSCL (GI) 8 0.34 0.62 0.19 0.05 -0.05 0.41 0.22 0.05 -0.10
RSCL
(SENSORY)8
0.10 0.12 0.05 0.94 0.05 -0.02 0.04 0.18 0.03
RSCL
(FATIGUE) 8
0.28 0.70 0.11 0.27 0.07 0.14 0.32 -0.12 0.36
RSCL
(MISCELL) 8
0.71 0.35 0.24 0.28 0.12 0.04 0.19 0.17 -0.11
ERSS 8 0.56 0.51 0.32 0.10 0.06 -0.07 -0.09 0.29 -0.16
VARIABLE Factorl Factor2 Factor3 Factor 4 Factor5 Factor6 Factor7 Factor 8 Factor9
(significant figures emboldened and italicised)
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The criterion for significance of the factor loading in Table 79 was those
variables with a loading of >0.5 [Child, 1990]. The factor analysis of these
variables have produced nine factors which account for almost 89 per cent
of the total variance. An examination of the rotated factor matrix shows
the factor loadings. Variables loading most highly on factor one are the
CARES physical, sexual and global score at Interview 4, the RSCL
miscellaneous symptom score at Interview 4, the ERSS total score at
Interview 4, the CARES physical, sexual and global score at Interview 8,
the RSCL miscellaneous symptoms score at Interview 8 and the ERSS total
score at Interview 8. This factor would seem to represent a measure of
physical rehabilitation status.
The variables loading most highly on factor two are numerous: from
Interview 1 the HAD anxiety and depression scores, and the RSCL
psychological score; from Interview 4 the HAD anxiety and depression
scores; the CARES psychosocial score and global score, the RSCL
psychological score, gastrointestinal score and fatigue and the ERSS total
score; and from Interview 8 the HAD anxiety and depression scores, the
CARES physical, psychosocial and global scores, the RSCL psychological,
gastrointestinal, fatigue scores and the ERSS total score. Factor two would
therefore appear to represent a measure of psychological distress.
The variables loading most highly on factor three are the CARES physical,
psychosocial, medical interaction and global score and the ERSS score from
Interview 1. Factor three would therefore appear to represent a measure of
rehabilitation status at the outset of the study.
There is only one variable which loads on factor four and this is the RSCL
sensory score at Interview 4. Factor four would therefore appear to
represent a measure of sensory symptoms.
Factor five represents a measure of demographic details because the two
variables which load on it are the patient's age and the number of
children.
Two variables load on factor six and these are the CARES medical
interaction scores at Interview 4 and 8. The medical interaction score on
the CARES represents difficulties relating to the medical staff and one
156
possible interpretation of this factor is that it represents medical
interaction problem
Factor seven represents a unique factor because the only variable which
loads on it is social class. This factor would therefore appear to represent
social class.
Two variables load on factor eight and these are the RSCL sensory and
miscellaneous symptoms score at Interview 1. This factor would appear to
represent physical symptomatology.
Only one factor loads on factor nine and this is the RSCL fatigue score at
Interview 1 and therefore this factor would appear to represent physical
fatigue.
These nine factors represent a considerable degree of reduction of
redundancy in explaining almost 89 per cent of the variance of the data
from an initially large pool of variables ( Tables 80 and 81 ).
Table 80
Factors derived from the rotated factor matrix and the variance explained
by each factor.














5. DEMOGRAPHIC DETAILS 5.20







9. PHYSICAL FATIGUE 2.40
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Table 81
Factor eigenvalue, percentage of variance explained by each factor and the
cumulative variance for the rotated factor matrix.




1 19.39 46.20 46.20
2 3.90 9.30 55.50
3 3.71 8.80 64.30
4 2.48 5.90 70.20
5 2.19 5.20 75.40
6 1.97 4.70 80.10
7 1.43 3.40 83.50
8 1.23 2.90 86.40
9 1.02 2.40 88.80
The pattern emerging from this analysis is more or less unambiguously
concerned with relevant elements in the experience of the disease and
treatment. The content of the first factor (physical rehabilitation status) is
the clearest, and that of the other eight factors (i.e. psychological distress,
rehabilitation status at outset, sensory symptomatology, demographic
details, medical interaction, patient's social class, symptomatology at
outset, and physical fatigue) cumulatively accounts 43 per cent of the
variance. The factor analysis of the data from the descriptive study appears
to demonstrate that the rehabilitation needs of patients with metastatic
breast cancer can be distinguished empirically.
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Summary of Results from the Descriptive Study
The Study
A sample of 80 patients with metastatic breast cancer were assessed every
eight weeks using a variety of measures.
The Sample Size
The sample decreased in number from 80 to 36 over the course of eight
interviews due to patients dying from their disease.
Characteristics of the Total Sample
The mean age of the women in the descriptive study was 53.8 years and
the majority of women belonged to social class 3 (skilled) according to the
OPCS classification.
The majority of patients were married and had two children who were
older than 18 years of age and who were no longer living at home with the
patient.
The majority of patients had been diagnosed to have breast cancer between
one and five years before the diagnosis of metastatic breast cancer, and the
majority had originally received a combination of surgery and
radiotherapy as first line treatment of breast cancer.
The majority of women had bony metastases and received hormone
therapy as treatment.
Characteristics of patients who survived throughout the course of the
study
Thirty-six patients survived throughout the course of the study.
The mean age of women who survived was 59.3 years and the majority of
women belonged to social class 3 (skilled) according to the OPCS
classification.
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The majority of patients who survived were married and had two
children who were older than 18 years of age and who were no longer
living at home with the patient.
The majority of patients who survived had been diagnosed to have breast
cancer between one and five years before the diagnosis of metastatic breast
cancer, and the majority had originally received a combination of surgery
and radiotherapy as first line treatment of breast cancer.
Characteristics of patients who died during the course of the study
Forty four patients died during the course of the study.
The mean age of women who died was 49.2 years and the majority of
women belonged to social class 3 (skilled) according to the OPCS
classification.
The majority of patients were married and had two children who were
older than 18 years of age and who were no longer living at home with the
patient.
The majority of patients had been diagnosed to have breast cancer between
one and five years before the diagnosis of metastatic breast cancer, and the
majority had originally received a combination of surgery and
radiotherapy as first line treatment of breast cancer.
Comparisons of the characteristics of the sub-samples
The ages of patients who died and those who survived differed
significantly. The results suggest that the survivors were older than those
patients who died during the course of the study.
There were no statistically significant differences between the patients who
died during the study and those who survived in terms of marital status
and social class.
Significant differences were found between those patients who died and
those who survived in terms of medical treatment. The results suggest
that significantly more patients who survived were receiving hormone
therapy compared to those who died.
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Medical professional contact
Contact with members of the medical profession both in the community
and the hospital was monitored throughout the duration of the study.
General practitioner and hospital doctor was consistently high. However,
contact with other members of the multidisciplinary team was
consistently low throughout the study. The contact remained low despite
the prevalence of physical, psychological or social problems.
Mood in the "total" sample
There were no statistically significant differences in mean anxiety and
depression scores as measured by the Hospital Anxiety and Depression
(HAD) scale across the eight interviews (mean HAD anxiety and
depression was approximately 7).
A large proportion of patients (38.8 per cent) scored above the cut off level
for possible "case" anxiety on the HAD at the first interview. However,
during the course of the eight interviews, this proportion scoring in the
possible "case " range for anxiety had reduced, with 16.7 per cent of
patients scoring in this range at the eighth interview.
A large proportion of patients (31.3 per cent) scored above the cut off level
for possible "case" depression on the HAD at the first interview. However,
during the course of the eight interviews, this proportion scoring in the
possible "case " range for depression had reduced, with 16.7 per cent of
patients scoring in this range at the eighth interview.
Mood in those patients who died and those who survived
The mean HAD anxiety score of patients who survived throughout the
course of the study (mean HAD anxiety was approximately 6) had lower
mean anxiety scores throughout the course of the study compared with
the mean scores of the "total" sample of patients.
The mean HAD depression score of patients who survived throughout
the course of the study (mean HAD depression was approximately 6) had
lower mean depression scores throughout the course of the study
compared with the mean scores of the "total" sample of patients.
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Fewer of the "survivors" compared with the total sample scored in the
"probable case" range for anxiety on the HAD using the cut-off scores
suggested by the authors (range:17 per cent to 25 per cent).
Fewer of the "survivors" compared with the total sample scored in the
"probable case" range for depression on the PIAD using the cut-off scores
suggested by the authors (range:14 per cent to 22 per cent).
The mean HAD anxiety score for those patients who died during the
course of the study was high (10.5) at the last interview before death.
The mean HAD depression score for those patients who died during the
course of the study was high (10) at the last interview before death.
The proportion of patients who fell into the "probable case" range for
anxiety and depression was high (anxiety- 66 per cent; depression 50 per
cent).
Comparisons of mood in those patients who died and those who survived
during the course of the study
Comparisons of the HAD anxiety data from patients who died during the
course of the study and those patients who survived demonstrated a
statistically significant difference suggesting that those patients who died
during the course of the study had higher levels of anxiety at the last
interview before death than the "survivors" at the eighth interview.
Comparisons of the HAD depression data from patients who died during
the course of the study and those patients who survived demonstrated a
statistically significant difference suggesting that those patients who died
during the course of the study had higher levels of depression at the last
interview before death than the "survivors" at the eighth interview.
Symptomatology
The mean Rotterdam Symptom Checklist (RSCL) scores of patients with
metastatic breast cancer suggest that they had significant levels of
psychological, gastro-intestinal, sensory, fatigue and miscellaneous
symptoms.
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The mean scores on the RSCL scores of patients who survived throughout
the descriptive study were slightly lower than the mean scores of the total
group of patients.
The mean scores on the RSCL scores of patients who died during the
course of the study were slightly higher than the mean scores of the total
group of patients.
Rehabilitation status
The mean Cancer Rehabilitation Evaluation System (CARES) global and
subscale (physical, psychosocial, medical interaction, sexual and marital)
scores suggest that patients rehabilitation status is adversely affected by
their metastatic disease.
The mean Edinburgh Rehabilitation Status Scale (ERSS) total and subscale
(support, inactivity, isolation, and effect of symptoms on lifestyle) scores
suggest that patients are disabled by their metastatic disease.
Rehabilitation status in those patients who died during the course of the
study and those who survived
The mean scores on the CARES global scores of patients who survived
throughout the descriptive study were slightly lower than the mean scores
of the total group of patients.
The mean scores on the CARES global scores of patients who died during
the course of the study were slightly higher than the mean scores of the
total group of patients.
The comparison of the data of the global CARES score from the two
groups demonstrated a significant difference suggesting that those patients
who died during the course of the study had significantly higher CARES
global scores than those patients who survived throughout the course of
the descriptive study.
The mean scores on the ERSS total scores of patients who survived
throughout the descriptive study were slightly lower than the mean scores
of the total group of patients.
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The mean scores on the ERSS total scores of patients who died during the
course of the study were slightly higher than the mean scores of the total
group of patients.
The comparison of the data of the ERSS total score from the two groups
demonstrated a significant difference suggesting that those patients who
died during the course of the study had significantly higher ERSS total
scores than those patients who survived throughout the course of the
descriptive study.
Contribution of factors to rehabilitation status
No significant associations were found between demographic variables
(age, marital status, social class, number of children) and rehabilitation
status as measured by the CARES global score and the ERSS total score.
No significant associations were found between rehabilitation status
(measured by the CARES global score and the ERSS total score) and a range
of disease and treatment variables.
Significant relationships were found between mood (measured by the
HAD) and rehabilitation status.
Significant relationships were found between symptomatology (measured
by the RSCL) and rehabilitation status.
Using stepwise multiple regression analysis, the variance of the CARES
global scores was examined, identifying mood, patient's symptomatology,
and age of the patient as contributing significantly to it.
Using stepwise multiple regression analyis, the variance of the ERSS total
scores was examined, identifying mood, patient's symptomatology, age
and the CARES physical and marital domain scores as contributing
significantly to it.
The data from Interviews 1, 4 and 8 were reduced successfully using factor
analysis. The factor analysis reduced the data to nine factors accounting for
almost 89 per cent of the variance. The factor analysis suggests some
interesting interrelationships between the variables. The first factor,





The Pilot Intervention Study
Introduction
This small pilot intervention study was carried out after collection of the
data of the main descriptive study. Nineteen patients were approached
and, as two patients refused to participate, 17 patients were recruited to the
pilot intervention study. Patients were randomised to either the
intervention group (n=10) or the "control" group (n=7). Patients in both
groups were interviewed every eight weeks and patients were interviewed
four times over the course of six to eight months. The fourth and final
interview was conducted by a research assistant in order to introduce
externally validate the study.
CHARACTERISTICS OF THE SAMPLES
Age
The ages of the two groups of patients are shown in Table 82.
Table 82
Age of patients in the intervention study by group: means, ranges,






mean range s.d. mean range s.d. U P
54.70 37-72 11.14 55.71 45-64 11.03 29.50 0.59
There was no statistically significant difference in terms of the age of
patients in the two groups using the Mann-Whitney U test.
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Social Class
The social class distribution of the two groups of patients is shown in
Table 83.
Table 83
Distribution of patient's social class in the pilot intervention study by
group




1 Professional 1 1
2 Intermediate 4 2
3 Skilled 3 2
4 Semi-skilled 0 2
5 Unskilled 2 0
Total 10 7
The social class of the two groups, which was coded according to the Office
of Population, Consenses and Surveys [1980] classification of occupations,
did not achieve a statistically significant difference using a chi square test
(X2 = 4.48; df= 4; N.S.).
Marital Status




Distribution of patient's marital status by group









The majority of patients in both groups were married, with only a very
small number being single, separated or divorced, or widowed. There was
no statistically significant difference in terms of marital status between the
two groups (X2 = 4.29; df= 2; N.S.). In addition, only one patient in each
group lived alone.
The number, age and number of children living at home of the patient
The interview schedule gathered information regarding the number of
children the patient had, their age and the number living at home with
the patient (Tables 85, 86, and 87 ).
167
Table 85








One child 1 1
Two children 6 4
Three children 0 1
Four children 0 1
Total 10 7
There was no statistically significant difference in terms of the distribution
of the patient's number of children between the two groups (X2 = 5.02; df=
4; N.S.).
Table 86







Not applicable 3 0
<5 years old 1 0
5-10 years 1 2
10-18 years 0 0
>18 years 5 5
Total 10 7
There was no statistically significant difference in terms of the distribution













One child 3 1
Two children 0 0
Three children 0 0
Four children 0 1
Total 10 7
There was no statistically significant difference in terms of the distribution
of the number of children patients had staying with them at home
between the two groups (X2= 4.29; df= 3; N.S.).
Time since initial diagnosis of breast cancer
The time since the initial diagnosis of breast cancer was categorised into
one of four categories: under three months; between three months and
one year; between one year and five years; and over five year (Table 88).
Table 88









3 months -1 year 1 0
1-5 years 4 4
> 5 years 2 3
Total 10 7
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There was no statistically significant difference in terms of length of time
since initial diagnosis between the two groups (X2 = 3.79; df= 3; N.S.). The
majority of patients in each group had been diagnosed between one and
five years previously. Those patients who had been diagnosed in the
previous three months newly presented with metastatic breast cancer
Original treatment for primary breast cancer
The first line treatment patients received at initial diagnosis was
categorised into surgery alone; surgery and radiotherapy; surgery,
radiotherapy and chemotherapy; and no treatment (no patients in the two
samples had surgery and adjuvant chemotherapy alone, hormone therapy
alone, or chemotherapy alone as primary treatment therefore these do not
appear) (Table 89).
Table 89

















There was no statistically significant difference in terms of initial
treatment at first presentation (X2= 3.92; df= 3; N.S.). The majority of
patients in both groups had previously had surgery and radiotherapy as
treatment at first presentation of breast cancer.
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Site of metastatic spread
The site of metastatic spread was categorised into one of four categories for
the purpose of the intervention study: bone; lung; liver; and brain (Table
90).
Table 90












The majority of patients in the intervention group had bone metastases,
whereas in the control group the majority had lung metastases. However,
there was no statistically significant difference in terms of metastatic
spread between the two groups (X2 = 4.02; df= 3; N.S.).
Patient's medical treatment
Patient s medical treatment for metastatic breast cancer was categorised













The majority of patients in both groups were receiving chemotherapy.
There was no statistically significant difference in terms of current
treatment between the two groups (X2 = 0.75; df= 2; N.S.).
Size of Samples at Each Interview
Patients died during the course of study. One patient died in the
intervention group thereby reducing the size of the sample from ten to
nine. Two patients died in the control group, reducing the sample from
seven to five. The number of patients in each group at Interviews 1-4 is
shown in Table 92.
Table 92
Sample sizes at each interview in the intervention group and the
"control" group







Patients in both the intervention group and "control" group were asked at
each interview to list the members of the multiprofessional team they had
seen in the previous months. Tables 93 and 94 list the per centages of
patients who had seen the particular member of the team in the month
before each interview.
Table 93
Medical professional contact during the month before each interview (per
centages shown of those patients who had seen the relevant member of
the multidisciplinary team): intervention group
INTERVIEW 1 2 3 4
% % % %
hospital doctor 100 40 70 80
general practitioner 90 60 90 80
psychologist/
psychiatrist
0 40 30 30
nurse counsellor 30 20 30 40
district nurse/ health
visitor
10 50 40 40
social worker 10 10 20 10
physiotherapist 10 0 40 40
occupational
therapist
10 20 20 20
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Table 94
Medical professional contact during the month before each interview (per
centages shown of those patients who had seen the relevant member of
the multidisciplinary team): "control" group
INTERVIEW 1 2 3 4
% % % %
hospital doctor 100 17 80 100
general practitioner 100 50 80 80
psychologist/
psychiatrist
0 0 0 0
nurse counsellor 57 33 20 25
district nurse/ health
visitor
0 0 0 0
social worker 0 0 0 0
physiotherapist 0 0 20 25
occupational
therapist
0 0 20 25
The results from each group concerning the contact with members of the
multidisciplinary team were subjected to chi square tests to ascertain any
differences between the two groups. There were no statistically significant
differences between the two groups in terms of contact with the following
members of the multidisciplinary team: hospital doctor; general
practitioner; psychologist/ psychiatrist; nurse counsellor; social worker;
occupational therapist; and physiotherapist. The only comparison which
achieved statistical significance was contact with the district nurse or
health visitor at interview 2 (X2= 4.36; df = 1; p < 0.05).
Type of intervention carried out by the rehabilitation co-ordinator
The type of intervention carried out by the rehabilitation co-ordinator
with patients in the intervention group was categorised into one of six
categories: counselling and information giving; initiating contact with
174
psychiatrists/ clinical psychologists; initiating contact with
physiotherapists; initiating contact with occupational therapists; initiating
contact with social workers; and other intervention (which consisted of
supplying forms for disabled parking permits, Mobility Allowance,
Attendance Allowance etc.) (see Table 95).
Table 95
Type of intervention carried out by the rehabilitation co-ordinator (total
percentage of referrals after each interview)
INTERVIEW 1 2 3 4
% % % %
counselling/
information
100 100 100 100
psychologist/
psychiatrist
30 10 0 0
social worker 10 20 10 10
physiotherapist 0 30 10 10
occupational
therapist
10 10 10 10
other 0 0 20 25
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RESULTS OF THE STANDARDISED QUESTIONNAIRES IN THE PILOT
INTERVENTION STUDY
Hospital Anxiety arid Depression Scale HAD)
Patients in both groups completed the HAD at each interview. The mean
anxiety and depression scores of the HAD, standard deviations, and results
of the Mann-Whitney U test are shown in Tables 96 and 97.
Table 96
HAD (Anxiety) scores in both groups of patients: means, standard
deviations, and Mann-Whitney U values.
HAD ANXIETY Intervention Group Control Group Comparison
AT EACH INTERVIEW MEAN S.D. MEAN S.D. U P
1 7.30 4.52 7.57 5.09 34.5 0.96
2 7.40 4.81 4.83 4.87 20.50 0.30
3 6.40 5.01 5.20 3.70 22.50 0.75
4 7.44 4.77 5.50 3.32 15.00 0.48
Table 97
HAD (Depression) scores in both groups of patients: means, standard









1 6.40 3.75 7.71 3.15 27.50 0.46
2 6.60 3.66 5.67 3.88 25.50 0.63
3 6.70 4.99 7.00 4.85 22.00 0.71
4 7.44 4.64 6.00 5.72 15.00 0.47
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No statistically significant differences are seen between the anxiety and
depression as measured by the HAD in either the intervention group or
the control group using the Mann Whitney U test.
Using the cut off scores suggested by the authors [Zigmond and Snaith,
1983], Tables 98 and 99 below show the numbers and per centages of
patients in both the intervention and "control" group (respectively) who
fall in the normal, borderline and case ranges on the anxiety and
depression subscales of the HAD.
Table 98
HAD Anxiety and Depression Scores Using the Cut-Off Scores:
Intervention Group
HAD Score Anxiety Depression
n <%) n (%)
HAD 1 0-7 (normal) 5 50 6 60
n=10 8-10 (borderline) 2 20 3 30
11-21 ("case" level) 3 30 1 10
HAD 2 0-7 (normal) 5 50 5 50
n=10 8-10 (borderline) 3 30 5 50
11-21 ("case" level) 2 20 0 0
HAD 3 0-7 (normal) 7 70 6 60
n=10 8-10 (borderline) 1 10 1 10
11-21 ("case" level) 2 20 3 30
HAD 4 0-7 (normal) 4 44.4 4 44.4
n=9 8-10 (borderline) 2 22.2 3 33.3
11-21 ("case" level) 3 33.3 2 22.2
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Table 99
HAD Anxiety and Depression Scores Using the Cut-Off Scores:
"Control" Group
HAD Score Anxiety Depression
n (%) n (%)
HAD 1 0-7 (normal) 4 42.85 3 42.86
n=7 8-10 (borderline) 1 14.30 2 28.57
11-21 ("case" level) 3 42.85 2 28.57
HAD 2 0-7 (normal) 4 66.67 4 66.67
n=6 8-10 (borderline) 1 16.67 1 16.67
11-21 ("case" level) 1 16.67 1 16.67
HAD 3 0-7 (normal) 4 80.00 3 60.00
n=5 8-10 (borderline) 1 20.00 1 20.00
11-21 ("case" level) 0 0.00 1 20.00
HAD 4 0-7 (normal) 2 50.00 3 75.00
n=5 8-10 (borderline) 2 50.00 0 0.00
11-21 ("case" level) 0 0.00 1 25.00
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The Rotterdam Symptom Checklist (RSCL)
Patients in both groups completed the RSCL. The means and standard
deviations for each domain of the RSCL are presented in Tables 100 - 104.
These also show the results of Mann-Whitney U tests on the data.
Table 100











1 8.30 4.94 7.86 6.18 33.50 0.88
2 6.10 4.89 4.67 5.28 22.00 0.38
3 7.40 6.11 6.80 4.55 24.50 0.95
4 8.89 6.53 7.00 4.89 21.00 0.63
Table 101











1 5.00 4.27 7.45 5.29 25.50 0.35
2 5.50 2.72 5.83 5.35 28.50 0.87
3 4.90 4.07 6.40 4.62 21.50 0.66
4 6.55 4.69 4.00 4.08 12.00 0.25
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Table 102











1 0.80 0.79 0.43 1.13 22.00 0.20
2 0.80 0.92 0.50 1.22 22.50 0.42
3 0.90 0.88 0.40 0.55 17.00 0.32
4 0.89 1.17 0.25 0.50 13.00 0.32
Table 103










1 5.30 2.45 6.14 2.67 29.00 0.56
2 5.60 2.67 4.00 3.52 21.00 0.33
3 5.20 3.22 6.00 3.67 20.50 0.58




RSCL Miscellaneous Symtpom Domain mean scores, standard deviations,










1 5.70 2.79 5.28 4.46 32.00 0.77
2 5.30 3.33 5.17 3.87 27.00 0.75
3 6.70 4.83 5.80 4.08 21.00 0.62
4 7.22 4.23 4.75 3.59 11.5 0.23
Tables 100-104 above indicate that there were no statistically significant
differences using Mann-Whitney U tests on the RSCL data.
The Cancer Rehabilitation Evaluation System (CARES)
Patients in both groups completed the CARES at each interview. The
means, standard deviations and Mann-Whitney U values of the global
and subscale scores of the CARES are shown in Tables 105-110.
Table 105










1 0.80 0.45 0.96 0.46 27.00 0.44
2 0.88 0.43 0.94 0.57 28.00 0.82
3 0.95 0.48 0.81 0.47 20.00 0.54
4 1.10 0.59 0.80 0.47 14.00 0.39
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Table 106
CARES physical subscale scores of each group: means, standard deviations,
and Mann-Whitney U values.
CARES Physical








1 1.19 0.54 1.36 0.61 26.00 0.38
2 1.06 0.55 0.95 0.70 27.00 0.74
3 1.42 0.90 0.69 0.40 11.50 0.10
4 1.68 1.18 1.20 0.78 20.50 0.58
Table 107
CARES psychosocial subscale scores of each group: means, standard
deviations, and Mann-Whitney U values.
CARES Psychosocial







1 0.87 0.56 1.10 0.64 28.50 0.53
2 0.98 0.55 1.04 0.53 29.00 0.91
3 0.97 0.62 0.90 0.56 23.00 0.81
4 1.17 0.72 1.08 0.68 17.50 0.72
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Table 108
CARES medical interaction subscale scores of each group: means, standard










1 0.20 0.26 0.29 0.37 30.00 0.63
2 0.30 0.42 0.08 0.13 22.00 0.38
3 0.20 0.40 0.20 0.45 23.00 0.81
4 0.22 0.32 0.25 0.50 19.00 0.88
Table 109
CARES sexual subscale scores of each group: means, standard deviations,









1 1.63 1.62 1.86 1.68 31.00 0.70
2 1.78 1.52 2.17 2.04 25.50 0.63
3 2.10 1.91 2.00 1.58 24.00 0.90
4 1.56 1.67 1.50 1.29 18.00 0.77
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Table 110
CARES marital subscale scores of each group: means, standard deviations,









1 0.25 0.41 0.02 0.06 24.50 0.31
2 0.33 0.50 0.00 0.00 18.00 0.19
3 0.42 0.51 0.00 0.00 12.50 0.12
4 0.59 0.87 0.12 0.16 16.00 0.57
The results of the Mann-Whitney U tests on the data from the CARES
(global and subscale scores) indicate that no significant differences were
found between the two groups of patients.
The Edinburgh Rehabilitation Status Scale (ERSS)
Patients in both groups were assessed using the ERSS. The mean total
scores, standard deviations, and the results of the Mann-Whitney U test
are presented in Table 111.
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Table 111
ERSS total scores of each group: means, standard deviations, and Mann-
Whitney U values.








1 6.00 3.71 5.29 3.45 34.00 0.92
2 5.90 3.38 4.20 2.77 16.50 0.29
3 7.30 3.71 5.60 3.85 19.00 0.46
4 8.44 5.57 4.75 3.77 9.50 0.19
Using the Marrn-Whitney U test on the ERSS total scores of both groups at
each interview, no significant differences were found between the two
groups. No significant differences were found in the subscales of the ERSS
and have not been presented.
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Responses of patients in the intervention group to evaluation
questionnaire
At the fourth and final interview patients in the intervention group (n=9)
were given an evaluation questionnaire to complete by the research
assistant.
Responses to the closed questions on the evaluation questionnaire
The patients in the intervention group answered a range of questions
concerning their overall impression and satisfaction with the service. The
responses to each question are given below in Tables 112-119.
Table 112
The number of visits and telephone calls patients received from
rehabilitation co-ordinator
Response Number
More than enough 2
Enough 7
Total 9
The majority of patients said that they had received "enough visits" and
phone-calls from the rehabilitation co-ordinator (no patients felt that they
had received "not enough").
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Table 113
The information and advice on problems patients received from
rehabilitation co-ordinator
Response Number
Advice on some problems




The majority of patients said that they had received advice on "all
problems". No patients said that they had received no advice on their
problems.
Table 114
The practical help with the problems patients instigated by rehabilitation
co-ordinator
Response Number
Practical help on all problems 9
Total 9
All the patients said that they had received practical help from the
rehabilitation co-ordinator for "all their problems" (no patients said that




The amount of practical help with problems patients received instigated by
rehabilitation co-ordinator
Response Number





The majority of patients said that they had received "more than enough
help" (no patients said that they had received "not enough" help).
Table 116




All patients said that the practical assistance they received was "very








All the patients said that the length of time taken to provide information
or help was "just right" (no patients said that the time taken was "too
slow" or "too quick").
Table 118





All patients said that they were "very satisfied" with the visits from the




Perceived difference to patient's life by the visits of the rehabilitation co¬
ordinator
Response Number
Made life better 7
Made no difference to life 2
Total 9
The majority of patients said that the visits by the rehabilitation co¬
ordinator "made life better" (no patients said that "it made life worse").
Answers to open questions on the evaluation questionnaire
The qualitative responses to the open questions were categorised into
concerns and issues. A useful definition of these is:
"
a concern is any matter of interest important to one or more
parties....The importance of concerns may often be assessed by
reference to the number of persons that express them, but a
concern expressed be even one individual may, because of that
individual's special perspective or degree of insight, be vital. An
issue is any statement , proposition or focus that allows for the
presentation of different points of view; any proposition about
which reasonable persons may disagree, or any point of
contention" [Guba and Lincoln, 1981, p 304]
The aspects of the service which patients were most satisfied with
Many patients identified three concerns relating to their satisfaction with
the rehabilitation co-ordinator service:
(a) Having someone to talk to/ confide in for all the members of the
family.
As one patient said
"Just to be able to talk freely with someone and who all the
family felt at ease with in our own home"
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and another
"It was good to be able to confide in [the rehabilitation co¬
ordinator] - somebody who was outwith the family"
It was apparent from observation that patients and their families
appreciated the visits at home, giving them some "control". Most patients
felt nervous when going to the hospital for clinic appointments or
treatment. Frequently patients and members of the family asked about a
particular matter which had been raised at a previous clinic appointment.
(b) Regular contact either by telephone calls or visits
Many patients agreed that the regular visits or phone-calls were
reassuring.
One patient said
"You always knew that she would phone regularly and also she
gave us her phone number if there was anything we needed to
ask about. It was reassuring to know that."
and another
"After an appointment at the hospital [the rehabilitation co¬
ordinator] would phone to see how I got on and if there were
any problems. Then she would visit regularly."
(c) Having immediate advice
An aspect which many patients agreed with regarding the rehabilitation
co-ordinator service was being able to get "immediate advice"
"You knew that when you phoned her that she would try and
see to your problem immediately by getting in touch with
someone at the hospital or whatever. That was important
because it made us feel less anxious."
The aspects of the service which patients were least satisfied with
The only concern identified was that patients did not know what the study
would involve.
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For example, one patient said
"I felt unsure when first approached to take part in the study. I
really didn't know what to expect."
If the service was offered to other patients in the future, what were the
patient's suggestions
Three concerns were identified in answer to this question:
(a) The content of the questionnaires.
Some patients found some of the questions too personal. For example, one
patient said
"There should be less intimate questions in the questionnaires".
(b) The timing of the interviews.
Some patients agreed that the visits should be more frequent. For
example, one patient said
"Every month would be great because a lot could have happened in eight
weeks."
(c) The availability of the service. Patients agreed that the service
should be available to more patients. For example one patient said
that
"It should automatically be offered to other patients."
192
Summary of the results from the pilot intervention study
The intervention study
A total sample of 17 patients were randomised to either an intervention
group (n= 10) or a "control" group (n= 7). Patients in both groups were
interviewed at home every eight weeks four times. The fourth and final
interview was conducted by a research assistant in order to introduce a
measure of independence to the study.
The sizes of the samples
The sample size in both groups decreased during the course of the study
due to patients dying from their disease. The size of the intervention
group decreased from ten to nine, and the "control" group decreased from
seven to five during the course of the study.
Demographic differences between the two groups
There were no statistically significant differences between the two groups
in terms of age, marital status, social class, number and age of children.
Differences relating to disease and treatment variables
There were no statistically significant differences between the two groups
in terms of the time since initial diagnosis, original first-line treatment,
site of metastatic spread, and treatment for metastatic disease.
Differences relating to data from standardised questionnaires
There were no statistically significant differences between the two groups
in terms of HAD scores, RSCL scores, CARES scores, and ERSS scores at
Interviews 1-4.
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Responses of patients in the intervention group to the evaluation
questionnaire
The majority of patients in the intervention group were satisfied with the
service provided by the rehabilitation co-ordinator. The results suggest
that patients received enough visits, advice and practical help on all their
problems, the practical assistance they received was very helpful and the
length of time taken to provide information or help was just right. The
majority of patients said that the visits by the rehabilitation co-ordinator
made their life better. The qualitative responses to the open questions
suggested patients found the aspects of the service they were most satisfied
with related to the ability to talk openly and confide with someone, the
regularity of the visits and the phone-calls, and being able to get
immediate advice. Patients said that they did not know what to expect
from taking part in the study but, if it was offered to other patients in the
future, it should be offered automatically, some of the questionnaires






Breast cancer is the most common type of cancer in women. Each year in
the U.K. 26,000 women are newly diagnosed with breast cancer and nearly
16,000 die from it [Cancer Research Campaign, 1991]. In recent years there
has been increasing interest in the psychological impact of breast cancer
and its treatment on women. However, few systematic studies have been
carried out describing the rehabilitation needs of these women. Studies
monitoring the psychological impact and rehabilitation needs of women
with breast cancer have predominantly focused on those women with
primary breast cancer: few studies have been carried out monitoring the
needs of women with metastatic disease. The studies presented here have
described the rehabilitation needs and undertaken a small pilot
intervention study to test out a method of resolving the rehabilitation
needs in a sample of women with metastatic breast cancer.
This Chapter discusses the results of the descriptive study and pilot
intervention study in terms of: the hypotheses tested; previous research
studies monitoring rehabilitation needs and psychosocial sequelae of
breast cancer and its treatment. The limitations of the main study and
pilot intervention study are addressed and recommendations for further
study are discussed.
The hypotheses tested in the descriptive study: accepted or rejected?
(1) Patients have rehabilitation needs throughout the course of
their metastatic disease:
The results of the descriptive component demonstrate that patients
have rehabilitation needs throughout the course of their metastatic
disease, therefore Hypothesis One is accepted.
(2) Rehabilitation needs are not detected in the majority of patients
with metastatic breast cancer:
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The results of the descriptive study support this hypothesis, given
the low levels of medical professional contact seen throughout data
collection of the main descriptive study. Hypothesis Two is
therefore confirmed.
Demographic factors (such as age, marital status, social class) are
associated with rehabilitation needs:
No significant associations were found between rehabilitation
status as measured by the CARES global score and the ERSS total
score and the following demographic details: age, marital status and
social class. However, the multiple stepwise regression analysis
demonstrated that age did contribute to rehabilitation needs, when
analysed in the context of mood status: younger patients with
higher HAD scores, demonstrated higher CARES global scores.
Hypothesis Three therefore is rejected in terms of marital status
and social class, and acceptedin terms of age.
There is correlation between physical symptomatology and
anxiety and depression in patients:
Strong associations were found between physical symptomatology
and anxiety and depression in patients. Hypothesis Four is therefore
accepted.
Rehabilitation needs _ . change during the metastatic phase of
breast cancer. The mean CARES-SF global scores and mean ERSS
total scores do not change significantly across the eight interviews.
Therefore Hypothesis Five is < rejected.
There are differences in rehabilitation needs of patients
receiving different treatments for their metastatic disease:
No associations were found between treatment variables and
rehabilitation needs. Hypothesis Six is therefore rejected.
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The hypotheses tested in the pilot intervention study: accepted or
rejected?
(7) Patients have rehabilitation needs throughout the course of
their metastatic disease:
The results of the pilot intervention component demonstrate that
patients have rehabilitation needs throughout the course of their
metastatic disease. Hypothesis Seven is therefore ; accepted.
(8) A rehabilitation co-ordinator does improve significantly the
detection of rehabilitation needs:
There were no significant differences in terms of medical
professional contact between the two groups. Hypothesis Eight is
therefore rejected.
(9) A rehabilitation co-ordinator does improve significantly
referral for treatment of rehabilitation needs:
There were no significant differences in terms of medical
professional contact between the two group. Hypothesis Nine is
therefore rejected.
(10) Patients perceived the services of a rehabilitation co-ordinator to be
of > benefit during their metastatic disease:
Patients reported the services of the rehabilitation co-ordinator to be
of value to them in many respects. Hypothesis Ten is therefore
accepted.
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Discussion of the Results of the Descriptive Study in the Context of
Previous Research Studies
Rehabilitation needs
Results from the current study show that change in patients' mean
CARES-SF global score, medical interaction and marital subscale scores did
not change significantly across the eight interviews. However, patients
mean physical, psychosocial and sexual subscale score did change
significantly across the eight interviews.
In a study by Schag et al [1991] monitoring rehabilitation needs in a sample
of primary breast cancer patients using the CARES-SF on three different
occasions (one, seven and thirteen months after diagnosis of primary
breast cancer) the global CARES-SF score decreased significantly between
the first interview and the third interview. This result complied with the
prediction of Schag et al that the rehabilitation needs of newly diagnosed
breast cancer patients with localised disease would show a decline over the
course of the first year after primary surgery. In examining the subscale
scores of the CARES-SF, Schag et al found that the mean physical and
psychosocial subscale scores showed significant change between all
interview points. No mention was made by the authors of the sexual
subscale, however, the marital subscale score on the CARES-SF did not
show improvement until 13 months after surgery (the final interview).
Similar findings were found by Wingate et al [1989] monitoring the
rehabilitation needs of a group of women following mastectomy for
primary breast cancer.
The findings of the study by Schag et al and Wingate et al. and the present
study markedly differ. It is interesting to compare the mean scores at the
last interview in the present study and the study by Schag et al The mean
CARES-SF global score in the present study was 0.80 and the mean
CARES-SF global score in the study by Schag et al was 0.40. This would
suggest that the patients in the present study had greater rehabilitation
needs than patients with primary breast cancer. This finding is not
surprising. More research is needed, however, to monitor patients with
metastatic breast cancer in order to understand what is the "normal" level
of functioning in this population over time.
198
Given the overlap between the definitions of "quality of life" and
"rehabilitation", comparisons can be made between the findings of quality
of life studies and the present study. Similar to the findings of Schag et al
[1991], quality of life studies comparing the effect of radical and conserving
surgery have found that quality of life improved and the suffering from
psychological and physical complaints decreased with time in both groups
of patients [de Haes et aL 1986; Schain et ai 1983].
Comparisons of the findings of the present study with the findings of
studies monitoring the psychosocial sequelae of diagnosis and treatment
of breast cancer or quality of life studies are made difficult due to the fact
that many research studies concentrate on a single point in time, often not
specified and often not linked to disease-related variables [Freidenbergs,
1981-1982]. These studies predominantly focus on the impact of the disease
and its treatment on mood. In addition, they focus on the impact of
primary disease and its treatment.
The paucity of literature specifically monitoring the rehabilitation needs of
patients with advanced cancer makes comparison of the results of the
present study difficult. The same problem exists in interpreting the
patients' ERSS scores in the present study. The authors of the ERSS
validated its use in non-cancer populations. However, in order to
understand the ERSS scores in terms of dysfunction, the authors suggest
multiplying the ERSS total score by 3.57 [Affleck et al. 1988]. The mean
percentage dysfunction for the patients in the main descriptive study
would range from a minimum of 21 per cent to 34 per cent. This does give
meaning to the mean ERSS total score and in fact suggests that, on
average, patient's level of dysfunction was not severe. Those patients who
died during the course of the study demonstrated a higher mean
percentage dysfunction at the last interview before death (36 per cent). This
result is not surprising given the high levels of symptoms patients were
experiencing. This finding is consistent with quality of life studies of
terminally ill cancer patients. In a study by Morris and Sherwood [1987]
patients tended to undergo serious reductions in life quality prior to the
last twelve weeks of life: "cancer patients experience a major loss of
quality of life at a period prior to the last 12 weeks of life, followed by
another major loss during the last few weeks of life" [Morris and
Sherwood, 1987]. This finding of decreased quality of life in most areas of
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function during the last few weeks of life was irrespective of where the
patient was: at home or an in-patient at hospital or hospice.
The mean subscale scores of the ERSS demonstrated that the "effect of
symptoms" subscale consistently was higher than the other mean subscale
scores on the ERSS. The mean "isolation" subscale score was consistently
the lowest throughout the course of the eight interviews. In attempting to
interpret these results the higher mean score obtained on the "effect of
symptoms on lifestyle" may be due to the side-effects of treatment. Despite
the majority of patients receiving hormone therapy as treatment for their
metastatic disease, a considerable number of patients were receiving
chemotherapy. The side effects of chemotherapy, such as alopecia, nausea,
vomiting, and lethargy are often referred to in the literature. The effect of
these side effects on the patient's lifestyle can be profound.
In attempting to interpret the consistently lower mean scores on the
"isolation" subscale of the ERSS (which is a social behavioural subscale for
involvement in roles and relationships), reference can be made to recent
studies monitoring social support of patients with cancer. Cobb [1976]
defined social support as information leading individuals to believe they
are cared for and loved, esteemed and valued, and belong to a network of
communication and mutual obligation. Most researchers agree that social
support is a multidimensional construct comprising of informational
support (provision of knowledge), tangible support (specific activities
which are perceived to be helpful to the individual) and emotional
support (someone with whom the individual can confide and share)
[Bloom, 1986]. Marital status has frequently been used as an indirect
measure of emotional support [Bloom, 1986]. In the present study the
majority of patients were married and had children who were on average
older than eighteen years of age. It would seem likely, therefore, that
patient's close family members "rallied round" when the patient was
diagnosed with metastatic disease and therefore the mean score on the
"isolation" subscale of the ERSS was low (i.e. adequate involvement in
roles and relationships) throughout the study. Northouse [1988] examined
the role of social support and mood in patients and their husbands
following the wife's mastectomy. Both the patients and their husbands
who reported higher levels of social support reported fewer adjustment
difficulties immediately after surgery and one month later. There is
consistent evidence linking social support with better psychosocial
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adjustment to primary breast cancer and its treatment [Woods and Earp,
1978; Bloom et al. 1978; Vachon, 1986]. However such an association has
not been described in the area of patients with metastatic breast cancer.
Mood
There was no statistically significant difference in terms of patients mean
HAD anxiety and depression scores across the eight interviews. Previous
studies of patients with cancer have reported increased distress over time.
For example, a longitudinal study by Ell et al [1988; 1989] studied patients
with cancer over a two year period. Results demonstrated a pattern of
increasing distress over a time. However, another study by Hughes [1985]
of patients with lung cancer found that patients mean depression scores
decreased over time.
In the present study, comparisons of the mean HAD anxiety and
depression scores or the two "sub-groups" (the patients who died during
the course of the study and those patients who survived throughout the
course of the study) did demonstrate a significant difference. Those
patients who died during the course of the study demonstrated
significantly higher levels of anxiety and/ or depression at the last
interview before death compared with those patients who survived. This
finding perhaps can explain the opposing results obtained by Hughes [1985]
and Ell et al [1988; 1989]: those patients who are dying from their disease
demonstrated higher levels of distress.
The findings in the current study comparing the mean HAD anxiety and
depression scores in the patients who died during the course of the illness
and those who survived are consistent with the findings of previous
studies by Morris et al [1986] and Morris and Sherwood [1987]. Morris
stated that "most distressed conditions predominate for only a short time"
before death with a sudden decline in quality of life when death is
imminent [Morris et al. 1986].
Using the cut-off scores suggested by the authors [Zigmond and Snaith,
1983] the HAD scores can also be used to indicate case levels for anxiety
and depression. The data from the main descriptive study suggested that a
relatively large proportion of patients scored in the case range for either
anxiety and depression at diagnosis of metastatic breast cancer. However,
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over the course of the eight interviews the proportion of patients scoring
in the case range decreased. One possible explanation of this finding is that
patients were very distressed at diagnosis of metastatic breast cancer but
with time passing "adapted" to their diagnosis: at diagnosis patients felt
"helpless" and "hopeless", but over time " hope" was restored. Several
studies have invoked the concept of "coping" to explain the adjustment of
patients to cancer [Weisman and Worden 1976-1977; Lloyd et al. 1984; Ell et
al, 1989]. Many theoretical models have been described to explain the
coping and adjustment reactions to a diagnosis of cancer. Folkman [1984]
and Folkman and Lazarus [1980] have described a model of coping in
which the patient makes cognitive appraisals of the "threat" of the disease.
In the context of diagnosis of metastatic disease the patient would make an
appraisal based on "life threat" probably derived from fears of death,
physical suffering and deterioration. The theory would predict that this
would relate negatively to adjustment and would create a disruption to
the patient's equilibrium. This would explain the relatively large
proportion of patients scoring in the case range for anxiety and depression
on the HAD at diagnosis of metastatic breast cancer. However, following
this initial period, secondary appraisal would occur when the patient
evaluates their coping resources. This perceived control would then cause
levels of anxiety and depression to decrease over time. Despite the mean
anxiety and depression scores in the present study demonstrating no
significant change over time, the number of patients scoring in the case
range for anxiety and depression on the HAD does decrease over time. The
perceived control of the situation has been described by Taylor et al [1983]
as "mastery over the situation" which in turn leads to a state of reduced
distress and increased coping.
A further finding of the current study in terms of mood concerned those
patients at the last interview before death: approximately two out of three
patients scored in the case range for anxiety and one in two patients scored
in the case range for depression. This is an high proportion of patients. At
this final interview, patients were experiencing high levels of physical
symptomatology and as a result perhaps realised the severity of their
situation. In fact research carried out in patients at a similar stage of their
illness has described this period as representing "nearness to death"
[Cassileth et al 1985].
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Raised levels of anxiety and/ or depression have been noted by numerous
researchers in cancer patients receiving palliative therapy [Hinton, 1963;
Cassileth et al, 1985]. These studies have often taken the view that
symptoms such as pain, breathlessness, weight loss and limited functional
ability contribute significantly to psychological distress. One could put
forward the view that the high levels of distress are a reflection of the
perceived loss of control over their life situation. Using the model of
coping suggested by Lazarus [1980] and Folkman and Lazarus [1980], one
might conclude that patients at this stage in their illness are making an
appraisal of the "life threat" facing them, and that if their appraisal is
accurate, one would predict a negative effect on adjustment, resulting in
high levels of psychological distress. Hence, there is a complex interaction
between physical symptoms and negative cognitive appraisal. The
multiple stepwise regression analysis from the present study suggests a
complex inter-relationship between rehabilitation status, mood and
symptomatology. Therefore, attempts to rehabilitate patients with
metastatic breast cancer should embrace all these elements in order to be
effective.
Few studies have been conducted examining distress in patients with
metastatic breast cancer. A recent study by Hopwood et al [1991] examined
patients with advanced cancer of the breast (n=122) and she found that 27
per cent of the sample scored in the case range on the HAD on either the
anxiety subscale, the depression subscale or both. A further 18 per cent
scored in the borderline range on either the anxiety subscale or depression
subscale. It is, however, difficult to compare the findings of the study by
Hopwood et al [1991] with the present study. Hopwood et al interviewed
patients with "advanced breast cancer" but no details are given regarding
the length of time since diagnosis of advanced disease. In addition, the
definition of "advanced disease" is unclear because the disease could be
locally advanced with no distant metastases. Hence, the apparently
homogeneous group of patients could indeed be composed of patients at
different stages of the disease process. However, an interesting finding of
this study was that 13 per cent of patients who scored in the case range on
the HAD who were interviewed on a second occasion 1-3 months later,
were persistently anxious or depressed. This result is similar to the
proportion of patients in the present study who scored in the case range
for anxiety and or depression on the HAD at the eighth interview
(approximately 17 per cent for anxiety and depression).
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Hopwood et al [1991] concluded that "affective disorder may occur in up to
one in four patients with advanced cancer of the breast, and be persistent
in one third of these". In contrast, the present study suggests that affective
disorder may occur in up to one in three patients with metastatic breast
cancer and be persistent in a quarter of these.
The results of the present study are comparable to a number of other
studies in which self-assessment methods were used. Craig and Abeloff
[1974] using a well-known scale (the Symptom Checklist-90) with 30 cancer
patients reported depression in 50 per cent and elevated anxiety in 30 per
cent. Farber et al [1982] using the same scale found that 40 per cent of
cancer patients scored in the "depressed range". The findings of the
present study lie within the range of psychological morbidity found by
other researchers working in this area, although others have not restricted
themselves to a homogeneous sample of cancer patients and have used
small numbers which may explain the variability of the results.
The relationship of mood and rehabilitation status
A strong association was found between mood and rehabilitation status in
the present study. This finding is not surprising given rehabilitation status
embodies psychological function in its definition.
Previous studies have investigated the association between mood and
physical function in the early period (up to six months after diagnosis of
primary disease). Goldberg et al [1984] found that there a was strong
association between depression and the Karnofsky Performance Status at
six months after diagnosis of cancer. However, no association had been
found at previous interviews at two and four months after diagnosis.
Hughes found that there was a highly significant association between the
Karnofsky Performance Status and depression, and between the presence
of hypercalcaemia at the time of diagnosis. A study by Cella et al [1987]
investigated the relationship between a general concept of psychological
distress, extent of disease and performance status in a large sample of
patients with lung cancer. The study found that there was a statistically
significant association between the extent of physical impairment and
mood disturbance. There was also an interactive effect with the extent of
disease so that the increase in mood disturbance seen in patients who
have a more impaired physical status is more pronounced for patients
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with extensive disease [Cella et al. 1987]. However, more studies are
needed to describe fully the relationship of mood and rehabilitation status
in patients with advanced disease.
Symptomatology
Over the course of the eight interviews patients mean RSCL demonstrated
significant change in psychological and gastro-intestinal symptoms. The
difference was apparent between interviews one and five for gastro¬
intestinal symptoms (symptomatology being greater at interview five). A
possible explanation for this finding is that a number of patients had not
commenced treatment at the first interview, but by the fifth interview
were experiencing the side-effects of treatment (particularly those patients
receiving chemotherapy). Despite the difference in the mean scores of the
psychological symptoms being significant, no one pair of interviews could
account for the difference.
Other studies using the RSCL have been conducted by de Haes [1987] in
patients receiving chemotherapy for ovarian cancer and they were
interviewed on one occasion. Comparisons therefore of trends between
the present study and the study by de Haes et al are impossible. However,
patients in the study by de Haes et al who were receiving chemotherapy
experienced tiredness, lack of appetite, worrying, feeling depressed,
nervousness, nausea, feeling tense, heartburn, loss of hair and
constipation. These symptoms fall almost entirely into the categories of
psychological or gastro-intestinal symptoms (with the exception of
tiredness and loss of hair). These findings are similar to the symptoms in
the present study who were receiving chemotherapy.
Contribution of symptomatology to rehabilitation status
In the present study a strong association was found between
symptomatology as measured by the RSCL and rehabilitation status as
measured by the CARES and the ERSS.
Other studies have been conducted monitoring the association between
symptomatology and psychological status. The definition of rehabilitation
encompasses psychological function and therefore the findings of these
studies are relevant. Studies have reported a significant association
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between physical symptoms and psychological distress in patients with
cancer [McCorkle and Quint-Benoliel, 1983; Hughes, 1985; Bukberg et al.
1984; Cella et al. 1987], Symptomatology, such as pain, breathlessness,
weight loss and fatigue which could be regarded as an aspect of physical
disability, has been found to raise the prevalence of depression. Hinton
[1963], for example, found that 40 per cent of terminally ill cancer patients
with pronounced symptoms were depressed in contrast to 20 per cent of
patients where symptoms were not a feature. However, other studies have
failed to demonstrate such an association [Taylor et al, 1985; Cassileth et al,
1984]. The discrepancies in these findings may be due to the studies
monitoring the distress and symptomatology in patients with different
types of cancer, or the studies adopted different methodologies or
assessment tools.
Detection of rehabilitation needs
In the present study, detection of rehabilitation needs was monitored by
the contact patients had with members of the multidisciplinary team. It is
clear from the low percentage of patients at each interview who had seen
various members of the rehabilitation team that "detection" of problems
was poor. This was particularly the case with the "para-medical"
professionals (clinical psychologist, physiotherapist, social worker and
occupational therapist). The reasons for this can be numerous: patients
were being interviewed in their own home and the majority of patients
had only brief contact with the hospital, attending for out-patient follow-
up clinic appointments or attending for chemotherapy or radiotherapy.
Patients were only admitted to hospital as an in-patient when there was a
perceived medical "crisis" requiring immediate hospitalisation for
treatment purposes. This relatively short contact with hospital staff did
not therefore lend itself to the detection and, hence, referral to a member
of the multidisciplinary team. In addition, because patients were still
living in their own home, rehabilitation strategies, which are a novel idea
in the hospital-based oncology department are relatively unheard of in the
community, which rely on domiciliary physiotherapy and occupational
services, social work departments and general practitioners etc.
Irrespective of the problems relating to the detection of rehabilitation
needs in the population of metastatic breast cancer patients, education of
the members of the multidisciplinary team that rehabilitation of patients
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is not only a possibility but necessary if the true potential for patients with
cancer is to be realised.
Low detection of rehabilitation needs demonstrated in the present study is
in keeping with the findings of previous studies monitoring the detection
of rehabilitation needs and psychiatric morbidity in patients with cancer. A
major finding of a study by Lehmann et al [1978] was that the main barriers
to optimal delivery of rehabilitation care were the lack of identification of
patients problems and/ or the lack of referral to available services by
physicians unfamiliar with the concepts of rehabilitation. In addition, the
stigma of a diagnosis of cancer persists thereby forming a barrier to the
implementation of comprehensive rehabilitation and Dietz suggested
that:
"deep seated fear of cancer has, for a long time, prevented
widespread public understanding of the potential for cure or
long- term survival and rehabilitation."[Dietz, 1980, p 145]
Maguire [1984] in a study of general practitioners who had cancer patients
under their care found that they based their work on a central or false
assumption. The general practitioners assumed that any patient who
developed psychological problems serious enough to warrant help would
consult the general practitioner and request treatment. Maguire found in
this study that the general practitioners avoided asking direct questions
about how the patients were coping with their diagnosis or treatment
because they felt that they were not sufficiently up-to-date with the latest
knowledge about cancer and its treatment. Goldberg et al [1980] argued that
general practitioners failed to recognise psychiatric morbidity as a direct
consequence of such attitudes.
Maguire [1985] also found that doctors working in specialist cancer centres
who can openly talk about diagnosis, prognosis and treatment find
difficulty enquiring how the patient has been adjusting psychologically.
Maguire also found that nurses have problems in talking in any depth
with cancer patients [Maguire, 1985]. Less than one in four cancer patients
who develop psychiatric problems disclose them to anyone involved in
their care, perceiving the doctors and nurses too busy to deal with such
problems [Comaroff and Maguire, 1981]. Patients believe that if they
complain to the doctors about the worries they have about their diagnosis
and treatment, the treatment on which their lives depend may be stopped
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altogether. Therefore, patients perceived that it was safer not to disclose
their worries and concerns [Derogatis et al. 1976]. As a direct result:
"This low disclosure of problems enables doctors and nurses to
maintain the view that few cancer patients develop anxiety,
depression or sexual problems" [Maguire, 1985, p821]
However, despite the publication of such papers, the poor detection of
psychiatric morbidity and rehabilitation problems in cancer patients
remains, as highlighted in the present study. Possible solutions have been
suggested to improve detection of psychiatric problems. However,
Maguire et al [1980] have argued that it will take a considerable time to
alter the priorities of medical and nursing training and ensure that greater
attention is given to the learning of essential interviewing skills and
assess psychological impact of the illness and its treatment.
The suggestions to improve the detection of psychological problems
include training nurses or social workers to monitor patients over time
and aid detection and refer patients to an appropriate clinician [Maguire,
1985]. Others have suggested the use of self-assessment questionnaires in
the clinical setting to aid detection of mood disorders. Slevin [1992]
advocates the use of questionnaires such as the HAD or the RSCL in the
clinical setting to aid detection of psychological problems. This suggestion
has in fact been adopted by certain researchers and recently Razavi et al
[1992] demonstrated that the HAD scale was a specific, simple and
inexpensive tool which accurately detected psychiatric disorders in a
lymphoma out-patient population. The scale proved to be acceptable to
both patients and physicians in the busy clinic situation. Razavi et al
conclude that:
"Future research must seek to look for the feasibility and
validity of screening procedures in other site-specific
malignancies along with the development of more simple,
sensitive and specific methods of detection." [Razavi et al. 1992,
pl871]
Another suggestion aims at prevention of psychological problems by
offering counselling to patients with cancer. It has been found that
counselling need not be prolonged and indefinite and offering an average
of six hours is sufficient to relieve anxiety and depression, improving
fighting spirit and quality of life [Greer et al. 1992].
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In addition to the detection of psychological problems in patients with
cancer it is also important to identify physical, social and vocational
problems. The literature describes a number of techniques for detection of
these latter problems. Fayers et al [1991] describe the use of a daily diary
card which was developed by the Medical Research Council to aid the
detection of physical problems in patients undergoing treatment for lung
cancer. Liang et al 119901 devised a questionnaire to improve the detection
of psychosocial needs in cancer patients. Whilst these approaches are
currently in their infancy, further research using similar tools is required
to assess their efficacy in the area of detection of patient's rehabilitation
needs.
Pilot Intervention Study: the results discussed in the context of previous
research
The two groups of patients were well matched on a range of demographic
variables (marital status, social class, number and age of children) and
diagnostic and treatment variables (time since first diagnosis of breast
cancer, first line treatment, site of metastases, and treatment for metastatic
breast cancer).
This was a small pilot study and was mainly carried out to test out a
method of "intervention" by a rehabilitation co-ordinator. It is not
surprising that no significant differences were found in this pilot
intervention study between the two groups in respect of their
rehabilitation status, mood, symptomatology, and contact with members
of the multidisciplinary team.
Other studies which have adopted a rehabilitation co-ordinator or "case
management" approach have suggested that in order for the service to be
effective it should be implemented for at least one year [Chamberlain and
Rapp, 1991J. These findings were from studies carried out with non-cancer
populations and the application of the concept to oncology in the current
study appears to suggest that six to eight months was insufficient to
demonstrate significant differences between the two groups in terms of
rehabilitation status, symptomatology and mood. There are few outcome
studies of case management or rehabilitation co-ordinator service
provision and this is true even in areas where the concept has been
applied for considerable lengths of time. Preliminary data in the field of
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head injury does suggest, however, that it improves the detection of problems in this client group and
facilitates referral to appropriate services [McMillan etal, 1992],
The evaluation questionnaire which patients in the intervention group completed at the fourth interview
indicated satisfaction widt the service. There were no negative comments about the service provided by the
rehabilitation co-ordinator. This was an important finding and the reasons for this satisfaction could be
many. For example, the inclusion of the patient and their families in the rehabilitation goal-setting perhaps
gave them a sense of control or "autonomy" over the situation. In a study by Penman et al [1984] adaptive
or maladaptive coping strategies were identified in post-mastectomy patients. Penman and colleagues found
that women judged to be coping best after surgery used a greater range of tackling behaviours, exhibiting
active engagement with issues raised by diagnosis and surgery. In contrast, poorer copers were
characterised by greater use of avoiding and capitulating behaviours, demonstrating more evasion of
illness-related issues and a more passive, fatalistic outlook with respect to illness and treatment. In the
study by Penman, better copers were less distressed than poorer copers. In the present study this was not
demonstrated. Patient satisfaction with service provision has also been associated with die patient feeling
"included" in the medical consultation. Inclusion of the patients and their family in rehabilitation goal-
setting is in keeping with current decision-making patterns in healdi care where diere is "shared decision
making" regarding medical treatment and intervention. In recent years there has been a shift in medical
decision-making, where formerly doctors were seen as making all the decisions regarding treatment and
care, towards a more egalitarian approach: doctors and patients sharing responsibility regarding these
decisions. This has been characterised as a shift away from physician paternalism to patient autonomy
[Emanuel and Emanuel, 1992].
Anodier possible explanation for the patient's satisfaction widi die service provided by die rehabilitation co¬
ordinator relates to her "presence". This could be construed as a type of social support. Using Schaefer's
model of social support [Schaefer et al. 1981] which consists of informational, tangible and emotional
components, the rehabilitation co-ordinator could be seen to be offering elements of each of these.
Informational support refers to the provision of knowledge relevant to the patient's situation, tangible
support refers to specific support which is helpful to the patient e.g. provision of fonns for Mobility
Allowance, and emotional support is the perceived availability of a thoughtful and caring individual (i.e.
the rehabilitation co-ordinator) with whom the patient can share their iimennost dioughts and feelings. A
future research study could test tiiese elements of social support by a randomised control study where diere
are five "intervention" groups: each group is given either purely informational support, or tangible support,
or emotional support, or a combination of all diree types of social support, or, finally a control group given
no support. The patient's satisfaction with the service could dien be compared between the five different
groups.
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The Descriptive Study Evaluated
The descriptive study used a homogeneous group of cancer patients at a
specific stage of their disease and assessed them at regular intervals to
monitor their rehabilitation needs using standardised questionnaires
which had been found to be reliable and valid. This study attempted to
provide new information regarding the problems faced by women with
metastatic breast cancer. This study demonstrated that it was possible to
monitor the rehabilitation needs in this group throughout the course of
their disease. It was a valuable exercise in that it raised the profile of
rehabilitation in the field of cancer care and highlighted the plight of these
women. It was important in describing problems in the detection of
rehabilitation needs and suggests a future role for the education of health
care professionals working in this area.
A number of improvements could have been made in the design and
method of the study. The size of the sample in the descriptive study
reflected the number of patients available within the time restraints of the
study. However, more patients should have been accrued to the
descriptive study. In addition, the representativeness of the sample may
not have been adequate. All the patients were recruited in a consecutive
series at Longmore Hospital, Edinburgh which, at that time, was the
Regional Centre for the treatment of breast cancer. However, the patients
in the present study may not have represented the overall typical picture
of patients with metastatic breast cancer.
The descriptive study also made no attempt to control variables beyond
those specified. However, the results of the present study demonstrate that
two distinct groups of patients emerged: those patients who survived and
those patients who died during the course of the study, the younger
patients having more aggressive disease than those older patients who
develop metastatic breast cancer. It could be argued that a study of patients
of a specific age be selected for inclusion in a separate study. Therefore, it
would appear that despite every attempt to focus on a homogeneous
group of patients with cancer at a specific stage of the their disease, it may
not have been sufficiently specific.
The rehabilitation needs of the group of patients in the present study
could have been compared with a "control" group of patients, for example
following coronary artery bypass surgery. These patients have been shown
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to have rehabilitation needs following surgery and may have proved an
interesting comparison group.
Bloom and Ross [1982] however, defend not using other patient groups for
comparisons and advocate the definition of a clear question to be
answered in a specific group of patients with cancer. Their rationale in
supporting this argument is that such comparisons introduce a source of
bias because between-subject designs are notoriously motivated by a desire
to prove:
"that cancer patients are indeed suffering more Researchers
working with individuals in the health care system (not only
those with cancer) would do well to avoid having to
demonstrate that one group of patients is suffering more than
another" [Bloom and Ross, 1982, p260].
The choice of the standardised questionnaires in this study could have
been improved. The CARES-SF was chosen because it was the only
standardised questionnaire available, at that time, which specifically
monitored the rehabilitation needs of patients with cancer. However, the
selection of the CARES-SF was, in retrospect, a dubious choice as many
doubts have been raised by its use. The cost of this questionnaire would be
prohibitive in a larger longitudinal study. The rationale for choosing a
standardised questionnaire is usually based on the grounds that
comparisons with the findings of other studies can be made. Given the
cost of this questionnaire, it is doubtful whether it will be used in studies
in this country.
The scoring procedure of the CARES-SF, which is set out in the Manual
produced by the authors was found to be extremely time-consuming and
complicated. Slevin [1992] pointed out that "any questionnaire which is
difficult to score will not prove feasible" in a quality of life study of cancer
patients. This point is highly relevant to the present study because it is
doubtful whether the CARES-SF would be used in a longitudinal study
design where there were more than 50 patients, because the time spent
scoring the questionnaire would be prohibitive.
The questions in the sexual subscale of the CARES-SF were found by
patients in the present study to be too personal. As a result many of the
patients did not answer them and therefore when the questionnaires were
scored by the researcher, these were rated "zero" indicating that there was
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no problem in this area. This may have been misleading because, if the
wording had been less personal, patients may have been able to answer
freely giving a more accurate picture of their functioning in this subscale.
The CARES-SF was developed in the United States where there is perhaps
more willingness to discuss sexual matters. It would therefore be helpful
to British studies using the CARES to validate its use amongst a British
population. In addition, with the application of the CARES-SF in the
present study it became apparent that many of the patients did not know
how to respond to the problem statement "I find that my clothes do not
fit". Patients were asked to respond to this on a scale from "not at all" to
"very much". The use of two negatives was confusing: one in the problem
statement and another negative in the rating scale. The use of the double
negative is a fundamental mistake in questionnaire development
[Bennett and Ritchie, 1975].
The Hospital Anxiety and Depression Scale proved to be easy and quick to
use by patients in the study. In addition, the scoring system of the HAD
was very straightforward. However, it became apparent with use of the
HAD that many patients who were fatigued by physical symptoms rated
the statement "I feel as if I am slowed down" on the highest category -
"nearly all the time" indicating, according to the scoring system suggested
by the authors, the presence of depressive symptoms. This issue was raised
by Ibbotson et al [1988] but despite this observation, the HAD still produced
the best overall performance for screening for psychiatric morbidity in a
population of patients with cancer when compared to the General Health
Questionnaire and the Rotterdam Symptom Checklist, using the
Psychiatric Assessment Schedule as the "gold standard". Hopwood et al
[1991] found that the HAD was a useful screening instrument in the
detection of psychiatric morbidity but they suggested further research
would enable refinements to the cut-off scores thereby improving its
sensitivity and sensitivity.
The Rotterdam Symptom Checklist was found to be straightforward to
complete by the patients and it was easy to score. One criticism regarding
its use was interpreting the scores in terms of normative data. In terms of
using the RSCL as a screening instrument to detect psychological or
physical symptoms (gastro-intestinal, fatigue, sensory and miscellaneous
symptoms) it was difficult to recognise when patients were experiencing
abnormally high levels of symptoms as no "cut-off" scores are available.
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This has been noted by Watson et al [1992] in a recent large study using the
RSCL. They conclude that:
"many health-related QL assessment methods available for
cancer patients provide a numerical rating for specific
symptoms. Very few provide guidelines for the clinical
interpretation of scores or give any indication to the clinician of
what ought to be considered an intolerable and/ or unacceptable
side-effect. Where studies involve direct comparisons between
different arms of cancer treatment trials this may not be a crucial
issue but, for assessment of QL within normal clinical practice, it
is often not clear how clinicians can use the data to assist in their
clinical decision making and the RSCL is no exception" [Watson
et al. 1992, pp 42-43]
In addition, several different versions of the RSCL are available, each
having different numbers of items containing different questions. This
undermines the validation attempts by the authors because one is not
aware which version of the RSCL was validated. It would appear that this
scale is still undergoing development as Slevin [1992] points out that the
RSCL:
"does not adequately cover sexual or social dimensions of quality
of life and additional physical items have been proposed for use
with specific groups of cancer patients" [Slevin, 1992, p 466].
It has to be borne in mind that this type of research is still in its infancy
and further developments and refinements will be made to existing
standardised questionnaires. It is extremely important therefore to keep
abreast of these developments when designing a research study of this
nature.
It could be argued that the main study should have utilised measures of
locus of control or personality inventories because rehabilitation
encompasses the way in which the individual adapts to his/her disability.
In defence, the researcher considered using such measures during the
planning phase of the study. However, it became apparent that, given the
broad definition of rehabilitation, a multimodal approach was necessary
adopting a battery of standardised questionnaires to probe adequately each
aspect of rehabilitation. The patients in this study were to be interviewed
on a regular basis. In addition, a large number of patients were fatigued
due to their disease and/ or treatment. Therefore, every attempt had to be
made to keep the number of questionnaires to a minimum or risk patient
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compliance. As a result, the decision was made to omit measures of
personality and locus of control.
The descriptive study attempted to ascertain the detection of rehabilitation
needs in a sample of patients with metastatic breast cancer. The
operationalisation of "detection" of these problems in the present study
may be open to criticism. A connection was made between detection of a
particular problem and the contact patients had with members of the
multidisciplinary team. For example, if a patient had not been seen by a
psychiatrist or clinical psychologist, and on assessment they had scored in
the case range for either anxiety or depression on the HAD, the researcher
assumed that this problem had not been detected. At the outset of the
study, the researcher had investigated many methods of trying to ascertain
detection of rehabilitation problems. One possible method was to read the
patients medical notes at regular intervals in order to ascertain whether
referral had been made to a particular discipline. However, this was flawed
because detection of a particular problem could have been made by
another member of the multidisciplinary team and this would not have
been necessarily recorded in the medical notes. For example, a nurse at the
Out-Patient Clinic may have noted that a patient had lymphoedema, and,
without telling the patient's Consultant, had contacted the physiotherapist
and organised treatment. None of this would have been recorded in the
patient s medical notes. The chosen method was therefore, despite its
limitations, judged to be the best option available for ascertaining
detection of rehabilitation needs.
Respondent fatigue and attrition of patients from the main study was not
a problem which is surprising given the nature and stage of patient's
disease. The decrease in the number of patients at each interview was due
solely to patients dying from their disease. Further analysis was carried out
on the data from two different "sub-groups" (those who survived and
those who died during the study) affording further valuable information
on this total sample of patients.
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The Pilot Intervention Study Evaluated
This pilot intervention study attempted to test out a method of improving
the detection of rehabilitation problems through the intervention of a
rehabilitation co-ordinator interviewing patients with metastatic breast
cancer at regular intervals from diagnosis of metastatic disease. This
component adopted the same standardised questionnaires as those used in
the main descriptive study. Therefore, the criticisms levelled at these
questionnaires in the main study also apply to the pilot intervention
study.
One obvious criticism regarding the pilot intervention study applies to the
extremely small sample size in the "intervention" and "control" groups.
At the outset of the study, the intention was to recruit 20 patients:
randomising ten patients to each group. However, the time-constraints of
the study did not enable the larger quota of patients to be recruited. In
addition, even twenty patients would have been a small sample. Ideally,
there should have been a larger group of patients in both groups in the
intervention study matched in terms of demographic, diagnostic and
treatment variables.
Another criticism which is justified, is the short duration of the study:
patients being seen on four occasions over a course of six to eight months.
The decision to see patients on four occasions for this length of time was
due to the time-constraints of the study. Ideally, patients should have been
seen for at least a year to determine whether intervention by a
rehabilitation co-ordinator had any effect on the rehabilitation needs of
patients with metastatic breast cancer. Chamberlain and Rapp [1991] have
found that significant differences between intervention groups and
controls in case-management studies seem "discernible after a year but not
before".
It could be argued that there is a naive assumption underpinning the
effect of a rehabilitation co-ordinator: that intervention could "hold back
the tide" of the inevitable sequelae of advanced disease and its treatment.
This criticism however, in the author's view is unjustified. It has been
shown in the main descriptive study that patients have rehabilitation
needs (particularly psychological needs). The question remains whether
these needs could be resolved over time through intervention,
irrespective of how long the patient has to live. Research suggests for
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example that intervention does make a difference to psychological
problems [Greer et al 1992] as well as to physical problems in patients
undergoing chemotherapy for testicular cancer [Robinson, 1990].
The essentially quantitative methodology adopted in the pilot
intervention study could be criticised because it was perhaps limited in its
scope. This criticism could be justified when one looks at the results from
the evaluation questionnaire which patients in the intervention group
completed at their fourth interview. Despite the results monitoring the
rehabilitation needs not demonstrating any statistically significant
difference between the two groups of patients (which is not surprising
given the small sample), patients in the intervention group were
extremely satisfied with the service they received and perceived that the
service had improved their life. The more subjective aspects of coping
with their disease and treatment were perhaps lost in the plethora of
standardised measures monitoring rehabilitation needs. Therefore, the
methodology adopted in this pilot intervention study could have adopted
a mixed quantitative and qualitative approach: the former tapping
variables which the researcher deemed relevant to the patient s
rehabilitation; the latter adopting a more global view of the concerns and
issues which the patient deemed relevant to her rehabilitation. The two
research paradigms, which historically have seemed diametrically
opposed, have in recent years been recognised as offering a "way forward"
when used in tandem: "both the qualitative and quantitative paradigms
have weaknesses which, to a certain extent, are compensated for by the
strengths of the others" [Steckler et al. 1992].
The timing of interviews in the intervention study was at eight weekly
intervals. A possible criticism was that this not was not sufficiently regular
to detect subtle changes in rehabilitation needs. Contact was maintained
between the interviews by telephone and enabled the researcher to keep
up-to-date with patient's medical management and problems. Although it
is not possible to state what is the optimum interval between interviews,
future research studies in this area may need to manipulate the interval
between interviews in order to assess the most sensitive period to enable
the most effective detection of changes of patient's needs.
Difficulty in acting as a rehabilitation co-ordinator both of a personal
nature (dealing with the distressing nature of patient's disease) and also of
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a professional nature (the researcher's professional background) may have
contaminated the data from the pilot intervention study. The researcher's
professional background was as a physiotherapist and therefore she may
have been more acutely aware of physical needs and therefore be biased in
her assessment, of patient's needs. Attempts were made to overcome bias
in the latter study by having a research assistant carry out the final
interview and administer the evaluation questionnaire to patients in the
intervention group. Future studies could adopt a different approach to
rehabilitation co-ordination by having a researcher administering the
questionnaires and a different person acting as the rehabilitation co¬
ordinator in order to avoid possible bias.
In addition, problems were encountered by the rehabilitation co-ordinator
in referral of patient's to the appropriate services. The underlying
assumption of rehabilitation co-ordination is that the services exist.
However, in some instances these were not found to be available. For
example, clinical psychology services were limited when this study was
being carried out. Therefore, if patients were found to have high levels of
anxiety and depression, the rehabilitation co-ordinator had to refer the
patient for psychiatric intervention and the waiting list for this was
lengthy. These types of problems can hinder the effectiveness of the
service offered by the rehabilitation co-ordinator and therefore need to be
addressed carefully in any study of this nature in the future.
Future Research Directions
The results of the two studies presented here suggest a number of avenues
for further research in this area.
The obvious development of the descriptive study into a larger study
using a longitudinal design would provide even more detailed and useful
information in this area. In addition, such a study could be used as an
attempt to replicate the current findings. Such a cross validation study
would be essential before embarking on the provision of services based on
the current findings. In tandem with this project a larger intervention
study would also need to be undertaken with women with metastatic
breast cancer and the duration of this study would need to be longer than a
year. In this way the efficacy of a rehabilitation co-ordinator could be fully
evaluated in this area of cancer care.
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The subjects in the present study were being treated in a major cancer
centre in Scotland. Future research projects in this area may give greater
insights into the impact of breast cancer and its treatment on patients if
subjects from district general hospitals were used. Researchers have for
some years speculated that the care and attention given to patients treated
in specialist cancer centres is quite different to that offered to those in the
district general hospital [MacKillop and Johnston, 1986; MacKillop et al.
1988; Mclllmurray, 1990]. This question, therefore, needs to be addressed
perhaps through the use of a multi-centre trial using both specialist cancer
centres and other hospitals.
This study has used women with metastatic breast cancer and therefore
the results are only applicable to this group. Future studies must address
the rehabilitation needs of patients who have cancer at a different site. The
range of different types of cancer is very broad, each having potentially
their own specific rehabilitation needs. For example, patients having
amputation of a limb for an osteosarcoma will have very different
rehabilitation needs to a patient undergoing extensive surgery for cancer
of the head and neck, and patients being treated for lung cancer will also
have different needs. It has been demonstrated from the findings of the
present study that the stage of the disease is important to address when
designing a study. The present study identified the needs of women with
metastatic breast cancer. Future studies need to identify the needs of men
with site-specific cancers (for example, teratoma) and also cancers which
affect both men and women (for example, lung cancer which is rapidly
increasing in women [Edinburgh Lung Cancer Group, 1987]).
Future investigations should control for the extraneous prognostic
variables that may affect adjustment, such as age, different treatments, site
of metastases, and time since diagnosis of primary breast cancer. Whilst
the present study has provided a useful initial examination of patient's
needs with metastatic breast cancer, greater control of the variables would
give even more insight.
The present study focused on the rehabilitation needs of the patient.
Future studies in this area should include an investigation into the role of
the family in rehabilitation of the patient with cancer. Cancer presents,
afterall, a dilemma for both the patient and their family and has, in fact,
been referred to as "a family disease" with immediate impact of family
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functioning, roles, relationships and employment [Cassileth and
Hamilton, 1979]. A number of researchers have concluded that the family
is important in this area and have noted the dearth of studies including
them. As Naysmith et al conclude [1983] "there is surprising little data
regarding family interactions while an adult member of the family deals
with cancer" (p26). This would be in line with current views that the
patient and their family are involved in the goal setting process in
rehabilitation [Dudas and Carlson, 1988].
A further research avenue related to the impact of cancer on the family
would be to investigate the role of the family in the rehabilitation of the
patient with cancer. Such an approach would help the family members as
a common finding in the research literature is that families feel impotent
and helpless in the patients care [Vachon et al. 1977]. In this latter study for
example the carers of cancer patients were compared with the carers of
patients with cardiac problems. The carers of the cancer patients felt that
there was little they could do to help the cancer patient and as a result
experienced significant feelings of anxiety and depression. The carers of
cardiac patients, however, felt that they had an essential role to play in
providing aid to the patient. This aid was focused on encouraging the
patient to make lifestyle changes (diet and taking physical exercise) that
they felt would be beneficial to the patients health. These carers were, as a
result, significantly less anxious and depressed than those caring for
patients with cancer and also they had a greater sense of well being.
Helping the carer, therefore, to have a role in the rehabilitation of cancer
patients may have a beneficial effect on the carer and as a result merit
further investigation.
The results of the present study demonstrated that the detection of
rehabilitation problems was poor in the sample of patients. Future
research needs to be carried out to test out what can be done to improve
the detection of these problems. The problem of detection and methods of
improving rates of detection has to do with two areas: that of educating
members of the multidisciplinary team what rehabilitation has to offer
these patients; and secondly to train members of the team to detect these
problems. The former area has links with recent methods of educating
general practitioners in palliative care where distance-learning packages
have been used to facilitate education in this important area. Similar
methods could be employed to educate members of the multidisciplinary
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team to improve their knowledge base in cancer care. Such education in
rehabilitation oncology would enable these practitioners to focus on the
potential available to the patient rather than being pre-occupied with "the
cancer" thereby "fostering a positive attitude" to patients with cancer
[Watson, 1986]. Training members of the team to detect rehabilitation
problems would also facilitate the detection of these problems. Using a
similar model to that adopted by Wilkinson et al [1988] a specific member
of the team could be trained in the relevant skills, then given the task of
monitoring cancer patients over time. Using a randomised controlled
trial, the detection rates of rehabilitation problems could be compared to
see whether it was effective.
The prevention of rehabilitation problems, in particular the psychosocial
problems, also needs to be addressed in future studies. For example, a
randomised controlled trial could be carried out whereby patients in the
"intervention" arm of the trial were seen on a regular basis in a group for
relaxation and gentle exercise, and seen individually for counselling.
These patients would be assessed regularly using standardised
questionnaires to measure their rehabilitation needs and levels of
psychological and physical symptoms. The results would be compared to
those from the control group who had received no intervention. A
similar approach has been found to be successful in patients following
coronary artery bypass surgery in reducing levels of anxiety and depression
and rehabilitation needs [O'Rourke et al. 1991]. In addition, "bibliotherapy"
techniques could be used in this group of patients whereby patients are
given a self-help manual to help them come to terms with their specific
disease and its treatment and suggesting positive methods of overcoming
any problems. Self-help booklets are widely available for patients with
cancer. However, they are usually focused on primary disease and its
treatment, and give very general advice on diet etc. A highly specific
manual could extend the self-help approach to encompass all the elements
of comprehensive rehabilitation. A similar manual has been developed
for patients following myocardial infarction and results demonstrated that
patients who had had acute myocardial infarction were psychologically
less distressed at one year, had significantly less contact with their general
practitioners, and significantly fewer were readmitted to hospital in the
first six months [Lewin et al. 1992].
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Future research in this area will also need to address certain organisational
issues in the composition of the research team. Both studies utilised one
person to design the study, collect the data and implement the
intervention (with the exception of the final interview in the pilot
intervention study which was carried out be a research assistant). Over the
course of the study this proved to be extremely stressful for that person for
a number of reasons. The setting up of the study required the researcher to
liaise with a number of different hospital oncology departments with
which she was not affiliated. This required a range of negotiating skills as
she was viewed with suspicion by these departments and as a result had to
gain acceptance by them. Secondly, working with women who had a
disease such as metastatic breast cancer imposed a range of stresses and
strains. The work was intrinsically linked with suffering as a result of the
illness and its treatment and, as was demonstrated in the results, dealing
with death became a major issue for the researcher. Finally, the study
necessitated a large amount of travelling because the interviews were
conducted at the patient's homes which were scattered throughout south¬
eastern Scotland and this imposed a quite different series of stresses.
Future research, therefore, will need to make appropriate arrangements
for providing support to the researcher/researchers working in this area.
In addition, the composition of the research team would need to be
carefully considered. In the present study, the researcher was female and
was working with female patients. The compliance may have been
completely different if the researcher in the present study had been male
or if in future studies the patient group were to be male, with a female
researcher. The areas of the research study that may have suffered
particularly, would have been those areas related to sexual functioning as
this was found to be a very sensitive area for the women who took part in
the current study. In future research studies in this area therefore, careful
consideration would need to given to these points.
Future research in this area should aim at a greater understanding of the
rehabilitation needs and the role of rehabilitation in cancer care. Emphasis
must be focused on ways of improving the detection of these needs,
facilitating referral to rehabilitation services, thereby restoring patient's to
their optimum level of physical, psychological and social function. As
Morris and Sherwood argue, the aim of research in this area should be:
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'To increase the success of palliative effort and to decrease
dependency, more research and dissemination of knowledge is
needed. In particular, we need more data on the ability of clinical
interventions to effect quality of life outcomes positively both in
the last weeks of life and throughout the treatment process."
[Morris and Sherwood, 1987, p552]
Similarly Fallowfield and Clark [1991] make a plea for a greater
understanding of the wide ranging effects of breast cancer, they conclude
that: X
"Meanwhile there is much to be done to help relieve the
psychological distress and dysfunction produced by the diagnosis
and treatment [of breast cancer]. The experiences of women
unfortunate enough to have breast cancer show that there
is little room for complacency. Many women display quite
extraordinary fortitude and courage during the course of their
disease; others find that the disease exposes the limitations of
their coping repertoires. We could all do very much more to
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I write with reference to your recently submitted application to the Ethics
of Medical Research Sub-Committee for Medicine and Clinical Oncology entitled
"The assessment of need for rehabilitation in patients with metastatic breast
cancer".
I now write to inform you that this application was given ethical approval at






Illness not only causes symptoms but often affects other aspects of people's
lives e.g. families, work, independence etc.
I am a researcher undertaking a project to explore the varied physical,
psychological and social needs of patients. It is hoped that this study will
contribute towards improving patient's care.
If you are in agreement, I would come and see you every eight weeks and ask you
to tell me a bit more about yourself as well as the effects of your illness and
its treatment. In addition to this, I will ask you to complete several simple
short questionnaires concerning how you are feeling. The initial interview
would occur at the Longmore Hospital. However, if you give permission,
subsequent interviews would most likely take place at your home.
You are under no obligation to take part in this study and you can of course
withdraw at at any time. If you do agree to take part we would like you to fill
in our questionnaires only for as long as you feel able to.
The information you give will be treated in strictest confidence and will not
affect treatment in any way. If I feel that you are expressing worries which
may be helped by medical care, I may wish to discuss this with your own doctor.
This would only be done however after consultation with you. The information
given will be analysed anonymously along with that from other people who have





I, (name) agree to participate in this study. The
nature and purpose of the study have been explained to me by Colette Fulton and
are acceptable to me.
I understand that I am entering this research of my own free will and am free
to withdraw at any time, without necessarily giving any reason. In addition, my
participation or non-participation in this project will in no way affect the






Physical illness not only causes symptoms but often affects other aspects of
people's lives e.g. their interests, their families or their work. For this
reason we are asking patients to tell us a bit more than usual about
themselves to help us put research on the effects of illness and treatment
into the context of people's lives as a whole.
Biographical Data
1. Age
2. Marital Status: M/Cohab Sep/Div Wid Single
3. Do you have any children? No Yes
4. If "yes", how many? 12 3 4
5. What age is the youngest? 0-5 yrs 6-10 yrs ll-18yrs Older
6. How many children are still living at home?
12 3
7. Do you live on your own? No Yes
8.1 would now like to ask you some questions about your work.
What is your occupation
(If Mar/ Cohab) what is your spouse's occupation
249
II Health and illness
9. Until this illness, how has your health been over the years?
Good Fair Poor
10. How long ago were you diagnosed as having cancer of the
breast?
Within past six months
Within past year
Between one and five years
More than five years ago
11. What treatment did you have when you were first diagnosed?
Surgery
Surgery and chemotherapy












13. Who have you seen in the last month of the following: (give
details e.g. how often and for what reason)
a/ General Practitioner
b/ Hospital Doctor





h/ Psychiatrist/ Clinical Psychologist
i/ Other (please specify)
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From patient's medical notes
Diagnosis: TNM status:
Date of initial diagnosis:
Initial Treatment: Surgery Chemo XRT Comb
Metastatic Involvement:
Date of diagnosis of metastasis:
Current Treatment: Surgery Chemo XRT Comb
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Follow-up Interview







2. Have you been to the hospital since I saw you last?
yes no
3. If "yes" what was the reason for the visit?
Chemo Clinic Injection In-patient Other
253
4. Who have you seen in the last month of the following: (give
details e.g. how often and for what reason)
a/ General Practitioner
b/ Hospital Doctor





h/ Psychiatrist/ Clinical Psychologist




Correlation matrix of variables from interviews 1,4 and 8.
Correlation matrix
Aae No.child Soc .Class Anx 1 Deo 1 3hvs 1 "ledint 1 Sex 1
Age 1
No .child -.315 1
Soc.Class -.421 -.133 1
Anx 1 -.118 -.225 .139 1
Dep 1 .02 -.191 -.1 1 .792 1
Phys 1 .144 -.302 .033 .526 .703 1
Medint 1 .02 .053 .0 1 4 .132 .37 .732 1
Sex 1 -.398 .293 .297 .037 -.059 .029 .103 1
Global I -.232 .0 1 1 .053 .519 .504 .463 .404 .441
Gil -.053 -.06 -.023 .344 .464 .376 .204 .133
Sens I -.188 .094 .165 .098 -.161 -.219 -.105 .349
Fat 1 -.254 .153 .109 .164 .407 .453 .446 cn
Symp 1 .014 -.094 .131 .232 .359 .341 .3 19 .402
ERSS1 137 -.22 -.02 .448 .667 .856 .769 -.008
Psycho I -.133 -.056 .151 .508 .57 .653 .584 .122
Psyl . 165 -.40 1 .023 .71 1 .744 751 .244 .02
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Correlation matrix of variables from interviews 1,4 and 3.
Correlation matrix
Age No child Soc.CIasa Anx 1 Deo 1 Phvs 1 Medint 1 Sex 1
Anx4 -.181 -.187 .157 .845 .791 .564 .18 -.081
Dep4 -.163 -.125 .069 .609 .673 .656 .335 .021
Psy4 -.305 -.093 .134 .76 1 .625 .47 . 1 49 .06 1
614 -.19 -.067 .231 .623 .498 .4o3 .266 .034
Sens4 .044 -.062 .1 19 .043 .225 .173 .249 .146
Fat4 -.341 -.176 .29 .507 .556 .537 .324 .07
Sympt4 -.266 -.147 .277 .35 .395 .533 .40 1 .314
Phys4 -.333 -.142 .245 .451 .334 .421 .286 .035
Psycho4 -.24 -.089 .042 .668 .648 .649 .438 .057
Medint4 -.105 .113 0 .326 .341 .173 .21 1 -.286
5ex4 -.287 .024 .06 .071 .083 .367 .272 .483
Global4 -.31-3 -.135 .099 566 .533 .572 .353 .137
EP.S34 -.323 -.! 15 .101 .424 .433 .446 .192 .3 13
anx3 -.162 -.164 .104 .301 .797 .603 .203 -.095
dep3 -.225 -.1 .09 1 .603 .663 .624 .3 1 .0A9
pay3 -.32 -.066 .137 .747 .653 .501 .17 .056
Correlation matrix
Age No child So c. CI as 3 Anxl Deo I P h v g I Medio 11 Sexl
613 -.236 -.006 .225 61 1 .508 .43 .277 .044
Sens8 .07 -. 1 133 03 .253 . 19 I 227 .127
Fat3 -.323 -.195 299 522 569 .544 .3 1 3 .062
Sympt3 -.266 -.147 .277 35 395 .533 .40 1 .314
Phys8 -.353 -.118 .228 442 393 429 .292 .085
Psycho3 -.265 -.066 .053 662 .645 .644 .443 .072
Medint8 -.105 .113 0 326 .341 .173 .21 1 -.286
Sex8 -.287 .024 06 071 .083 .367 .272 .483
GlobalS -.348 -.102 .098 .56 .552 .568 .357 .142
ERS33 -.29! -.206 .0 17 .532 .592 536 .362 .239
257
Correlation matrix of variables from interviews 1,4 and 8.
Correlation matrix
Global 1 Gl 1 Sens 1 Fatl Svmo 1 ERSS 1 Psvcho1 Psvl
Global 1 1
Gil .163 1
Sens 1 .168 .297 1
Fat 1 .493 .513 .031 1
Symp 1 .471 .589 .172 .632 1
ERSS 1 .504 .275 -.311 .462 .42 1
Psycho 1 .532 .111 -.386 .391 .445 .776 1
Psy 1 .402 .403 -.065 .328 .409 .593 .566 1
Correlation matrix
Global 1 Gil Sens 1 Fat 1 Svmol EPSS 1 Psycho! Psvl
Anx4 .33 .424 -.131 .202 .15 .43 .487 .575
Dep4 .342 .367 -.221 .34 .031 .463 .389 .49
Psy4 .302 .357 -.125 193 .062 .33 1 .444 .413
GI4 .235 .426 -.105 .28 .233 .336 .525 .331
Sens4 .087 .396 .244 .21 .291 .078 -.026 .021
Fat4 .131 .374 -.153 .326 .076 .322 .41 .435
Sympt4 .294 5 -.003 .265 .299 .331 .39 .327
Phys4 .15 .347 -.119 . 1 1 .028 .293 .369 .195
Psycho4 .32 .46 1 -.198 .29 1 .108 .553 .56 1 .455
riedint4 -.018 329 -.109 .163 .054 .25 1 .246 . 1 42
Sex 4 .103 .208 -.091 .242 -.016 .176 .173 .086
Global4 .328 .429 -.127 .236 .096 .446 .46 .353
ERSS4 .28 .464 -.048 .219 .127 .276 .27 1 .248
anx8 .329 .424 -.179 .247 . 136 .433 .475 .539
dep8 .34 313 -.259 .337 .03 1 .449 .427 .48 1
psy 3 .312 .375 -.163 .247 .067 .346 .457 .435
258
Correlation matrix of variables from interviews 1,4 and 3.
Correlation matrix
Global 1 Gil Sens 1 Fat 1 Svmp 1 ERSS1 Psvcho1 Psv 1
GI8 .24 .397 -.144 .3 1 6 .217 .334 .548 .367
Sens3 .086 .449 .25 .23 .354 .079 -.008 .082
Fat8 .131 .405 -.149 .337 .1 14 .321 .415 .462
Sympt8 .294 .5 -.003 .265 .299 .331 .39 .327
Phys8 .151 .347 -.144 .14 .023 .293 .378 .203
PsychoS .326 .454 -.21 .302 .12 .552 .53 .449
Medint8 -.018 .329 -.109 .168 .054 .251 .246 .142
Sex8 .103 .208 -.091 .242 -.016 .176 .173 .086
GlobalS .329 .412 -.155 .263 .088 .439 .473 .353
EPS33 .509 .51 .007 .336 .327 .565 .459 .421
Correlation matrix
Anx4 Deo4 P 5 v 4 Gl 4 Sens4 Fat4 Svmo t4 Phvs4
Anx 4 1
Dep4 .763 1
Psy4 .91 .76 1
GI4 .75 .668 .732 1
3ens4 .192 .158 208 .174 1
Fat4 .744 .701 .741 .625 .32 1
Sympt4 .523 .60 1 .591 .599 .333 .579 1
Phys4 .672 .733 .755 .789 .208 .647 .738 1
Psycho4 .804 .333 .869 .779 .159 .734 .678 .806
nedint4 .333 .512 .27 1 .569 -.032 .325 .127 .393
3ex4 .214 .447 .33 1 .335 .126 .381 .534 .613
G!obal4 .763 .822 .823 .79 .177 .67 1 .779 .924
ERSS4 .652 .703 .757 .6 1 1 .391 .618 .8 15 .813
anx8 .971 .824 .863 69 .147 .758 .508 .627
dep8 .763 .981 .762 .629 .12 .71 .541 .71 1
psy8 .9 1 4 .318 984 .763 .135 .775 .534 .743
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Correlation matrix of variables from interviews 1,4 and 8.
Correlation matrix
Anx4 3eo4 Psv4 G14 3ens4 Fat4 3vmot4 Phvs4
GI8 .749 .704 .782 .99 .151 .654 .574 .782
3ens8 .222 .165 .223 .215 .991 .323 .386 .216
Fat8 .756 .7 .745 .643 .33 .998 .532 .649
3ympt8 .528 .601 .591 .599 .383 .579 1 .738
Phys8 .67 .768 .745 .779 .195 .663 .727 .994
PsychoS .803 .831 .869 .774 .154 .741 .671 .305
Hedinta .383 .512 .271 .569 -.032 .325 .127 .393
Sex8 .214 .447 .381 .335 .126 .331 .584 .613
GlobalS .764 .846 .82 .78 .166 .696 .754 .913













.907 .372 .623 1
.76 .125 .742 83 1
.797 .44 .241 .751 .635 1
.82 .491 .422 .797 .667 .823 1
.835 335 .398 .338 .758 .904 .829 1
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Correlation matrix of variables from interviews 1,4 and 3.
Correlation matrix
Psvcho4 Medint4 3 ex4 Global4 ERSS4 anx8 deo8 osv8
GI8 .789 .616 .346 .793 .603 .713 .678 .782
Sens8 .161 -.01 .106 .131 .381 .176 .125 .2
Fat8 .731 .332 .369 .67 .514 .768 .708 .779
3ympt8 .678 .127 .534 .779 .815 .508 .541 .584
Phys8 .8 12 .435 .623 .928 .808 .647 .753 .752
Psycho8 .993 .424 .49 .905 .757 .798 .828 .839
Hedint8 .425 1 -.023 .372 .125 .44 .491 .335
3ex3 .491 -.023 1 .623 .742 .241 .422 .398
GIobal8 .907 .402 .624 .994 .866 .768 .831 .849
ER3S3 .722 .121 .50! .773 .813 .608 .551 .645
Correlation matrix
GI8 5ens8 rat3 5vmot8 3hvs3 ^svchoS ledintS Sex 8
GI8 I
3ens8 . 133 1
Fat8 .67 .342 1
Sympt3 .574 .386 .532 1
Phys3 .785 .204 67 .727 1
PsychoS .79 .157 .733 .671 .815 1
Hedint8 .616 -.01 .332 .127 .435 .424 1
3ex8 .346 .106 .369 .534 .623 .49 -.023 1
GlobalS .796 .169 .594 .754 .927 .909 .402 .624










Questionnaire to evaluate intervention by
rehabilitation co-ordinator
The following questions are designed to find out how satisfied or
dissatisfied you were with the service you received from Colette
Fulton. Can you please listen to each question and answer each
appropriately.
1. First I would like to ask you about the number of visits and telephone calls
you received from Colette Fulton.




2. Did you receive information and advice from Colette on all the problems
you wanted help with?
Would you say
None of the problems?!!!
Some of the problems?!!!
All of the problems?!!!!
3. Did you receive practical help from Colette with all the problems you
wanted help with?
Would you say
None of the problems?!!!
Some of the problems?!!!
All of the problems?!!!!





5. How helpful was the practical assistance you received?
Would you say
Not at all helpful G
Helpful G
Very helpful G
6. When you were provided with information or action was taken on your




7. Taking everything into consideration, how satisfied were you with the





8. Taking everything into consideration, do you think the visits you received
made any difference to your life?
It made things worse G
It made no difference G
It made things better o
9. Please could you describe, in your own words, which aspects of the
service you were most satisfied with? (For example:- Having someone to
discuss problems with; having someone to give you advice etc.)
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10. Please could you describe, in your own words, which aspects of the
service you were least satisfied with? (For example:- the number of visits
and phone calls or amount of help you received.)
11. If we offered the service to other people in the future, do you have any
suggestions to improve it? Please describe.
Thank you so much for completing this questionnaire.
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